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• ZUSAMMENFASSUNG • 
 
    Als Apoptose, oder programmierten Zelltod, bezeichnet man einen physiologischen 
Mechanismus, der gebraucht wird, um schädliche oder beschädigte Zellen in 
kontrollierter Art und Weise zu entfernen. Dies ist ein aktiver Prozess der genetisch 
gesteuerten Selbstzerstörung, welcher eine biologisch bedeutende homöostatische 
Funktion übernimmt. Durch extensive Forschung in den letzten 15 Jahren wurden die 
wichtigsten Komponenten apoptotischer Signalkaskaden identifiziert. Es wurde ebenfalls 
aufgezeigt, dass das Phänomen der Apoptose in Metazoen evolutiv hoch konserviert ist. 
Dennoch blieben faszinierende Fragen bezüglich des programmierten Zelltodes bislang 
unbeantwortet: Warum erzeugt ein Organismus Zellen, die schlussendlich Selbstmord 
begehen? Welches sind die Auslöser, welche eine Zelle in dieses Schicksal treiben? In 
dieser Dissertation präsentiere ich meine Arbeit der letzten drei Jahre über das Studium 
der Entscheidung über Leben und Tod von Zellen in der Keimbahn des Nematoden 
Caenorhabditis elegans. 
 
    Um neue Gene zu identifizieren, welche an der Regulation von Apoptose in der 
Keimbahn beteiligt sind, klonierte ich Mutationen, welche ein erhöhtes Mass an 
Keimbahn Apoptose bewirken (Kapitel 2). Des weiteren führte ich einen reverse genomic 
screen aus (Kapitel 3). Mit dem Ansatz der so genannten genomweiten RNA-Interferenz 
(RNAi) wurden mehr als 20 Gene identifiziert, welche Keimzellen vor Apoptose zu 
schützen vermögen. Darüber hinaus wurden diese Gene mittels Epistasie-Experimenten 
in p53-abhängige, oder -unabhängige Signalwege eingeordnet Da apoptotische 
Signalkaskaden evolutiv hoch konserviert sind, besteht die Möglichkeit, dass das 
Studium dieser neuen apoptotischen Gene in C. elegans Hinweise darüber liefert, wie 
auch in Säugetieren Genomische Stabilität, p53-Aktivierung und Fertilität kontrolliert 
wird. 
 
    Das p38 MAPK Gen pmk-3 wurde im Screen identifiziert (Kapitel 4). PMK-3 fördert 
das Ueberleben von Keimzellen, und dessen Inaktivierung löst p53 unabhängige 
Apoptose aus. pmk3 wird in der Keimbahn exprimiert und dessen Aktivität ist notwendig 
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um das Ueberleben von Zellen in diesem Gewebe zu sichern. Ich liefere den genetischen 
Nachweis, dass die MAPKKK MTK-1 und die MAPKK MKK-4 als Kinasen oberhalb 
von PMK-3 in der selben Signalkaskade agieren, und dass der Transkriptionsfaktor MEF-
2 die überlebensfördernde Rolle von PMK-3 in der Keimbahn von C. elegans vermittelt. 
 
    Schliesslich führte ich einen genetischen ‘modifier screen’ aus, um Gene zu finden, 
welche in der Keimbahn Apoptose auslösen. Aufgrund des experimentellen Aufbaus des 
screens fand ich neue Allele von zuvor bekannten Genen, welche für die Apoptose 
essentiell (ced-3) und für das Entfernen von apoptotischen Zellen (ced-2 und ced-6) 
verantwortlich sind. Dieser Ansatz führte auch zur Identifizierung von zwei neuen 
Chromosomalen Loci, op385 und op387, welche die physiologische Apoptose, jedoch 
nicht DNA-damage induzierten Zelltod supprimieren. op385 und op387 konnten kleinen 
Abschnitten auf den Chromosomen V, resp. X zugeordnet werden. Obschon die 
molekulare Natur dieser Gene zur Zeit unbekannt ist, könnte deren Identifkation die der 
Apoptose in der Keimbahn zugrunde liegenden Geheimnisse lüften. 
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• SUMMARY • 
 
    Apoptosis can be defined as a physiological mechanism that removes unneeded, 
harmful, or damaged cells in a regulated manner.  It is an active process of gene-directed 
cellular self-destruction that usually serves a biologically meaningful, homeostatic 
function. Extensive research, over the last fifteen years, has identified the key 
components of apoptotic cascades, and showed that apoptosis is conserved in metazoans. 
However, there are still fascinating questions concerning apoptosis that remain largely 
unanswered: Why are some cells born to eventually commit suicide? And what are the 
cues that determine this cell fate? In this dissertation, I present the work I carried out in 
the last three years to study the life-versus-death decision of cells in the germ line of the 
nematode C. elegans. 
 
    To identify new genes that regulate germ cell apoptosis, I cloned mutations that cause 
increased levels of germline apoptosis (Chapter 2), and performed a reverse genomic 
screen (Chapter 3). By using a genome-wide RNAi approach, more than 20 genes were 
identified that protect germ cell from undergoing apoptosis. Furthermore, epistasis 
analysis placed these genes in p53-dependent or -independent pathways. Because 
apoptotic pathways are conserved, it is possible that the study of these new apoptotic 
genes in C. elegans will shed light on the mechanisms that control genomic stability, p53 
activation, and fertility in mammals. 
 
    The p38 MAPK gene pmk-3 was identified in the RNAi screen (Chapter 4). PMK-3 
promotes germ cell survival, and its inactivation causes p53-independent germ cell 
apoptosis. pmk-3 is expressed in the germ line, and its activity is required in this tissue to 
promote cell survival. I provide genetic evidences that the MAPKKK MTK-1 and the 
MAPKK MKK-4 are the kinases upstream of PMK-3, and that the transcription factor 
MEF-2 mediates PMK-3’s pro-survival role in the C. elegans germ line. 
 
    Finally, I performed a genetic modifier screen to discover genes that trigger germ cell 
apoptosis (Chapter 5). Because of the experimental setup, I recovered alleles of already 
 viii
known genes essential for apoptosis (ced-3) and corpse removal (ced-2 and ced-6). This 
approach also led to the identification of two new loci, op385 and op387, that suppress 
physiological germ cell death but not DNA damage-induced apoptosis. op385 and op387 
have been mapped to small intervals on chromosome V and X, respectively. Although the 
molecular natures of these genes are currently unknown, their identification could unravel 
the mysteries underlying C. elegans germline apoptosis.  
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• CHAPTER 1 • 
APOPTOSIS IN C. ELEGANS 
 
1.1 INTRODUCTION 
    Apoptosis, or programmed cell death, is a complex process of gene-directed cellular 
self-destruction that usually serves a biologically meaningful, homeostatic function. 
Because of its complexity, it is not surprising that biologists have turned towards simpler, 
genetically tractable systems to understand the regulation and mechanistic of apoptosis. 
Determination of the complete cell lineage of C. elegans hermaphrodites by John Sulston 
set the basis for the study of apoptosis in the worm (Figure 1.1a) (Sulston and Horvitz, 
1977; Sulston et al., 1983). It was then possible to perform genetic screens in order to 
identify genes involved in the regulation, execution, and termination of apoptosis (Figure 
1.2). By cloning and characterizing several of these genes, the laboratory of H. Robert 
Horvitz played a major role in establishing C. elegans development as an excellent 
paradigm to dissect the genetics of apoptotic cell death. More importantly, the genes 
cloned in the Horvitz laboratory were shown to have functional mammalian homologues. 
These results were the first evidences that apoptosis is conserved across distantly related 
species, and suggested that its study in worms might shed light on how and why it occurs 
in higher metazoans, including humans. 
    In this review, we summarize our current knowledge of the regulation, execution, and 
termination of apoptosis in C. elegans. Special emphasis will be placed on new findings, 
which have not been discussed elsewhere. We will also try to draw a general picture of 
apoptosis, by highlighting similarities and differences between apoptotic death in C. 
elegans and mammals. 
 
1.2 APOPTOSIS DURING C. ELEGANS EARLY DEVELOPMENT 
1.2.1 The worm core apoptotic machinery 
    Genetic screens for mutant worms with abnormal cell death identified mutations in 
four genes essential for all somatic cell deaths: ced-3, ced-4, ced-9, and egl-1 (ced, cell 
death abnormal; egl, egg laying-defective). Further genetic characterization revealed that 
ced-3, ced-4, and egl-1 are pro-apoptotic because loss-of-function (lf) mutations in any of 
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these genes block most if not all apoptotic deaths in the soma (Conradt and Horvitz, 
1998; Desai et al., 1988; Ellis and Horvitz, 1986). The first mutation identified in ced-9 
was a gain-of-function (gf) mutation that blocks apoptosis; the ced-9(lf) phenotype 
confirmed that this gene has anti-apoptotic activity because its inactivation results in 
ectopic cell deaths (Hengartner et al., 1992). Epistasis studies ordered these genes in a 
‘linear’ genetic pathway, with egl-1 upstream of ced-9, and ced-9 upstream of ced-4 and 
ced-3 (Figures 1.2 and 1.3). 
    ced-3 and ced-4 encode a caspase and an adaptor protein similar to Apaf-1, 
respectively (Xue and Horvitz, 1995; Xue et al., 1996; Yuan and Horvitz, 1992; Yuan et 
al., 1993). Similar to their mammalian homologues, CED-3 and CED-4 interact to form 
an apoptosome-like complex, and they are essential to all apoptotic cell deaths in the 
worm. The mammalian apoptosome is formed of caspase-9, Apaf-1, and the electron 
carrier cytochrome c. So far, no role has been assigned to the worm cytochrome c in 
apoptosis. In mammalian cells, mitochondrial release of cytochrome c allows quick 
response to apoptotic stimuli (e.g. genotoxic stresses). The simplicity of the worm might 
not require this further level of complexity, and it is apparent that regulation of 
transcriptional networks is sufficient to control all developmental programmed cell deaths 
in the C. elegans soma (see below).  
    The Bcl-2 family member CED-9 promotes survival of all cells in C. elegans: null 
mutations in ced-9 are lethal, and this lethality can be suppressed by mutations in either 
ced-3 or ced-4 (Hengartner and Horvitz, 1994a; Hengartner and Horvitz, 1994b). In 
somatic cells fated to die, ced-9 is inactivated by egl-1, a gene encoding a BH3-only 
domain protein (Conradt and Horvitz, 1998). egl-1 was placed upstream of ced-9 in the 
death pathway since a egl-1(lf) mutation does not suppress the lethal phenotype of ced-9 
null mutants. 
    A model, based on the interpretation of genetic, biochemical, and structural data, has 
been proposed to explain how apoptosis occurs in C. elegans (Yan et al., 2004). In most 
somatic cells, CED-9 sequesters CED-4 (and possibly CED-3) on the surface of 
mitochondria. However, in the 131 cells that normally undergo apoptosis, developmental 
cues transcriptionaly activate egl-1; EGL-1 binds to CED-9, thus disrupting the 
interaction between CED-9 and CED-4 (del Peso et al., 1998). This releases the CED-
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4/CED-3 death complex, leading to the activation of the caspase CED-3 and the initiation 
of apoptosis (Chen et al., 2000).  
 
1.2.2 Transcriptional regulation of egl-1 expression 
    In the C. elegans soma, a cell’s decision to live or die is determined by whether egl-1 
is expressed or not (Figure 1.3). Interestingly, we know really few regulators of egl-1 
transcription, and those known can only explain a small subset of the cell deaths observed 
during normal development. The two sister cells of the serotonergic NSM neurons 
undergo apoptosis in wild-type worms; these deaths depend on the worm core apoptotic 
machinery (egl-1, ced-9, ced-4, ced-3), but also two other genes: ces-1 and ces-2 (ces, 
cell death specification abnormal). Mutations that cause a gain of ces-1 function, or a loss 
of ces-2 function, promote survival of the NSM sister cells, without affecting most other 
cell deaths (Ellis and Horvitz, 1991). ces-1 and ces-2 encode a member of the Snail 
family of zinc-finger transcription factor and a basic region leucine-zipper (bZIP) 
transcription factor, respectively (Metzstein et al., 1996; Metzstein and Horvitz, 1999). 
Epistasis analysis showed that ces-2 acts upstream of ces-1: in ces-1(lf) ces-2(lf) double 
mutants, the NSM sister cells die, suggesting that ces-2 causes NSM sister cells death by 
inhibiting the cell death protective effect of ces-1. 
    Recently, elegant genetic and biochemical experiments from Conradt and co-workers 
established the molecular link between the ces genes and egl-1 transcription (Thellmann 
et al., 2003). The authors identified two new basic helix-loop-helix (bHLH) transcription 
factor genes, hlh-2 and hlh-3, which are expressed in the NSM sister cells and required 
for their death. In the NSM sister cells of wild-type animals, HLH-2/HLH-3 heterodimers 
activate egl-1 transcription by binding a regulatory sequence, called region B, in the egl-1 
promoter. Interestingly, the same study showed that CES-1 can also bind region B, 
suggesting a competition model between HLH-2/HLH-3 and CES-1 for region B of the 
egl-1 locus. According to this scenario, increased ces-1 activity, such as in ces-1(gf) or 
ces-2(lf) mutants, prevents the death of the NSM sister cells because CES-1 can 
successfully compete with HLH-2/HLH-3 for region B, and therefore block egl-1 
transcription (Figure 1.3) 
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    The fate of the hermaphrodite-specific neurons (HSNs) is also a good model to study 
cell-specific apoptotic death in C. elegans. These neurons are required for egg-laying in 
the hermaphrodite; they are useless in males and therefore normally undergo apoptosis. 
The original dominant gain-of-function mutation in egl-1 was identified because it 
specifically induces the death of the HSNs in hermaphrodites, thus giving the egg-laying 
defect (Egl) phenotype. The mutation was found to affect a binding site in the egl-1 locus 
for the transcriptional repressor TRA-1A, hence causing ectopic egl-1 expression and 
HSN death (Conradt and Horvitz, 1999). To identify positive regulators of egl-1 
expression in the HSN, Hoeppner and colleagues screened for suppressors of the Egl 
phenotype of egl-1(gf) mutant worms (Hoeppner et al., 2004). They found mutations in 
two genes, eor-1 and eor-2 (eor, egl-1 suppressor/DiO uptake defective/raf enhancer), 
that only block apoptosis in the HSNs: EOR-1 is a putative transcription factor, and 
EOR-2 is a new, but evolutionarily conserved, protein. Further characterization of the eor 
revealed that these genes are likely implicated in neuronal cell fate determination in the 
C. elegans nervous system in general, and specifically in the apoptotic cell fate of the 
male HSNs. However, it remains unclear how eor-1/eor-2 function to promote apoptosis 
in the male HSNs (Figure 1.3) 
    How many different transcriptional cascades, such as the ones described above, are 
required to explain all the 131 somatic cell deaths that occur during C. elegans 
hermaphrodite development? We still ignore the answer to this question, but it seems 
reasonable to think that cells emerging from different lineages will induce egl-1 
expression using different transcription factors. This possibility highlights the complexity 
to study the regulation of developmental apoptosis, even in simple system like the worm 
C. elegans. 
 
1.2.3 Inhibition of apoptosis: a new player 
    Contrary to the situation in flies and mammals, no inhibitor of apoptosis protein (IAP) 
has been identified so far in C. elegans. The C. elegans genome contains two genes, bir-1 
and bir-2, that encode proteins with BIR domains (BIR domains are often found in IAPs; 
they are thought to fit into the catalytic site of caspases and inactivate their protease 
activity). However, inactivation of bir-1 by RNA interference (RNAi) revealed that this 
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gene, like its mammalian homologue survivin, is involved in cytokinesis, but does not 
play any role in suppressing apoptosis in C. elegans (Fraser et al., 1999, Speliotes et al., 
2000). There is no known function for bir-2. 
    icd-1(inhibitor of cell death-1) was recently found in a screen for genes implicated in 
C. elegans early embryogenesis (Bloss et al., 2003). The authors discovered that reducing 
ICD-1 activity by RNAi results in one of two possible phenotypes: either early arrest 
during embryogenesis, or increased programmed cell death in embryos that developed 
past the first embryonic stages. Further characterization of icd-1(RNAi) animals 
demonstrated that various cell types, but especially neurons, undergo ectopic apoptosis, 
and that, importantly, icd-1 over-expression can block apoptosis. The most unexpected 
finding of the new study came when Bloss et al. performed epistasis analysis to 
determine whether the worm core apoptotic machinery is required for icd-1(RNAi)-
induced programmed cell death. They found that in older embryos and in larvae, loss of 
ced-4 function, but not loss of ced-3 function, could suppress the increased number of 
dying cells in icd-1(RNAi) animals. This result suggests that ICD-1 suppresses a CED-4-
dependent, CED-3-independent apoptotic program, thus conferring a pro-apoptotic 
function for CED-4 above its ability to activate CED-3. ICD-1 is similar to the β subunit 
of the nascent-polypeptide associated complex (NAC), which might regulates protein 
localization during translation (Rospert et al., 2002). Like βNAC, ICD-1 localizes to the 
mitochondria. 
    What triggers apoptosis in ced-3(lf); icd-1(RNAi) mutants? Unfortunately, the authors 
did not perform any experiment to answer this important question. Also, the possibility 
that ICD-1, like the human βNAC, is involved in some aspects of mitchondrial functions 
raises some concerns regarding the specificity of the icd-1(RNAi) phenotype. After all, 
CED-9 normally localizes to the mitochondrial membrane, and it is possible that the 
absence of ICD-1 at the mitochondrion interferes with CED-9’s survival function. 
Clearly, more experiments are needed to better understand the anti-apoptotic activity of 
ICD-1. 
 
1.2.4 pvl-5 protects hypodermal cells from apoptosis 
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    In wild-type hermaphrodites at the larval stage L2, there are 11 Pn.p hypodermal cells 
in the ventral midline arrayed along the anterior-posterior axis. Joshi and Eisenmann 
found that recessive mutations in the gene pvl-5 (pvl, protruding vulva) causes some of 
these hypodermal cells to undergo apoptosis; these deaths required CED-3, but 
surprinsingly not CED-4 (Joshi and Eisenmann, 2004). One possible model to explain 
this phenotype could be that pvl-5 normally suppresses transcription of ced-3 in the Pn.p 
cells, such that in the absence of pvl-5, CED-3 accumulates. Indeed, it is known that ced-
3 over-expression can bypass a requirement for ced-4 function (Shaham and Horvitz, 
1996). However, the epistasis with ced-9(gf) refutes this hypothesis: pvl-5; ced-9(gf) 
double mutants have ~11 Pn.p hypodermal cells, thus placing pvl-5 upstream of ced-9. 
Also intriguing is the fact that egl-1(lf) does not suppress the extra Pn.p deaths in pvl-5; 
this result was unexpected because it is believed that the gain-of-function mutation in 
ced-9 ‘mimics’ the egl-1(lf) mutation (del Peso et al., 1998). Molecular identification and 
characterization of pvl-5 are obviously the next logical steps to understand how this gene 
regulates the core apoptotic machinery in the C. elegans Pn.p hypodermal cells. 
 
1.3 GERM CELL APOPTOSIS IN C. ELEGANS HERMAPHRODITE 
1.3.1 Oocyte apoptosis in mammals 
    In the mammalian female ovaries, apoptosis occurs throughout fetal and postnatal life 
to claim up to 99.9% of the potential germ cells (Kim and Tilly, 2004). Although most 
germ cell deaths take place prior to birth, apoptosis continues to decimate the number of 
oocytes through a process called follicular atresia during juvenile and adult life. Once the 
supply of oocytes has been exhausted through apoptosis and ovulation, the ovaries 
senesce, leading to infertility and, in humans, to the menopause.  
    Molecular studies have found that pro- and anti-apoptotic members of the Bcl-2 family 
play major roles in regulating oocyte apoptosis in the mouse (Kim and Tilly, 2004). For 
instance, ovaries of mice knocked out for the pro-apoptotic gene bax have a marked 
accumulation of follicules (that is, oocytes enclosed in specialized somatic cells), 
whereas elimination of the anti-apoptotic genes bcl-2 or bcl-x produces mice with fewer 
oocytes. 
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    It remains unclear why so many oocytes undergo apoptosis in the mammalian female 
gonad. Three models have been proposed to explain this process (Tilly, 2001): germ cells 
die (1) due to a limited supply of growth/survival factors, (2) due to quality-control 
checkpoint pathways that eliminate ‘unhealthy’ cells, or (3) to provide nutrients for other 
developing oocytes, as it is seen with nurse cells apoptosis during Drosophila oogenesis 
(McCall, 2004). These models are certainly not exclusive, but hard to test in a complex 
organ such as the mammalian female gonad. In the next section of this review, we 
introduce the C. elegans hermaphrodite germ line as a powerful genetic model tissue to 
understand oocyte apoptosis, and other stimuli-induced apoptotic events. 
 
1.3.2 Physiological germ cell death in C. elegans 
    C. elegans hermaphrodites have two U-shaped gonads connected at a common uterus 
(Figure 1.4). At the distal end of each gonad, a growth factor produced by the somatic 
distal tip cell (DTC) promotes the mitotic proliferation of a small population of stem 
cells. In the distal arm, germ cell nuclei are not completely enclosed by membrane, and 
thus form a large syncytium. Once germ cells escape the influence of the DTC, they enter 
meiosis (transition zone) and progress into the pachytene stage of meiosis I. Upon 
activation of the RAS/MAPK pathway, germ cells exit pachytene arrest (Figure 1.4a) 
(Hubbard and Greenstein, 2000). Then, they can choose one of two possible cell fates: 
either to cellularize and develop into mature oocytes, or to undergo apoptosis (Figure 
1.1b). 
    Physiological germ cell death occurs only during oogenesis; no cell death is observed 
in male gonads or in hermaphrodite gonads that are making sperm. It increases with the 
age of the animals, claiming on average approximately 50% of the developing oocytes 
and, contrary to somatic apoptosis in worms, it is apparently stochastic (Figure 1.1b) 
(Gumienny et al., 1999). Like developmental cell death, physiological germline apoptosis 
requires CED-4 and CED-3, and is blocked by CED-9. However, it is not regulated via 
transcriptional activation of egl-1 since loss of egl-1 function does not abolish 
physiological germ cell death (Figure 1.3). We hypothesized that other genes, called 
germline apoptosis (gla) genes, form a novel regulatory pathway that controls 
physiological germ cell death, and we are currently trying to identify these gla genes 
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through genetic screens. The reason why so many apparently healthy germ cells succumb 
to apoptosis is as mysterious in C. elegans as it is in mammals. Our laboratory has 
proposed that germline apoptosis plays an homeostatic function, by eliminating excess 
germ cells that act as nurse cells to provide nutrients to maturing oocytes (Gumienny et 
al., 1999).  
    Few genes are known to specifically regulate physiological germ cell death. cgh-1 (C. 
elegans germline helicase-1) encodes a conserved DEAD-box type RNA helicase 
involved in gametogenesis in worms: cgh-1(RNAi) animals are sterile and have elevated 
level of germline apoptosis (Navarro et al., 2001). Because these germ cell deaths are not 
dependent on the DNA damage pathway (see below), it is tempting to speculate that 
CGH-1 might control physiological germ cell death through an as yet unknown 
mechanism. daz-1 (Deleted in Azoospermia-1) is another candidate gene that might play a 
regulatory role in physiological germline apoptosis in C. elegans. It encodes a RNA 
binding protein similar to the mammalian DAZ proteins, which are, in mammals, 
implicated in the production of gametes in both sexes.  Mutations in daz-1 cause sterility 
in hermaphrodites due to defects during meiosis progression, and also lead to increased 
germ cell apoptosis compared to wild-type worms (Karashima et al., 2000). The 
phenotypes of cgh-1(RNAi) and daz-1(lf) mutants suggest that physiological germ cell 
death is intrinsically linked to proper oocyte development.   
 
1.3.3 DNA damage-induced apoptosis in C. elegans 
    Germ cell apoptosis can be ectopically triggered by genotoxic treatment (e.g. γ-
irradiation, X-rays, UV, alkylating agents) (Gartner et al., 2000). Interestingly, it was 
found that these DNA damage-induced apoptotic deaths required a battery of conserved 
checkpoint genes (e.g. hus-1, rad-5, mrt-2), the worm homologue of the tumor suppressor 
gene p53, cep-1, as well as the pro-apoptotic gene egl-1 (Figure 1.3) (Ahmed et al., 2001; 
Ahmed and Hodgkin, 2000; Derry et al., 2001; Hofmann et al., 2002; Schumacher et al., 
2001). The current model proposes that upon DNA damage in germ cells, checkpoint 
components of the pathway activate CEP-1, which in turn transcriptionally induces egl-1. 
If this model holds true, it suggests that the situation in C. elegans germ cells is very 
similar to the (over-simplified) scenario that occurs in mammalian cells after DNA 
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damage, where p53 promotes transcription of the pro-apoptotic BH3-only domain protein 
genes PUMA and Noxa (Nakano and Vousden, 2001; Oda et al., 2000). Among 
interesting questions that have yet to be addressed regarding the DNA damage-induced 
germ cell apoptosis pathway in C. elegans, we need to identify the direct activators of 
CEP-1, and to determine if CEP-1 directly binds any regulatory sequences in the egl-1 
locus. 
    In humans, it is recognized that mutations in genes that control apoptotic responses 
upon DNA damage are associated with cancer development (Hanahan and Weinberg, 
2000). Interestingly, C. elegans has functional homologues of many of these genes, as 
was recently shown with the characterization of the worm counterparts of human BRCA1 
(Boulton et al., 2004) and c-Abl (Deng et al., 2004). The worm, by its simplicity and 
powerful genetics, will be a valuable model organism to study pathways implicated in the 
maintenance of genome integrity, pathways often too complex and redundant to be 
genetically dissected in higher metazoans. Furthermore, genetic screens in C. elegans 
should lead to the identification of novel and conserved genes involved in genomic 
stability and apoptotic responses. 
 
1.3.4 Innate immunity and germ cell death 
    Salmonella typhimurium kills C. elegans over the course of several days by a 
mechanism that involves the establishment of persistent infection in the worm intestine. 
Aballay and Ausubel found that mutations that block apoptosis render C. elegans hyper-
susceptible to Salmonella infections: ced-3 or ced-4 mutants die twice as fast as wild-type 
animals when fed on Salmonella. The authors also found that Salmonella infections 
trigger germ cell apoptosis in a egl-1-, ced-3-, and ced-4-dependent manner (Aballay and 
Ausubel, 2001). Furthermore, identification of other mutants hyper-sensitive to infections 
revealed that a conserved p38 MAPK pathway is required for the worm immune 
response, and Salmonella-induced germ cell death (Aballay et al., 2003; Kim et al., 
2002). In an effort to develop C. elegans as a system to study host-pathogen interactions, 
Aballay and co-workers performed a screen for Salmonella mutant strains unable to 
infect worms, and identified several Salmonella virulence factors required to elicit germ 
cell apoptosis in C. elegans (Tenor et al., 2004). It is currently unknown how these 
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virulence factors activate a p38 MAPK in worms, and how this kinase triggers the 
apoptotic cascade. Even more importantly, we still ignore how and why programmed cell 
death protects C. elegans against pathogen infections. 
 
1.3.5 Genome-wide RNAi screen for germline apoptosis genes 
      In order to identify new regulators of germ cell apoptosis, we performed a genome-
wide RNAi screen for genes that promote germ cell survival (Lettre et al., 2004). Using a 
RNAi feeding library that targets 86% of the predicted C. elegans protein-coding genes 
(Fraser et al., 2000; Kamath et al., 2003), we knocked down 16 757 genes and found 
several dozen candidates that protect germ cells from undergoing apoptosis. Further 
genetic epistasis studies revealed that most of the RNAi knockdowns identified in the 
screen required the checkpoint protein HUS-1 and the p53 homologue CEP-1 to trigger 
apoptosis. This suggests that RNAi inactivation of these genes indirectly induces 
apoptosis, through the activation of quality control checkpoint pathways. Among the 
genes that fall in the p53-dependent class, we found known genes involved in DNA 
repair and meiotic recombination (e.g. rad-50, rad-51), but also a score of novel genes. 
Characterization of these genes in C. elegans should provide several new hints 
concerning the different mechanisms that control genomic stability and p53 activation in 
mammals. 
    We also identified four genes which do not require hus-1 or cep-1 to induce apoptosis 
upon RNAi knockdown (Lettre et al., 2004). These genes − two putative RNA binding 
proteins, a p38 MAPK, and a RING finger protein − are under investigation in our 
laboratory as they are prominent candidate regulators of the physiological germ cell death 
pathway. 
 
1.4 ENGULFMENT OF APOPTOTIC CELLS IN C. ELEGANS 
1.4.1 Significance of apoptotic corpse clearance 
    In vivo, apoptotic cells are normally observed within other cells (Kerr et al., 1972; 
Wyllie et al., 1980). This process, where a motile professional eater (e.g. macrophage) or 
a static neighboring cell swallows a dying cell is termed phagocytosis or engulfment 
(Grimsley and Ravichandran, 2003; Savill and Fadok, 2000). Engulfment of apoptotic 
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cells prevents the release of cellular debris, which could result in inflammation and auto-
immunity if spilled into the surrounding environment. In its simplest form, phagocytosis 
is a two-steps process: first, the engulfing cell recognizes the dying cell; second, 
cytoskeletal rearrangements within the engulfing cell allow it to surround and eventually 
swallow the apoptotic corpse. Genetic studies of C. elegans mutants impaired in the 
removal of apoptotic cells have been instrumental in improving our understanding of the 
mechanisms that underlie phagocytosis in mammals (Reddien and Horvitz, 2004). In the 
next section, new findings in the field of apoptotic cell engulfment in worms are 
discussed. 
 
1.4.2 Genetics of engulfment in C. elegans 
    Seven genes (ced-1, -2, -5, -6, -7, -10, and -12) functioning in two parallel genetic 
pathways are known to control engulfment of apoptotic cells in C. elegans (Figures 1.2 
and 1.5). These genes are important, but not essential for engulfment: in these mutants, 
engulfment is much less efficient than in wild-type animals, but still occurs to some 
extent. To date, there is no mutation (or mutant background) that completely blocks 
engulfment in worms. Double mutant analyses placed these genes into two partially 
redundant pathways (Figure 1.5), with ced-1, -6, and -7 on one hand, and ced-2, -5, -10, 
and -12 on the other hand: double mutants carrying mutations in the same group do not 
show a significant increase in the engulfment defect, but double mutants with one 
mutation in each group show a strong additive effect (Ellis et al., 1991; Gumienny et al., 
2001; Wu et al., 2001; Zhou et al., 2001a). Also, mutations in ced-2, -5, -10, or -12 are 
characterized by a second phenotype, which is mis-migration of the somatic DTC of the 
gonad. This is a further indication that these four genes belong to the same epistatic 
group. 
 
1.4.3 The C. elegans CED-1, -6, and -7 engulfment pathway 
    ced-1 encodes a large (>1000 amino acids) transmembrane protein with an 
extracellular amino-terminal domain that contains several EGF-like repeats, a single 
transmembrane domain, and an intracellular carboxy-terminal adaptor motif (Zhou et al., 
2001b). The mammalian orthologue of CED-1 has yet to be identified. One good 
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candidate is CD91/LRP: CD91 has a C-terminus end similar to CED-1, and it interacts 
with GULP, the mammalian homologue of the C. elegans ced-6 gene product (Su et al., 
2002). CED-6 is an adaptor protein with a PTB domain, a central leucine zipper domain 
that mediates homodimerization, and a proline-rich region that contains several putative 
SH3-binding sites (Liu and Hengartner, 1998). The functional mammalian homologue of 
CED-6 is GULP, as over-expression of GULP in ced-6 mutant worms rescues the 
engulfment phenotype (Liu and Hengartner, 1999). CED-7 is an ABC transporter similar 
to the mammalian ABCA1 subfamily (Wu and Horvitz, 1998a). ABC transporters use 
ATP to translocate various molecules across cell membranes (e.g. lipids, ions, sugars, 
vitamins). ABCA1 is highly expressed in macrophages engaged in engulfment, and 
macrophages deficient for ABCA1 are defective in apoptotic cell clearance (Hamon et 
al., 2000; Luciani and Chimini, 1996). Contrary to all other engulfment genes, which are 
normally required only in the engulfing cell, ced-7 function is needed in both the 
engulfing and the engulfed cell. 
    It is still unclear how cells orchestrate the activity of CED-1, -6, and -7 to promote 
engulfment of apoptotic cells. A CED-1::GFP fusion protein expressed in worms 
localizes to cell membranes and clusters around neighboring cell corpses, supporting the 
view that CED-1 might be a receptor important for phagocytosis (Zhou et al., 2001b). In 
ced-7 mutants, but not in ced-6 mutants, CED-1::GFP fails to cluster around apoptotic 
corpses, suggesting that the ABC transporter CED-7 cooperates with CED-1 in the 
recognition process of dying cells (Zhou et al., 2001b). Because over-expression of ced-6 
rescues the engulfment defect of ced-1 and ced-7 mutants, it was proposed that ced-6 acts 
downstream of these two genes (Liu and Hengartner, 1998). This view is supported by 
biochemical studies that have shown that CED-1 and CED-6, as well as their mammalian 
homologues, physically interact (Su et al., 2002). What are the CED-1 ligands? How does 
CED-7 control CED-1 localization? What proteins act downstream of CED-6? These are 
all interesting, but largely unanswered, questions. 
 
1.4.4 CED-2, -5, -10, and -12 control cytoskeletal rearrangements during engulfment 
    The second engulfment pathway in C. elegans is better understood. It culminates in the 
activation of a small Rac1-like GTPase (CED-10) and the subsequent cytoskeletal 
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reorganization required for phagocytosis and cell migration. CED-5 is a huge bridging 
protein (1781 amino acids) similar to mammalian DOCK180: CED-5 contains a Docker 
domain that specifically binds nucleotide-free Rac, and CED-5 physically interacts with 
CED-2 and CED-12 (Gumienny et al., 2001; Wu and Horvitz, 1998b). ced-2 encodes an 
adaptor protein with a SH2-domain and two SH3-binding sites, and is similar to the 
mammalian protein CrkII (Reddien and Horvitz, 2000). CrkII can regulate cell shape and 
motility, and is also known to directly bind DOCK180 (Klemke et al., 1998). However, 
the mechanism by which CED-2/CrkII promotes engulfment, and the significance of the 
CED-2/CrkII-CED-5/DOCK180 interaction, remains to be determined. The last 
engulfment gene that was cloned in C. elegans is ced-12. CED-12, and its mammalian 
homologue ELMO, has a PH domain and interacts with CED-5/DOCK180 (Gumienny et 
al., 2001; Wu et al., 2001; Zhou et al., 2001a). CED-2-CED-5-CED-12 forms a ternary 
complex that activates a signaling cascade important for cell migration and phagocytosis 
of apoptotic cells (Gumienny et al., 2001). 
    CED-10 is similar to Rac1, a small GTPase that controls cell morphology by regulating 
the cytoskeleton (Reddien and Horvitz, 2000). Genetically, ced-10 acts downstream of 
ced-2, -5, and -12 because its over-expression rescues the engulfment phenotype of these 
different mutant strains. However, recent over-expression studies from our laboratory 
indicate that ced-10 migth also act downstream of the ced-1, -6, and -7 pathway (J.M. 
Kinchen and M.O. Hengartner, in press). GTPases are molecular switches that can be 
found in an inactive GDP-bound state and an active GTP-bound state; GTPase activating 
proteins (GAPs) promote inactivation of the enzymes, whereas GTP exchange factors 
(GEFs) activate them. In mammalian cells, biochemical experiments revealed that 
DOCK180 and ELMO function as a bipartite Rac-GEF, able to promote phagocytosis 
and cell migration through Rac1 activation (Brugnera et al., 2002; Grimsley et al., 2004). 
Assuming that the CED-5/CED-12 complex has similar activity in worms, one can 
propose a model where signals emanating from the dying cell activate the GEF activity of 
CED-5/CED-12 (maybe through CED-2?), leading to CED-10 activation and 
reorganization of the actin cytoskeleton (Figure 1.5). 
 
1.4.5 Phosphatidylserine recognition in C. elegans 
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    Phosphatidylserine (PS) is a phospholipid normally present in the inner leaflet of the 
plasma membrane bilayer. However, during apoptosis, PS accumulates on the outer 
leaflet of the cell’s plasma membrane and is thought to be one of the primary ‘eat-me’ 
signals recognize by phagocytes. In mammals, the phosphatidylserine receptor (PSR) is 
expressed in most cells able to engulf apoptotic cells, and shows specific binding activity 
towards PS in vitro (Fadok et al., 2000). However, disruption of PSR in the mouse gave 
contradicting results: whereas one group reported an engulfment defect in psr-/- mice, 
with apoptotic cells accumulating in the lung, liver, and thymus (Li et al., 2003), another 
independent study did not observe any defect in apoptotic corpse removal in their PSR 
knockout mice (Bose et al., 2004). Both laboratories reported essential functions for PSR 
during embryogenesis. Even more complicated is the fact that PSR contains several 
nuclear localization signals sufficient to promote nuclear localization of a GFP fusion 
protein (Cui et al., 2004). It is currently undetermined how a nuclear protein could act as 
a ‘eat-me’ signal receptor in phagocytes. 
    C. elegans has one PSR homologue, psr-1. A mutation in the psr-1 locus was reported 
to cause a subtle engulfment defect in worms, and epistasis analysis placed psr-1 
upstream of the ced-2, -5, -10, and -12 pathway (Wang et al., 2003). In this study, over-
expression of human PSR in psr-1 mutant worms could partially suppress the engulfment 
defect, suggesting conservation of function. Therefore, it is possible that PSR-1 plays a 
minor role in the recognition of apoptotic cells in C. elegans, but it is clearly not the main 
receptor that recognizes apoptotic cells because the engulfment phenotype of psr-1(lf) 
worms is much weaker than the phenotype of any of the other worm engulfment genes. In 
contradiction with the published data, our laboratory has obtained two deletion alleles of 
psr-1 (including the allele characterized by Wang et al.) and has not been able to observe 
an engulfment defect (S. Züllig and M.O. Hengartner, unpublished observations). 
    Annexin I is an intracellular protein that translocates from the cytosol to the outer 
leaflet of the plasma membrane during apoptosis, and has been proposed to be the 
bridging molecule between PS on the dying cell and PSR on the phagocyte (Arur et al., 
2003). Annexin I colocalizes with PS, and is required for PSR clustering around 
apoptotic cells. RNAi knockdown of nex-1, the C. elegans orthologue of mammalian 
annexin I, has been reported to lead to a moderate, but significant, engulfment defect 
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(Arur et al., 2003). However, a nex-1 mutant does not have an observable engulfment 
phenotype (L. Neukomm and M.O. Hengartner, unpublished observations). It is possible 
that RNAi against nex-1 also cross-inactivate the three remaining genes in the C. elegans 
genome that encode annexin-like proteins, and that knockdown of these four genes is 
required to observe a defect in apoptotic corpse clearance. In any case, mutations in these 
nex genes are desired to definitely determine the role of annexins in the phagocytosis of 
apoptotic cells in C. elegans, and also to find out how they interact with the other ced 
engulfment genes. 
 
1.4.6 Engulfment promotes apoptosis 
    Figure 1.2 presents programmed cell death in C. elegans as a linear process, where a 
cell first dies, after which point it is recognized by a neighboring cell and removed. 
However, elegant genetic studies have shown that the apoptotic pathway is not strictly 
linear, and that engulfment promotes apoptosis (Hoeppner et al., 2001; Reddien et al., 
2001). Screening for mutations that enhanced the defect in programmed cell death of a 
weak ced-3 mutation, Reddien and co-workers unexpectedly isolated mutations in 
engulfment genes (Reddien et al., 2001). Hoeppner et al. used four-dimensional 
microscopy to study the kinetics of death and engulfment, and showed that blocking 
engulfment enhances cell survival in animals with a weak ced-3(lf) mutation (Hoeppner 
et al., 2001). These two groups proposed that phagocytosis actively promotes apoptosis to 
make sure that once a cell has decided to commit suicide, there is no possible ‘turning 
back’. Future work should aim at identifying the molecular mechanisms by which 
engulfment cooperates with the death machinery. 
 
1.5 THE FINAL STEP: APOPTOTIC DNA FRAGMENTATION 
    Chromosomal DNA degradation into a ladder is one of the best described hallmarks of 
apoptotic cell death (Wyllie, 1980). In mammals, the nuclease CAD/DFF40 becomes 
activated and degrades genomic DNA when its inhibiting binding partner, ICAD/DFF45, 
gets cleaved by caspases (Nagata, 2000). In C. elegans, the Dnase II protein NUC-1 is the 
main nuclease responsible for degrading the DNA of cells undergoing apoptosis: a loss-
of-function mutation in nuc-1 results in accumulation of TUNEL-positive nuclei in 
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mutant embryos (Wu et al., 2000). Although not essential for apoptosis, DNA 
fragmentation is thought to occur in dying cells as a further way to kill it (destruction of 
the genetic code), to prevent DNA transformation, or to get rid of a potent auto-antigen 
(DNA) that could trigger an immune response (Nagata, 2000). 
    Work from Ding Xue’s laboratory has led to the identification of several other genes 
involved in apoptotic DNA degradation in C. elegans. This group found that CPS-6 (cps, 
CED-3 protease suppressor), the worm orthologue of mitochondrial endonuclease G 
(EndoG), a protein normally involved in mitochondrial DNA replication, also participates 
in apoptotic DNA degradation in C. elegans (Parrish et al., 2001). This finding is 
supported by biochemical experiments in mammalian cells that have shown that upon 
apoptotic stimuli, EndoG is released from mitochondria, translocates to the nucleus, and 
cleaves chromosomal DNA (Li et al., 2001). Xue and colleagues also demonstrated that 
the worm mitochodrial oxidoreductase apoptotis-inducing factor (AIF) WAH-1 (wah, 
worm AIF homologue) promotes DNA degradation and apoptosis in worms by 
cooperating with CPS-6/EndoG (Wang et al., 2002). Finally, Parrish and Xue used RNAi 
to inactivate 77 proteins that could be implicated in apoptotic DNA degradation because 
they have a nuclease domain (Parrish and Xue, 2003). They identified seven new 
nucleases, and characterized one of them further, CRN-1 (crn, cell death-related 
nuclease), the C. elegans homologue of human flap endonuclease-1 (FEN-1). They 
showed that CRN-1 cooperates with CPS-6/EndoG to promote fragmentation of genomic 
DNA in apoptotic cells (Parrish et al., 2003). How these different nucleases interact in 
worms, and why does the worm needs so many proteins for a non-essential process – 
apoptotic DNA degradation − are interesting questions that should find answers in the 
near future. 
 
1.6 PERSPECTIVES 
    Since the introduction of C. elegans as a model organism to genetically dissect 
programmed cell death, the study of apoptosis in worms has been prolific and is 
responsible for several breakthroughs in the field of apoptosis research. There is no doubt 
that further characterization of the new worm apoptotic genes, briefly reviewed here, will 
help to understand apoptosis in other species, including humans. 
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    But what is next? We have reached a point where we understand relatively well the 
death machinery of the worm. Our attention must now be focused on what lies upstream 
and downstream of the CED-9 | CED-4 → CED-3 pathway. The identification and 
characterization of novel genes that control the life-versus-death decision of cells, or that 
interact with the known engulfment genes is certainly the next big challenge for 
‘apoptologists’ working with C. elegans. To find these genes, new strategies, involving 
modifier genetic screens in sensitized backgrounds, will need to be undertaken. These 
screens are likely not to be trivial, but at the end should produce quite rewarding results. 
In this post-genomic era, other methods, such as the determination of expression profiles 
of apoptosis mutants or the establishment of interaction maps with the proteins involved 
in apoptosis through large-scale yeast-two-hybrid screens, should provide complementing 
information to the more traditional genetic approaches. We have learned a lot by studying 
programmed cell death in worms, yet it is obvious that C. elegans still have plenty to 
teach us on how and why apoptosis occurs. Not bad, not bad at all for a simple worm… 
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FIGURE 1.1 Morphology of apoptotic cells in C. elegans 
(a) Somatic cell death in C. elegans. Picture of a wild-type embryo at an early 1.5-fold 
stage was taken by Nomarski optics. The white arrow indicates a highly refractile 
apoptotic cell. Scale bar, 10 µm. (Picture from Lukas Neukomm). 
(b) Germ cell apoptosis in C. elegans hermaphrodite. Nomarski optics picture of a wild-
type hermaphrodite gonad taken ~24 hours post larval stage L4. The white arrow 
indicates a highly refractile apoptotic germ cell. Anterior is to the left and dorsal to the 
top. Scale bar, 10 µm. 
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FIGURE 1.2 The C. elegans apoptotic pathway 
The general ‘four steps’ programmed cell death pathway in C. elegans. Positive (→) and 
negative (|) genetic interactions are shown. (Adapted from Hengartner, 1997). 
APOPTOSIS IN C. ELEGANS 27
  
 
FIGURE 1.3 Regulation of apoptosis in C. elegans 
Three different pathways lead to apoptosis in C. elegans. The pale grey box contains the 
canonical apoptotic pathway, whereas the dark grey boxes indicate germline-specific 
components. Dashed arrows represent either unknown or indirect interactions. 
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FIGURE 1.4 C. elegans adult hermaphrodite germ line 
(a) Schematic diagram of an adult hermaphrodite C. elegans gonad. Apoptotic corpses 
are normally observed at and distal to the bend. (Adapted from Lettre et al., 2004). 
(b) Picture, and corresponding drawing, of a hermaphrodite C. elegans gonad taken ~36 
hours post the larval stage L4 by Normaski optics. Anterior is to the left and dorsal to the 
top. Scale bar, 50 µm. 
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FIGURE 1.5 Phagocytosis of apoptotic cells in C. elegans 
Molecular model for cell corpse removal in C. elegans. Two redundant genetic pathways 
have been described: one comprised of ced-1, -6, and -7, and the other of ced-2, -5, -10, 
and -12. Question marks indicate missing components. (This model is a courtesy of Steffi 
Züllig). 
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2.1 ABSTRACT 
    In a forward genetic screen for mutants with increased germline apoptosis op208, 
op152, and op199 were previously isolated. Here, I show that op208 is an allele of cpb-
3/gla-1, a gene encoding a CPEB-like RNA binding protein, and that op152 is a mutation 
in the gene teg-1, which is involved in germ cell proliferation and differentiation. Finally, 
op199 was not cloned, but mapped to a genetic interval that contains 24 predicted genes. 
 
2.2 INTRODUCTION 
    As mentioned in chapter 1, an important fraction of germ cells in the C. elegans 
hermaphrodite germ line undergo apoptosis; we refer to this process as ‘physiological 
germ cell death’ because it occurs without exogenous stresses (Gumienny et al., 1999). 
Interestingly, few genes are known to either promote or block the physiological germ cell 
death pathway, and we still do not know why ~50% of the developing germ cells die by 
apoptosis. On the assumption that identification of new regulators of this pathway might 
lead to further insights into the cause(s) of these germ cell deaths, a forward genetic 
screen was performed for mutants with increased levels of germline apoptosis (S. 
Milstein and M.O. Hengartner, unpublished). Briefly, wild-type worms were 
mutagenized with ethyl-methane-sulfinate (EMS), and the F2 population was screened 
using acridine orange (AO) to visualize apoptotic cells. AO can be used as a vital dye to 
specifically stain engulfed apoptotic corpses in the C. elegans germ line (S.M. and 
M.O.H., unpublished). Approximately 45 000 haploid genomes were screened and 21 
mutants were isolated. Milstein cloned gla-1 and gla-3, two of the genes identified in this 
screen. gla-1 encodes a member of the CPEB family of RNA binding proteins, and gla-3 
a TIS11-like zinc finger domain containing protein (S.M. and M.O.H., unpublished). In 
this chapter, I describe my efforts to map and clone three other mutants found in the ‘Gla 
screen’: op208, op152, and op199.  
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2.3 RESULTS 
2.3.1 op208 represents a new allele of gla-1 
    op208 mutant worms have a strong germline apoptosis (Gla) phenotype (Figure 2.1 
and 2.2c), but are otherwise phenotypically normal. Using two-factor mapping, Milstein 
had mapped op208 on chromosome I, close to the physical marker dpy-5. I carried out 
three-factor mapping with the two following sets of markers: unc-57 (-1.0 cM) dpy-5 (0 
cM), and dpy-5 unc-29 (+3.3 cM). The cross between op208 and unc-57 dpy-5 revealed 
that op208 is on the right, or close to the left, of dpy-5 because 6/6 Unc non-Dpy 
recombinants were Gla and 0/6 Dpy non-Unc recombinants were Gla. The cross between 
op208 and dpy-5 unc-29 was even more informative: 9/17 Unc non-Dpy recombinants 
were Gla and 5/21 Dpy non-Unc recombinants were Gla. Furthermore, among the Gla 
animals picked in the F2 generation to confirm the interval, one threw Dpy worms and 
another threw Unc worms. These data strongly suggest that op208 lies between the 
markers dpy-5 and unc-29, on the right arm of chromosome I (Figure 2.2a). To narrow 
down the genetic interval where op208 is located, single nucleotide polymorphism (SNP) 
mapping was used. Recombinants between dpy-5 op208 unc-29 animals and the 
polymorphic C. elegans strain CB4856 put op208 between the molecular markers 
C04F1[2] (+0.35 cM) on the left and C34G6[3] (+0.50 cM) on the right (Figure 2.2a). On 
the physical map, this genetic interval corresponds to ~151 kb, which contains 40 
predicted genes. One of the genes in this interval is gla-1 itself, which has a strong Gla 
phenotype when mutated. Although Milstein had performed complementation tests 
between op208 and the canonical gla-1 allele op234 and found complementation, I 
decided to repeat that experiment. The F1 non-Dpy animals from a cross between op208 
males and dpy-5 gla-1(op234) hermaphrodites were Gla, suggesting that op208 is in fact 
a new allele of gla-1. Indeed, sequencing the gla-1 locus of op208 animals revealed a 
single point mutation: a G-to-A transition in exon 4 (base pair 1572 of ORF) that changes 
methionine 524 into an isoleucine (Figure 2.2b). This mutation does not affect a 
conserved residue, but occurs within a very conserved region of the GLA-1 protein 
(Figure 3.2b). The op234 mutation in gla-1 is also a missense G-to-A transition (base pair 
1577 of ORF) that changes a conserved cysteine at position 526 into a tyrosine (Figure 
3.2b). Clearly, op208 represents an hypomorphic allele of gla-1 as the Gla phenotype of 
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op208 worms is weaker that the Gla phenotype of op234 mutants (Figure 2.2c). It 
remains to be determined whether op234 is a null allele, and therefore what the true 
phenotype caused by a complete loss of gla-1 function will be. 
 
2.3.2 op152 represents a new allele of teg-1 
    op152 is a temperature-sensitive allele identified in the forward genetic screen for 
mutants with increased germ cell death. At 20oC, op152 mutants do not have a Gla 
phenotype, but at 25oC, the Gla phenotype of op152 animals is strong (Figure 2.1 and 
2.3c). op152 also has pleiotropic effects: it causes cold-sensitive sterility at 15oC and a 
highly penetrant Mog (Masculinization of germ line) phenotype, i.e. an over-production 
of sperm cells and an accumulation of residual bodies in the proximal arm of the gonads. 
Intriguingly, blocking apoptosis in op152 mutants through inactivation of the essential 
caspase ced-3 results in the appearance of large necrotic-like structures in the germ line 
(Figure 2.1). The biological significance of this phenotype is still puzzling, and requires 
further analysis. 
    Two- and three-factor mapping was previously used to map op152 on the right arm of 
chromosome III, close to the physical marker dpy-18 (Figure 2.3a) (S.M. and M.O.H., 
unpublished). To refine the map position of op152, I used SNP mapping. By picking, at 
15oC, Unc non-Sterile F2 recombinants from crosses between the polymorphic strain 
CB4856 and unc-49 dpy-18/op152 or dpy-18/op152 unc-25 animals, I could place op152 
on the left of dpy-18, between the molecular markers Y47D3[13] (+7.4 cM) and pkP3060 
(+8.7 cM) (Figure 2.3a). The size of this interval is ~115 kb, and it is predicted to contain 
20 genes. One of these genes, teg-1, was cloned in Tim Schedl’s laboratory (University 
of Washington, St-Louis) as a regulator of germ cell proliferation and/or differentiation 
(D. Hansen and T. Schedl, unpublished). TEG-1 does not have any recognizable domains 
and its closest human match is the CD2 antigen cytoplasmic tail-binding protein 2. The 
gene is characterized by cold-sensitive sterility and a Mog phenotype when mutated; 
therefore an obvious candidate for op152. Complementation test was performed between 
op152 and the canonical teg-1 allele oz230, and non-complementation was found for the 
sterility and the Mog phenotypes. Sequencing of the six exons of teg-1 in op152 mutants 
revealed a single point mutation in exon 3 (base pair 618 of ORF), which changes 
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tryptophan 206 (UGG) into an opal stop codon (UGA). Furthermore, the op152 mutation 
abrogates a HaeIII restriction site, allowing detection after PCR amplification and 
restriction digest of genomic DNA extracted from op152 mutants (Figure 2.3b).  
    The identification of op152 as an allele of teg-1 was surprising because, whereas 
op152 is clearly Gla at 25oC (Figure 2.3c), the predicted null allele oz230 is not (D.H. and 
T.S., personal communication). One explanation could be that op152 is an usual teg-1 
allele (e.g. neomorph), although genetically it behaves as a recessive hypomorph. 
Another possibility is that an additional lesion, closely linked to teg-1(op152), causes the 
Gla phenotype. To distinguish between these two possibilities, I performed a rescue 
experiment. By biolistic transformation, I created transgenic animals bearing few copies 
of the following transgene: Ppie-1::gfp::teg-1. The pie-1 regulatory sequence was used to 
drive expression of the transgene in germ cells (Seydoux et al., 1996). The fusion protein 
GFP::TEG-1 showed nuclear localization and could only be observed in the distal arm of 
the gonads. When this transgene was crossed into teg-1(op152) worms, it rescued the 
sterility and the Mog phenotype, suggesting that the fusion protein is functional and that 
the activity of TEG-1 is required in germ cells. Moreover, time course analysis revealed 
that the transgene completely rescues the Gla phenotype of op152 animals at 25oC 
(Figure 2.3c). These observations suggest that op152 is an unusual recessive teg-1 allele, 
although further genetic characterization is required to confirm this hypothesis. 
 
2.3.3 gla-4(op199) maps at ~+17.5 cM on chromosome I 
    gla-4(op199) is the only mutant found in the forward genetics ‘Gla screen’ that has 
unusual corpse morphology. Indeed, gla-4(op199) worms do not have more germline 
apoptosis, but rather have three-to-four times bigger apoptotic corpses relative to wild-
type (Figure 2.1). Furthermore, the corpses in gla-4(op199), do not show the 
characterisitic button-like appearance, but are granular and have a visible nucleus (Figure 
2.1). op199 was mapped on the right of unc-29 (+3.3 cM), on chromosome I by Milstein.  
I used SNP mapping to find a small interval for this mutation. However, this task was 
tedious due to the lack of good physical markers close to the region of interest. 
Consequently, most recombinants isolated from the different crosses were non-
informative. I built the double mutants unc-101 (+13.3 cM) op199 and op199 unc-54 
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(+27.4 cM), which I crossed into CB4856 to pick Gla non-Unc recombinants in the F2 
generation (Figure 2.4). Genotyping these recombinants for polymorphisms allowed me 
to place op199 between the molecular marker Y26D4[2] (+17.4 cM) and ZK1225[1] 
(+18.1 cM) (Table 2.1). This interval corresponds to 122 kb, and contains 24 predicted 
genes. Thorough bioinformatic analysis of these 24 genes did not reveal an obvious 
candidate for gla-4. To clone gla-4(op199), available clones from the Ahringer RNAi 
feeding library were used to knock down 18 of these genes in a wild-type background 
(Table 2.2) (Fraser et al., 2000; Kamath et al., 2003). Unfortunately, these experiments 
were unsuccessful as the op199 phenotype could not be phenocopied by RNAi. These 
results indicate that either op199 is one of the six genes not tested by RNAi, or that RNAi 
feeding does not work efficiently to knock down gla-4 expression. 
 
2.4 DISCUSSION 
2.4.1 mRNA translation, GLA-1, and germ cell death 
     gla-1, annotated in Wormbase as cpb-3, encodes a CPEB protein. CPEBs 
(cytoplasmic polyadenylation element-binding protein) are highly conserved RNA 
binding proteins that modulate translational repression and mRNA localization (Figure 
2.2b) (Mendez and Richter, 2001).  In Drosophila, the CPEB protein Orb is crucial for 
anteroposterior and dorsoventral patterning during oogenesis, as well as for the formation 
of the egg chamber and entry into meiosis (Lantz et al., 1992). Similarly, the Xenopus 
CPEB orthologue plays an important role during oogenesis (Stebbins-Boaz et al., 1996). 
In the mouse, disruption of the CPEB gene is viable, but causes sterility. Detailed 
molecular analysis revealed that the sterility is due to an arrest during the early pachytene 
to diplotene transition in prophase of meiosis I (Tay et al., 2003; Tay and Richter, 2001). 
Furthermore, male meiotic germ cells undergo apoptosis in CPEB-/- mice (Tay and 
Richter, 2001). This is a very similar phenotype than in gla-1(lf) C. elegans 
hermaphrodite mutants, where increased germline apoptosis is seen only once germ cells 
escape pachytene arrest. 
    C. elegans has four CPEB proteins: FOG-1, CPB-1, -2, and -3. Surprisingly, two of 
these proteins, FOG-1 and CPB-1, are required for spermatogenesis but dispensable for 
oogenesis (Luitjens et al., 2000). FOG-1 is necessary for the cell fate decision to develop 
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into sperm rather than oocyte, and CPB-1 plays an essential role for progression through 
meiosis during spermatogenesis. Luitjens et al. did not identify any functions for cpb-2 
and cpb-3/gla-1 (Luitjens et al., 2000). Therefore, our work is the first to assign a 
function to a worm CPEB gene in oogenesis, namely the anti-apoptotic activity of cpb-
3/gla-1 (Figure 3.2c). We still ignore how CPB-3/GLA-1 regulates germ cell apoptosis, 
but we suspect that it might be through binding of specific mRNA targets. One might be 
able to identify putative targets by using the strategy developed to identify in vivo targets 
for the RNA-binding protein GLD-1 in C. elegans (Lee and Schedl, 2001). Briefly, 
transgenic animals with an epitope-tagged GLA-1 would be lysed and the protein-RNA 
complexes would be pulled-down. The mRNAs present in these complexes would be 
identified through hybridization to microarrays. Another important question to be 
addressed is what the null phenotype for cpb-3/gla-1 really is? Indeed, op208 and op234 
are unlikely to be null alleles as both are missense mutations (Figure 2.2b). Furthermore, 
we have not tested whether additional phenotypes are visible when the gla-1 alleles are 
put in trans over deficiencies. Because CPEBs play an essential role during oogenesis in 
several organisms, it would not be surprising if the trans-heterozygote combination gla-
1(op234)/Df produces a more severe phenotype (complete sterility?) than homozygous 
gla-1(op234). 
    In Xenopus, many dormant mRNAs in oocytes have short poly(A) tails; it is only when 
these tails are elongated that translation can occur. CPEB binds the 3’ untranslated region 
(UTR) of these mRNAs and, through interactions with the proteins Maskin and the 
5’UTR-bound eIF4E, causes circularization and repression of the transcripts. However, 
when CPEB is phosphorylated, it facilitates translation: it recruits the cleavage and 
polyadenylation specificity factor (CPSF) and poly(A) polymerase. Interestingly, it has 
recently been shown in C. elegans that GLD-2, a regulator of mitosis/meiosis decision in 
the germ line, and GLD-3, a Bicaudal-C homologue, form a complex with poly(A) 
polymerase activity (Eckmann et al., 2002; Wang et al., 2002). It has also been proposed 
that this enzymatic activity is required for translation of mRNAs important for germ cell 
proliferation and/or differentiation (Wang et al., 2002). It will be interesting to test 
whether the CPEB cpb-3/gla-1 gene genetically interacts with the gld-2/gld-3 pathway. 
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As a first step to test this hypothesis, I scored gld-2(q497) animals for germline apoptosis, 
but could not detect any abnormal phenotypes. 
 
2.4.2 teg-1 links germ cell proliferation and differentiation to apoptosis 
    In the distal arm of the C. elegans hermaphrodite germ line, germ cells must decide 
between proliferation and differentiation, that is, entry into meiosis. The GLP-1/Notch 
signaling pathway promotes cell division and/or inhibits differentiation through 
inactivation of two key redundant genes: gld-1 and gld-2. In glp-1(gf) or gld-2(lf) gld-
1(lf) mutants, germ cells remain proliferative and form a tumorous germ line (Seydoux 
and Schedl, 2001). To identify new genes involved in the switch between mitosis and 
meiosis, Hansen and Schedl performed a genetic screen for tumorous enhancers of a 
weak glp-1(gf) mutation (teg genes) (D.H. and T.S., unpublished). They identified and 
cloned teg-1, a gene that encodes a protein similar to a human protein that interacts with 
the T-lymphocyte receptor, CD2. Therefore, it was surprising to find out that op152, one 
of the mutants identified in the ‘Gla screen’, is a new allele of teg-1. One can imagine a 
model where TEG-1 is a repair protein required throughout meiosis: it might be involved 
in entry into meiosis at the distal end of the gonad, and also during pachytene progression 
at the bend of the gonad. Maybe our teg-1(op152) allele only affects the pachytene role of 
TEG-1, whereas teg-1(oz230), which is a predicted null, influences the earlier event, i.e. 
meiotic entry. This model could explain the phenotypic discrepancies between op152 and 
oz230. Also, it could provide an explanation for the phenotype of the teg-1(op152); ced-
3(n717) double mutants. In these animals, germ cell death is completely blocked, but 
necrotic-like vacuoles appear in the gonad (Figure 2.1). Assuming a role in repair for 
TEG-1, its absence in the death-sensitive zone of the germ line would lead to apoptotic 
death of impaired germ cells. If apoptosis cannot be used to eliminate these defective 
germ cells, as in teg-1; ced-3 worms, the cells would lyse and die by necrosis.  
    Recently, it has been shown that GLD-1 binds the mRNA of the worm p53 homologue 
cep-1 (B. Schumacher and A. Gartner, unpublished). In a screen for mutants hyper-
sensitive to DNA damage, the authors of the study found an unusual gld-1 allele, which 
encodes a protein unable to specifically repress the cep-1 mRNA. Presumably, in this 
mutant, more CEP-1 is present and upon genotoxic stress, more germline apoptosis 
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occur. Because teg-1 genetically interacts with the gld-1 pathway (D.H. and T.S., 
unpublished), it would be interesting to check if the level of cep-1 mRNA and CEP-1 
protein are normal in teg-1(op152) animals. Importantly, irradiation experiments should 
be carried out to investigate whether the teg-1(op152) mutants are hyper-sensitive to 
DNA damage. Clearly, more work needs to be done to understand how germ cell 
proliferation and differentiation are linked to apoptosis. 
 
2.4.3 gla-4(op199) remains a stranger 
    Using SNP mapping, I could map op199 in a 0.7 cM interval on the right arm of 
chromosome I (Figure 2.4). RNAi knock down of 18 of the 24 predicted genes in that 
interval did not allow me to phenocopy the gla-4(op199) phenotype, suggesting that gla-
4 is one of the six genes not tested, or that gla-4(RNAi) does not work (Table 2.2). To 
clone gla-4(op199), I propose the following strategy: (1) create RNAi feeding vectors for 
the six genes in the interval that have not been tested yet, (2) perform RNAi-feeding in 
the RNAi-hyper-sensitive strain rrf-3(pk1426) (Simmer et al., 2002), (3) use RNAi 
soaking or injection, and (4) create low-copy integrants of the most promising genes to 
rescue the op199 phenotype. The very peculiar morphology of the apoptotic corpses in 
gla-4(op199) worms makes this mutant very interesting, and justify further efforts to 
clone this gene.  
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2.5 MATERIALS AND METHODS 
2.5.1 Nematode strains and culture 
    Standard procedures for nematode culture and genetic manipulation were followed 
with growth at 20oC, unless otherwise noted (Brenner, 1974; Gumienny et al., 1999; 
Sulston and Hodgkin, 1988). The wild-type N2 Bristol strain was used. C. elegans gene 
mutations relevant to this study are as followed: LGI: unc-57(e406), dpy-5(e61), gla-
1(op234), gla-1(op208),  unc-101(m1), gla-4(op199), unc-54(e1092); LGIII: unc-
49(e382), unc-119(ed3), teg-1(op152), teg-1(oz230), dpy-18(e364), unc-25(e156); LGIV: 
ced-3(n717). Phenotypes are described either by Riddle (Riddle et al., 1997), or in this 
thesis. The polymorphic strain CB4856 was used for single nucleotide polymorphism 
(SNP) mapping as described by Plasterk and co-workers (Wicks et al., 2001). 
 
2.5.2 Light and fluorescent microscopy 
    Microscopic analysis of cells was done using standard live-animal techniques: worms 
were mounted on 4% agarose pad and anesthetized with 30 mM NaN3 in M9 buffer. 
Observations were done using a Leica DM RXA2 microscope fitted with Nomarski 
optics. Images were captured with a ORCA-ER digital CCD camera (Hamamatsu) and 
processed with OpenLab software. Fluorescence stereomicroscopy was done with a Leica 
MZ FLIII or a Zeiss Stemi SV11 M2BIO stereomicroscope. 
 
2.5.3 Biolistic transformation 
    GFP::TEG-1 lines were constructed with pID3.01B_teg-1 (the original vector, 
pID3.01B, is a gift from Dr. Geraldine Seydoux, John Hopkins University). The plasmid 
contains a translational fusion of gfp (N-terminus) with the full-length genomic 
sequences of teg-1 (ATG to stop codon). Cloning was performed using Gateway 
Cloning technology (Invitrogen) according to the protocol from the Seydoux 
laboratory. The plasmid also contains the rescuing unc-119 genomic sequence from 
pDPMM016. The constructs was bombarded into unc-119(ed3) worms as previously 
described (Praitis et al., 2001). To obtain germline expression, 0.5 µg of DNA per 
bombardment was used. Integration of the construct was determined by loss of visible 
Unc-119 offspring. 
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 2.5.5 Cloning 
    Cloning was performed according to standard molecular biology techniques described 
by Sambrook and Russel (Sambrook and Russell, 2001). Some ligation reactions were 
done using the Rapid DNA Ligation Kit (Roche). TOPO TA Cloning and Gateway 
Cloning were performed according to the protocols provided by the manufacturer 
(Invitrogen). 
 
2.5.6 Polymerase chain reaction (PCR) 
    PCR was performed using Biotaq DNA polymerase (Bioline), Pfu Turbo DNA 
polymerase (Stratagene), or the Expand High Fidelity PCR system (Roche) according to 
the manufacturers’ protocols.  
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TABLE 2.1 SNP mapping for gla-4(op199) 
 
 
pkP1073 
+17.4 cM 
Y26D4[2] 
+17.4 cM 
F22G12[1] 
+17.8 cM 
ZK1225[1] 
+18.1 cM 
ZK1053[2] 
+18.2 cM 
 
CB4856 X unc-101(m1) gla-4(op199) 
      
 4/4 2/4 0/4 0/4 0/4 
      
CB4856 X gla-4(op199) unc-54(e1092) 
      
 0/11 0/11 0/11 3/11 11/11 
      
The Gla-4 non-Unc-101 recombinants and the Gla-4 non-Unc-54 recombinants determine 
the left and right boundaries of the genetic interval, respectively. Only the few informative 
recombinants for this interval are included. Numbers represent the fraction of worms that 
retains the CB4856(Hawaii)-specific allele. 
GLA MUTANTS 44
 
 
TABLE 2.2 Candidate genes for gla-4(op199) 
Gene RNAi Description1 
Y26D4A.8 Y Connect nuclear MT to spindle body assembly 
Y26D4A.9 Y Serpin domain 
DNA DSB repair rad50 ATPase 
Y26D4A.10 N  
Y26D4A.11 N Integrase and Chromo domain 
C17H1.1 Y  
C17H1.2 Y  
C17H1.3 N ER to Golgi transport  
C17H1.4 Y ER to Golgi transport  
C17H1.5 Y INCENP  
ER to Golgi transport  
C17H1.6 Y ER to Golgi transport  
C17H1.7 Y Caldesmon  
Enzyme that transfers mannosylphosphate to cell wall  
C17H1.8 N Translocation between nucleoplasm and NPC  
F22G12.1 Y ER to Golgi complex  
Myosin heavy chain  
F22G12.2 N Integrase domain, DNA recombination – binding 
POL polyprotein (RT)  
DNA-damage inducible, production or recovery of mutations  
F22G12.3 Y Cyclin-like F-box 
F22G12.4 Y Ank repeat, FYVE zinc finger 
Ankhzn protein – Mouse ES cells – endosomes  
F22G12.5 Y Pleckstrin homology domain (intracellular signaling or cytoskeleton) 
F22G12.6 N Ankhzn protein  
F17B5.1 Y Enzyme that transfers mannosylphosphate to cell wall  
Thioredoxin  
F17B5.2 Y Acetyltransferase domain, C-type lectin 
F17B5.3 Y C-type lectin, Beta and gamma crystalline 
F17B5.4 Y Galactoside 2-L-fucosyltransferase 1 
F17B5.5 Y C-type lectin 
ZK1225.1 Y DUF235 
1As annotated in Wormbase. For the RNAi column, ‘Y’ indicates that RNAi knockdown of the gene was 
performed at 15oC, 20oC, and 25oC in a wild-type N2 background (Po generation). ‘N’ indicates that the 
corresponding clone was not present in the Ahringer feeding library, or that sequencing revealed that it 
contained the wrong insert. 
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FIGURE 2.1 Phenotypes of Gla mutants 
Mutants which are characterized by increased levels of germ cell death. DIC pictures of 
worms grown at 20oC (25oC for teg-1) were taken 24 hours post larval stage L4. 
Apoptotic germ cells can be seen as highly refractile disks (arrows). For the picture of 
teg-1; ced-3 animal, the arrow indicates a necrotic vacuole. For all the pictures, anterior 
is to the left and dorsal to the top. Scale bar, 10 µm. 
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FIGURE 2.2 Cloning and characterization of gla-1(op208) (next page) 
(a) Schematic diagram of the cloning strategy used to identify the op208 locus. The main 
physical and molecular markers used are indicated. gla-1/cpb-3 encodes a gene with six 
exons on chromosome I. It is transcribed from right to left along the chromosome. 
(b) Partial alignment of the protein sequence of C. elegans GLA-1, D. melanogaster Orb, 
zebrafish ZOR-1, and mouse CPEB. The aligned region of the protein corresponds to part 
of the zinc finger. The gla-1(op208) and gla-1(op234) missense mutations, and the 
corresponding amino acid changes, are indicated. 
(c) Time-course analysis of germ cell death in wild-type, gla-1(op234), and gla-1(op208) 
mutants. Worms were synchronized and scored for germ cell apoptosis by DIC every 12 
hours post L4 stage. Data shown represent mean ±s.d. of three experiments (n=20 gonads 
for each experiment). 
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FIGURE 2.2 
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FIGURE 2.3 Cloning and characterization of teg-1(op152) (next page) 
(a) Schematic diagram of the cloning strategy used to identify the op152 locus. The main 
physical and molecular markers used are indicated. teg-1 encodes a gene with six exons 
on chromosome III. It is transcribed from right to left along the chromosome. 
(b) op152 abrogates a HaeIII restriction site in exon 3 of the teg-1 locus. PCR 
amplification of exon 3 with specific primers (5’-ATTGAGCGTAGCATGAATTTTCTGG-3’ 
and 5’-AAATTTCCGGTAAACCGACAATTGC-3’) gives a 393 bp product. After restriction 
digest with HaeIII and agarose gel electrophoresis, two bands are obtained from wild-
type animals [246, 147 bp], three bands from heterozygote animals [393, 246, 147 bp], 
and one band from homozygote worms [393 bp]. Wild-type: N2 Bristol; Heterozygote: 
teg-1(op152)/hT2[qIs48]; Homozygote: teg-1(op152). M: molecular weight marker. 
(c) Time-course analysis of germ cell death in wild-type, teg-1(op152), and teg-1(op152); 
opIs115[Ppie-1::gfp::teg-1] animals grown at 25oC. Worms were synchronized and scored 
for germ cell apoptosis by DIC every 12 hours post L4 stage. For teg-1(op152) 
homozygotes, GFP negative progeny from teg-1(op152)/hT2[qIs48] heterozygote 
mothers were picked and scored. Data shown represent mean ±s.d. of two experiments 
(n=20 gonads for each experiment). 
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FIGURE 2.3 
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 FIGURE 2.4 Molecular cloning of gla-4(op199) 
Schematic diagram of the cloning strategy used to map gla-4(op199). The main physical 
and molecular markers used are shown. The 0.7 cM (122 kb) interval where gla-4(op199) 
maps is indicated. 
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3.1 PREFACE 
    In this chapter, I described a functional genomics approach used by our laboratory to 
discover most of the worm genes that protect germ cell from undergoing apoptosis. We 
performed a genome-wide RNAi screen using the RNAi feeding library from the 
Ahringer laboratory and looked for gene knockdowns that cause a Gla phenotype, that is, 
increased germline apoptosis. 
    Dr. E. Kritikou and myself did most of the primary screen, with help from M. Jaeggi 
and A. Calixto for chromosome I. Dr. Kritikou and I did the secondary screen. I 
performed all the epistasis analysis presented in Table 1 of the article. Dr. Kritikou 
characterized the bmk-1(ok391) mutant, whereas I focused my work on the pmk-3(ok169) 
mutant. Extensive genetic characterization of the pmk-3(lf) phenotype will be given in 
chapter 4. I wrote the article, which was then edited by Dr. Kritikou and Professor M.O. 
Hengartner. 
    At the end of this chapter, I included Supplementary Table 3.1 and Supplementary 
Figure 3.1. Although not essential for the comprehension of the article, these data might 
be useful for future lab members. 
GENOME-WIDE RNAI SCREEN 53
Genome-wide RNAi identifies p53-dependent and
-independent regulators of germ cell apoptosis in
C. elegans
G Lettre1,4, EA Kritikou1,4, M Jaeggi1, A Calixto2, AG Fraser3,5,
RS Kamath3, J Ahringer3 and MO Hengartner*,1
1 Institute for Molecular Biology, University of Zurich, Winterthurerstrasse 190,
8057 Zurich, Switzerland
2 Department of Biological Sciences, Columbia University, 1012 Fairchild
Center, 1212 Amsterdam Avenue, New York, NY 10027, USA
3 Wellcome CRC Institute and Department of Genetics, University of Cambridge,
Tennis Court Road, Cambridge CB2 IQR, UK
4 G Lettre and EA Kritikou contributed to this work equally
5 Current address: The Wellcome Trust Sanger Institute, Wellcome Trust
Genome Campus, Hinxton, Cambridge CB10 1SA, UK
* Corresponding author: MO Hengartner, Institute for Molecular Biology,
University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Tel: þ 41-1-635-3140; Fax: þ 41-1-635-6861;
E-mail: michael.hengartner@molbio.unizh.ch
Received 11.3.04; revised 18.5.04; accepted 03.6.04; published online 23.7.04
Edited by G Melino
Abstract
We used genome-wide RNA interference (RNAi) to identify
genes that affect apoptosis in the C. elegans germ line. RNAi-
mediated knockdown of 21 genes caused a moderate to strong
increase in germ cell death. Genetic epistasis studies with
these RNAi candidates showed that a large subset (16/21)
requires p53 to activate germ cell apoptosis. Apoptosis
following knockdown of the genes in the p53-dependent class
also depended on a functional DNA damage response
pathway, suggesting that these genes might function in DNA
repair or to maintain genome integrity. As apoptotic pathways
are conserved, orthologues of the worm germline apoptosis
genes presented here could be involved in the maintenance of
genomic stability, p53 activation, and fertility in mammals.
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Introduction
Apoptosis is a physiological mechanism by which unneeded,
harmful, or damaged cells commit suicide. It plays an
important role in development and homeostasis, and its mis-
regulation has been associated with various pathologies.1–3
Although we understand the molecular events occurring
during apoptosis relatively well, less is known about the
regulatory signals that trigger this cell fate.
Here we describe a systematic approach to identify new
genes that regulate germ cell apoptosis in Caenorhabditis
elegans. RNA interference (RNAi) was used to knockdown
expression of 16 757 worm genes to find antiapoptotic factors
that prevent excess germ cell death. Knockdown of 21 genes
reproducibly resulted in a moderate to strong increase in germ
cell apoptosis in wild-type animals. By epistasis analysis, we
show that a large subset of our RNAi candidates require p53
and a functional DNA damage response pathway to activate
germ cell apoptosis. Furthermore, we characterize mutations
in two genes identified in our screen, pmk-3 and bmk-1, and
show that these mutants indeed have more germ cell deaths
than wild-type worms. The identification of new C. elegans
germline apoptosis (gla) genes, many of which have
mammalian homologues, should shed light on the different
pathways that regulate apoptosis during metazoan develop-
ment.
Results
C. elegans hermaphrodites possess two U-shaped gonads
connected at a common uterus (Figure 1a). Each gonad has a
distal-to-proximal polarity, the most distal part being capped
by the somatic distal tip cell (DTC). The DTC expresses a
growth factor, LAG-2, which promotes the mitotic proliferation
of the adjacent germ cells. In the distal arms, germ cell nuclei
are not completely enclosed by membrane, and thus form a
large syncytium. Nevertheless, because each nucleus acts
independently of its neighbour, we will refer to these syncytial
nuclei as germ cells. Once germ cells escape the influence of
the DTC, they enter meiosis (transition zone in Figure 1a) and
progress into the pachytene stage of meiosis I; exit from
pachytene requires the activation of the RAS/MAPK path-
way.4,5 Germ cells can then further differentiate into oocytes,
or die by apoptosis. Germ cell apoptosis depends on the
caspase CED-3 and the Apaf-1 homologue CED-4, and is
blocked by the Bcl-2-like protein CED-9.6 Animals with a
conditional loss-of-function (lf) mutation in ced-9 have five
times more apoptotic corpses in their germ line than wild-type
worms.6 This result can readily be phenocopied by inactivat-
ing ced-9 with RNAi (Figure 1b).7
To identify other antiapoptotic genes, we inactivated 86% of
theB19 500 predicted C. elegans protein-coding genes using
a RNAi feeding library.8 To visualize apoptotic germ cells by
fluorescent microscopy, the vital dye acridine orange (AO)
was used. Ingestion of AO-stained Escherichia coli by C.
elegans specifically labels engulfed apoptotic corpses in the
germ line (Figure 1c).6 Using this assay combined with the
RNAi library, we identified 21 gene inactivations that cause a
Gla phenotype, that is, more germ cell apoptosis than
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observed in wild-type worms (Table 1). Sequence analysis of
these candidates revealed that knockdown of a large variety
of genes, belonging to several functional classes, induce germ
cell apoptosis (Table 1; sequences can be retrieved at
Wormbase; www.wormbase.org). Many of the genes identi-
fied in our screen encode proteins with known antiapoptotic
functions in other systems, thereby validating our approach.
For example, as has previously been shown,9,10 we found that
knocking down RAD50 or the RecA-like protein RAD51, two
proteins involved in homologous recombination and DNA
double-strand break repair, results in a Gla phenotype
(Table 1). Similarly, mice carrying a mutation in either
Rad50 or Rad51 show increased apoptosis.11,12 Moreover,
it has recently been reported that inactivation of the p53
inhibitor iASPP, and its worm counterpart ape-1, induces
apoptosis in a p53-dependent manner.13 We independently
identified ape-1 in our RNAi screen, and confirmed that its
inactivation requires p53 to cause a Gla phenotype (Table 1
and see below).
Why do so many different gene inactivations cause germ
cell death? In an effort to address this issue, we performed
epistasis analysis with our RNAi candidates. First, we showed
that in all cases a strong lf mutation in the caspase ced-3
completely suppresses the Gla phenotype, thus confirming
the apoptotic nature of the cell deaths detected by AO and
differential interference contrast (DIC) (Table 1). Apoptosis in
the hermaphrodite C. elegans germ line can be triggered by
genotoxic treatment, such as g-irradiation.10 It has been
shown that these DNA damage-induced germ cell deaths are
dependent on the worm p53 homologue cep-114,15 and the
checkpoint gene hus-1.16 To test if the gene candidates found
in our screen activate the DNA damage response pathway,
their expression was also inactivated by RNAi in cep-1 and
hus-1 mutants. The basal level of germ cell death in these
mutant backgrounds is lower than in wild-type worms (in
Table 1, compare control(RNAi) for each mutant). The reason
for this difference is unknown; one possibility is that in the
absence of HUS-1 or CEP-1, endogenous DNA damage (e.g.
aberrant meiotic intermediates) remains undetected and
therefore cannot cause apoptosis. We found that cep-1(lf)
and hus-1(lf) completely suppress the Gla phenotype of all but
five genes, suggesting that p53 is a key sensor of germ cell
stresses in C. elegans and that many of our RNAi candidates
indirectly affect germ cell apoptosis through the activation of
quality control checkpoint pathways (Table 1).16,17 For the five
gene knockdowns that are not suppressed by cep-1 or hus-1,
a reduction in the number of apoptotic germ cells was
observed in comparison to wild-type worms (Table 1, p53-
independent class). As already mentioned, these mutant
strains have initially less germ cell deaths than the wild-type
strain; this could explain the differences observed. Epistasis
analysis with ced-9(gf), a mutation that completely blocks cep-
1-dependent germ cell death, but does not affect physiological
germline apoptosis,6,10 confirmed the above results (Table 1).
Figure 1 RNAi and acridine orange can be combined for a high-throughput,
genome-wide screen for apoptotic germ cell death. (a) Schematic diagram of an
adult hermaphrodite C. elegans gonad. Apoptotic cells are normally observed at
and distal to the bend. (b) Knockdown of ced-9 by RNAi can phenocopy a
conditional loss-of-function mutation in ced-9. For each genotype, three
independent experiments are shown; the checked, black, and white bars
represent mean7S.D. for each individual experiment (n¼ 20 gonads), whereas
the dashed bars represent mean7S.D. of the three experiments. See Materials
and methods for a description of the statistics used in this study. (c) Left column
shows representative pictures of a gonad after RNAi feeding observed by
differential interference contrast (DIC) microscopy. Apoptotic germ cells can be
seen as highly refractile disks (arrowheads). Right column shows that acridine
orange (AO) stains specifically apoptotic corpses in the germ line. For all the
pictures, anterior is to the left and dorsal to the top. Scale bar, 8 mm
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As RNAi does not always faithfully reproduce the known lf
phenotypes, we sought to confirm our RNAi results with
genetic mutants. As a first step towards this aim, we obtained
and characterized deletion alleles for two of our RNAi
candidates, pmk-3 and bmk-1. Neither mutant has any
obvious growth defects (data not shown),18 but both pmk-
3(lf) and bmk-1(lf) mutants displayed an increased number of
germ cell corpses when compared with wild-type worms
(Figure 2a). PMK-3 is one of the three p38 MAPK isoforms in
C. elegans, which are all present on the same operon.18 The
worm p38 PMK-1 has been implicated in stress responses
and innate immunity, whereas the role of PMK-2 and PMK-3 is
still unclear.18–20 Contrary to the pmk-3(lf) Gla phenotype,
knockdown of either pmk-1 or pmk-2 does not increase germ
cell death (Figure 2b), suggesting a specific involvement of
the PMK-3 isoform of p38 in the protection against germ cell
apoptosis. bmk-1 encodes a C. elegans homologue of the
BimC kinesin-like motor protein involved in spindle forma-
tion.21 Double-mutant analysis revealed that ced-3 is epistatic
to both pmk-3 and bmk-1 (Figure 2b). In contrast, cep-1(lf),
Table 1 Gene candidates that increase germline apoptosis following RNAi
Germ cell deaths per gonadb
wild-type ced-3(lf) cep-1(lf) hus-1(lf) ced-9(gf)
Gene(locus) Descriptiona (t-test) (t-test) (t-test) (t-test)
Control Vector+gfp 2.270.2 0 1.570.2 1.070.1 1.570.2
p53-independent
T07C4.8(ced-9) Bcl-2 homologue 9.470.2 0 5.170.7 6.071.8 5.970.6
(P¼ 1.2E-41) (P¼3.7E-11) (P¼ 2.4E-19) (P¼ 1.2E-13)
T02E1.3a Zinc-finger domain, TIS11
family
9.171.1 0 5.770.6 4.670.2 5.270.7
(P¼ 4.5E-26) (P¼3.4E-12) (P¼ 5.2E-22) (P¼ 1.7E-12)
B0414.5(cpb-3) RNA-binding protein,
CPEB family
8.770.5 0 6.170.4 6.272.5 5.271.5
(P¼ 4.4E-28) (P¼3.6E-14) (P¼ 2.4E-21) (P¼1.0E-9)
R05D3.4 RING domain 8.071.4 0 5.171.9 4.870.6 7.471.7
(P¼ 2.0E-18) (P¼6.1E-10) (P¼ 7.2E-26) (P¼ 1.5E-15)
F42G8.4(pmk-3) p38 MAPK 4.171.7 0 2.370.2 2.370.3 3.070.3
(P¼3.5E-6) (P¼0.003) (P¼1.2E-8) (P¼1.4E-5)
p53-dependent
Y43C5A.6(rad-51) DNA repair protein RAD51
homologue
7.971.2 0 1.470.2 1.170.1 1.470.3
(P¼ 1.8E-30) (P¼0.24) (P¼ 0.28) (P¼0.43)
F23B12.8(bmk-1) BimC kinesin-like
homologue
4.471.1 0 1.370.1 1.470.6 1.870.8
(P¼ 1.7E-11) (P¼0.24) (P¼ 0.04) (P¼0.20)
C16C8.14 Ubiquitin domain-
containing protein
4.070.9 0 1.570.3 1.470.4 2.170.1
(P¼3.8E-8) (P¼0.46) (P¼ 0.03) (P¼ 0.015)
Y38H6C.17 Amino acid/polyamine
transporter
3.970.6 0 1.670.3 1.470.1 2.470.3
(P¼2.0E-9) (P¼0.28) (P¼ 0.03) (P¼ 0.005)
K02F3.5 bZIP transcription factor 3.970.8 0 1.370.4 1.670.5 2.070.3
(P¼6.9E-9) (P¼0.29) (P¼ 0.002) (P¼0.07)
T04H1.4(rad-50) DNA repair protein RAD50
homologue
3.870.1 0 1.470.2 1.070.1 1.570.4
(P¼1.1E-9) (P¼0.43) (P¼ 0.40) (P¼0.44)
F38H12.3 Nuclear hormone receptor 3.870.4 0 1.770.5 1.170.3 1.471.0
(P¼5.2E-8) (P¼0.18) (P¼ 0.34) (P¼0.41)
Y23H5A.2 Novel 3.870.9 0 1.470.2 1.270.5 2.470.0
(P¼8.0E-7) (P¼0.42) (P¼ 0.28) (P¼ 0.013)
F46F3.4(ape-1) p53-binding protein
(iASPP) like
3.770.6 0 1.570.0 1.370.4 1.970.3
(P¼2.3E-7) (P¼0.47) (P¼ 0.09) (P¼0.11)
H06H21.9 PDZ/DHR/GLGF domain 3.571.2 0 1.570.3 1.170.6 1.970.1
(P¼4.5E-6) (P¼0.46) (P¼ 0.30) (P¼0.15)
R11G11.7(pqn-60) Glutamine/asparagines-
rich domain, DUF148
3.570.4 0 1.670.7 1.370.1 1.670.6
(P¼6.6E-7) (P¼0.32) (P¼ 0.08) (P¼0.35)
R03D7.6(gst-5) Glutathione S-transferase 3.570.7 0 1.170.1 1.270.1 1.470.3
(P¼4.8E-6) (P¼0.05) (P¼ 0.23) (P¼0.35)
F28A10.1 DUF13 3.570.9 0 1.470.1 1.370.5 1.470.2
(P¼4.1E-5) (P¼0.42) (P¼ 0.05) (P¼0.39)
K02F2.6(ser-3) Rhodopsin-like GPCR 3.471.2 0 1.470.0 1.370.0 1.770.0
(P¼3.6E-5) (P¼0.46) (P¼ 0.05) (P¼0.24)
F29F11.2 UDP-
glucoronosyltransferase
3.470.6 0 1.970.6 1.470.2 1.870.2
(P¼6.7E-5) (P¼ 0.08) (P¼ 0.08) (P¼0.10)
K11D12.6 Trypsin inhibitor domain 3.470.3 0 1.770.4 1.470.7 2.070.6
(P¼6.0E-5) (P¼0.21) (P¼ 0.02) (P¼0.05)
aAs annotated in Wormbase. bSynchronized L1 worms were fed dsRNA-expressing bacteria until 24 h post-L4 stage, and then scored using DIC microscopy for a
germline apoptosis phenotype. Data shown are mean number of apoptotic corpses per gonad7S.D. of three independent experiments for wild-type, two
experiments for cep-1(lf), hus-1(lf), and ced-9(gf), and one experiment for ced-3(lf) (n¼ 20 gonads for each experiment). Wild-type: N2; ced-3(lf): ced-3(n717); cep-
1(lf): cep-1(gk138); hus-1(lf): hus-1(op244); ced-9(gf): ced-9(n1950). t-test values were obtained by comparing the number of germ cell corpses in each
experimental group with the respective control(RNAi) group
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hus-1(lf), and ced-9(gf) abrogated bmk-1(lf)-induced germ cell
death, but not the Gla phenotype of pmk-3(lf) worms
(Figure 2b). These results corroborate our RNAi data
(Table 1), and imply that loss of bmk-1 activates p53-
dependent germ cell death, whereas pmk-3 acts in a p53-
independent germ cell apoptotic pathway.
Discussion
In this paper, we describe the results of a genome-wide RNAi
screen for genes that affect apoptosis in the C. elegans adult
hermaphrodite germ line. We identified 21 genes that
reproducibly induce germ cell death when knocked down by
RNAi, confirmed that the additional germ cell deaths were
apoptotic in nature, and used various cell death mutants to
determine which death-inducing pathways were activated in
each case.
Interestingly, knockdown of most of the genes identified in
our screen appears to cause germ cell death indirectly,
through activation of p53-dependent checkpoint or quality
control mechanisms. The C. elegans p53 protein CEP-1 has
been shown to participate in a conserved signalling pathway in
response to DNA damage,16 suggesting that at least some of
these gla genes will be involved in the maintenance of
genome stability. Consistent with this hypothesis, the p53-
dependent class contains genes such as rad-50 and rad-51,
which are required for DNA repair and meiotic recombination,
as well as genes predicted to protect from reactive oxygen
species, such as gst-5.
We also identified in our screen ape-1, the worm orthologue
of the p53-binding protein iASPP. Mammalian iASPP is the
most phylogenetically conserved inhibitor of p53 identified so
far.13 It has been proposed that the primary function of iASPP
is to inhibit the proapoptotic activity of p53 in the absence of
genotoxic stress. As previously reported,13 we found that ape-
1(RNAi) induces germ cell apoptosis in a p53-dependent
manner, consistent with the hypothesis that C. elegans iASPP
APE-1 might also act as a p53 inhibitor by binding and
regulating CEP-1’s pro-apoptotic function. However, we found
that ape-1(RNAi) resulted in cep-1-dependent apoptosis only
in the presence of a functional upstream DNA damage
response pathway (Table 1). This indicates that releasing
CEP-1 from APE-1 inhibition is not sufficient by itself to trigger
p53-dependent germ cell death. It is possible that effective
activation of the apoptotic response might require not only
release from APE-1, but also modification of CEP-1 by
checkpoint regulators of the DNA damage response pathway.
Further genetic and biochemical analysis is clearly required in
order to understand the role of C. elegans iASPP in regulating
p53-mediated apoptosis.
In mammals, p53 has been shown to mediate apoptosis in
response not only to DNA damage, but also other stresses,
such as oncogene activation and hypoxia.22 In contrast, we
have been unable so far to identify a DNA damage-
independent death pathway for CEP-1 in C. elegans: all the
cep-1-dependent RNAi candidates that we report here also
showed a significantly reduced Gla phenotype in animals
mutant for the gene hus-1 (Table 1), which acts early in the
DNA damage response pathway. We suspect that the ability
of p53 to respond to oncogene activation might be a more
recent evolution than its ability to respond to DNA damage, as
tumour development is not much of a threat for simple, short-
lived invertebrates such as C. elegans. Alternatively, our
screen might simply have been unable to generate stresses
that activate other p53-dependent pathways.
Our screen led to the identification of a small number of
genes that, upon knockdown, induce germ cell apoptosis in a
p53-independent manner. One of these, ced-9, encodes the
C. elegans homologue of mammalian Bcl-2.23 CED-9 acts
downstream of p53 in the regulation of germ cell apoptosis,16
readily explaining the observed epistasis. The mechanism of
action of the other four genes – two predicted RNA-binding
proteins, a p38 MAPK, and the C. elegans homologue of the
S. cerevisiae Ring-finger protein Bre1p– is more obscure. We
have previously shown that about half of all potential oocytes
undergo apoptosis in the adult C. elegans germ line, and have
suggested that many of these deaths serve a homeostatic
function: to eliminate nuclei that served transiently as nurse
cells and thereby reduce the nuclear/cytoplasmic ratio of the
Figure 2 pmk-3(ok169) and bmk-1(ok391) mutants exhibit a Gla phenotype.
(a) Time-course of germ cell death in pmk-3(ok169) and bmk-1(ok391) mutants.
Worms were synchronized and scored for germ cell apoptosis by DIC every 12 h
post-L4 stage. Data shown represent mean7S.D. of three experiments (n¼ 20
gonads for each experiment). (b) ced-3(lf) prevents germ cell death in pmk-3 and
bmk-1 mutants, whereas cep-1(lf), hus-1(lf), and ced-9(gf) block only bmk-1(lf)-
induced germ cell death. Worms were scored 24 h post-L4 stage
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mature syncytial gonad.6 It is tempting to suggest that these
four genes function in the regulation of this physiological germ
cell death process. Alternatively, knockdown of these four
genes might simply activate another, p53-independent quality
control pathway that results in germ cell apoptosis.
Did our screen identify all the genes that can induce germ
cell death upon inactivation? Most certainly not. First, the
RNAi collection we used contained only about 85% of all
predicted C. elegans genes. Thus, about a seventh of the C.
elegans genome was not tested in our screen. Second,
because of the intrinsic variability and limited efficiency of
RNAi,24 we likely missed a significant number of positive
genes in our primary and secondary screens due to false
negative results. Third, the particular feeding protocol used in
our screen (feeding of Po L1 larvae, screening of Po adults)
would have precluded us from identifying any genes that are
required not only for germ cell survival but also for larval
growth, as well as genes that need to be fed for more than one
generation for the RNAi phenotype to become evident.
Indeed, we recovered in our screen only a fraction of the
genes previously described to affect germ cell apoptosis. For
example, we identified only two of the more than 12 DNA
damage response genes previously shown to induce germ
cell apoptosis upon RNAi-mediated knockdown.9,10,25,26
However, many of these genes needed to be fed for several
generations at high dsRNA concentrations for the apoptosis
phenotype to become evident. We also failed to identify in our
screen daz-1 and the ste13/ME31B/RCK/p54 homologue
cgh-1; both genes have been shown to induce germ cell
apoptosis through as yet unknown mechanisms upon
inactivation.27,28 We did however identify in our screen
CPB-3, one of four C. elegans CPEB family members. In
clam and Xenopus oocytes, CPEB has been shown to interact
functionally and physically with p47/p54, the orthologue of C.
elegans CGH-1.29 Whether CPB-3 and CGH-1 also interact in
C. elegans, and whether they cooperate to control germ cell
apoptosis, possibly by regulating the translation of mRNA
targets, remains to be determined.
Previous genome-wide RNAi screens in C. elegans have
been used to determine new gene functions8,24 as well as to
identify genes involved in body fat regulation30 and genome
stability.31,32 Our results demonstrate that systematic RNAi
screens can also successfully be used to identify genes that
affect apoptosis. Indeed, based on our RNAi data, we
identified two new genetic mutants that have excess germ
cell death, confirming our reverse genomic approach. Further
analysis of the apoptotic genes identified in our screen will
provide useful genetic entry points into the study of mechan-
isms that control germ cell survival, genomic stability and of
the genetic networks that regulate p53 activation.
Materials and Methods
Strains
C. elegans was cultivated using standard methods.33 All strains were
grown at 201C. The strains used in this study were the following: wild-type
N2 Bristol, hus-1(op244), cep-1(gk138), ced-9(n1653), ced-9(n1950gf),
pmk-3(ok169), ced-3(n717), bmk-1(ok391). ok169 and ok391 were
backcrossed to the wild-type strain three times before phenotypical
analysis. The deletion alleles were detected by PCR using the following
primer sequences: for ok169 50-CCCATTTTTCACTGCGTCTCAATCG-30
and 50-TCTGCTTCTCCAGGGATTAACGGTG-30, and for ok391 50-
ATTTGCTGCGAACCTTGACT-30 and 50-GCCGCGAATCATTGTATTT
C-30.
RNAi germ cell apoptosis screen
We carried out RNAi as described.34 In total, 30–50 synchronized L1
worms were placed on NGM agarose plates seeded with E. coli producing
double-stranded RNA (dsRNA). Worms were grown for 3 days, then
stained for 1 h in the dark by adding 500 ml of M9 buffer containing AO
(Molecular Probes; 0.02 mg/ml) to the plate. Worms were then transferred
to fresh agar plates, and allowed to destain for 1 h in the dark. AO staining
was assessed by fluorescent microscopy. RNAi candidates that induced a
Gla phenotype were tested again in duplicate. The presence of increased
germ cell corpses was confirmed by Nomarski optics 24 h post-L4 stage.
For all clones that produced a Gla phenotype, plasmids were isolated and
the DNA sequence encoding the dsRNA was sequenced to confirm the
identity of the inactivated gene.
Statistical analysis
In Figure 1b, the checked, black, and white bars represent mean7S.D. for
each experiment (n¼ 20 gonads), to illustrate variation within each
experiment. The dashed bar represent mean 7S.D. for the three
experiments, to illustrate variation amongst experiments. This latter
statistical representation is also used in Table 1 and Figure 2. Genes were
considered to cause increased cell death only if they reproducibly caused
significant increases in germ cell apoptosis (cutoff for inclusion in Table 1
was Po0.0001 versus wild-type). In Table 1, the cutoff value to establish
epistatic groups was chosen as Po0.001 (RNAi versus respective mutant
control). Although the P-value for cep-1(gk138); pmk-3(RNAi) (P¼ 0.003)
is above the cutoff value, we decided to group pmk-3 into the p53-
independent class based on the clear phenotype of the double mutant
(Figure 2b).
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Cell Death and Differentiation
 SUPPLEMENTARY TABLE 3.1 List of RNAi clones that cause a Gla phenotype in the primary 
screen 
Predicted gene  
(locus) 
Description Chromosome Physical map 
(Mbp) 
Protein degradation    
C16C8.14 Ubiquitin domain-containing protein II 3.45 
T12B5.3 F-box domain III 0.95 
T10F2.3 Ulp1 protease family III 5.17 
R05D3.4 RING domain III 8.36 
C06A6.4 Peptidase M20/M25/M40; 
ArgE/dapE/ACY1/CPG2/yscS 
IV 7.83 
K03D3.8 Retroviral aspartyl protease IV 16.31 
K11D12.6 Trypsin inhibitor domain V 5.03 
F35B12.6 Serine protease inhibitor V 11.62 
T04G9.2 Neutral zinc metallopeptidase; astacin X 0.78 
B0294.3 F-box domain X 1.89 
T25B6.2 Neutral zinc metallopeptidase; similar to human 
endothelin-converting enzyme 1 
X 9.03 
C27C12.7 Dipeptidyl aminopeptidase-like X 14.83 
    
Redox regulation    
F55A3.5 Glutathione peroxidase I 10.79 
R03D7.6 (gst-5) Glutathione S-transferase II 10.95 
F37B1.1 (gst-24) Glutathione S-transferase II 13.61 
C06A6.5 Thioredoxin domain IV 7.83 
    
Transcription    
F40G9.4 BTB/POZ domain III 0.19 
K02F3.4 Basic-leucine zipper transcription factor III 0.83 
F56B3.9 Zinc-finger, C2H2-type IV 0.77 
F53B2.5 Armadillo/beta-catenin-like repeat IV 12.53 
Y45F10B.1 (tsp-5) Tetraspanin IV 13.59 
Y32F6A.1 SET domain V 10.44 
F48D6.3 (hlh-13) Helix-loop-helix DNA binding domain X 4.25 
K09F5.5 SET domain X 7.74 
F54B11.6 MYND zinc finger domain X 13.60 
C11G6.1 (taf-3) Member of the TAF family X 16.33 
    
Signal transduction    
C37A2.4 (cye-1) Cyclin E I 6.79 
K02F2.6 (ser-3) Rhodopsin-like GPCR I 6.83 
F15A4.9 Arrestin II 12.48 
Y55B1AR.1 FTH domain III 0.60 
Y55B1AR.3 FTH domain III 0.60 
B0244.8 Low density lipoprotein (LDL) receptor III 5.73 
C05D10.2 Protein kinase III 6.07 
W03G1.6 Protein kinase IV 0.52 
Y38F2AL.5 Calcium-binding EF-hand IV 2.33 
T26C12.4 (gcy-23) Adenylate/guanylate cyclase catalytic domain IV 3.29 
H06H21.9 PDZ/DHR/GLGF domain IV 4.83 
C33H5.6 G-protein beta WD-40 repeat IV 7.78 
F42G8.4 (pmk-3) p38 MAPK IV 8.14 
C10C5.6a G-protein beta WD-40 repeat IV 9.39 
K11E8.1a (unc-43) Calcium/calmodulin-dependent protein kinase  IV 10.34 
Y24F12A.2 Gtr1/RagA G-protein IV 11.60 
F38H12.3 Nuclear hormone receptor V 4.09 
C03A7.6 Rhodopsin-like GPCR V 5.16 
R13D7.6 Rhodopsin-like GPCR V 7.40 
H27A22.1 Guanylate cyclase V 10.61 
B0240.3 (daf-11) Guanylate cyclase V 11.73 
E02A10.3 Calmodulin-like protein V 12.59 
R11D1.6 (str-181) 7 TM chemoreceptor V 12.72 
T01G5.1 Tyrosine-protein kinase (KIN15/KIN16 subfamily) V 15.12 
T10H4.5 (srw-16) 7 TM chemoreceptor, sri family V 15.28 
ZK1037.5 Ligand-binding domain of nuclear hormone receptor V 15.33 
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T14E8.3 Rhodopsin-like GPCR X 6.57 
K11G12.2 (acr-2) Nicotinic acetylcholine receptor subunit X 6.70 
F22F1.2 Serine/threonine protein kinase X 8.15 
ZC504.5 (gur-3) Gustatory receptor X 10.41 
F19H6.1 Protein kinase; similar to human NEK7 X 12.39 
    
Metabolism    
    
T15D6.2 (gly-16) Acetylglucosaminyltransferase I 12.39 
F31C3.3 Glycoside hydrolase, family 10 I 15.06 
Y57A10C.6 Thiolase II 12.43 
R13A5.10 Cytidine/deoxycytidylate deaminase III 7.58 
F13H6.4 Carboxylesterase V 6.37 
F15H10.6 Mitochondrial substrate carrier V 10.41 
F29F11.2 UDP-glucoronosyltransferase V 10.66 
T22G5.2 (lbp-7) Lipid binding protein V 13.88 
T06C12.10 Glycosyl transferase V 15.89 
C31A11.7 Acyltranferase 3 family  V 16.31 
Y38H6C.17 Amino acid/polyamine transporter V 20.54 
F47B10.2 Phenylalanine/histidine ammonia lyase X 10.90 
    
DNA damage response    
Y43C5A.6 (rad-51) DNA repair protein RAD51 homologue IV 10.28 
F46F3.4 (ape-1) p53-binding protein like V 11.68 
T04H1.4 (rad-50) DNA repair protein RAD50 homologue V 12.25 
    
Ion homeostasis    
C46A5.2 Na+ channel; amiloride-sensitive IV 7.76 
C09H5.2 Cation transport  ATPase  V 8.08 
W06D12.5 Potassium channel V 17.72 
C05E11.4 (amt-1) Ammonium transporter X 4.57 
B0395.1 (nhx-1) Sodium/proton antiporter X 16.01 
    
Structure    
F54D8.1 Nematode cuticule collagen III 5.11 
F53F1.1 Cuticlin V 13.41 
ZK1193.1 (col-19) Cuticular collagen X 0.42 
R04E5.10 (ifd-1) Cytoplasmic intermediate filament protein X 8.82 
    
Other    
B0414.5 (cpb-3) RNA binding protein, CPEB family I 5.80 
T02E1.3a Zinc finger domain, TIS11 family I 8.22 
F25H5.4 (eft-2) Elongation factor Tu I 9.17 
F46F5.4 DUF273 II 0.81 
C14A4.11 Similar to human Programmed Cell Death 10 protein II 10.61 
F35C5.12 Knottin II 12.91 
F28A10.1 DUF13 II 0.83 
K02F3.5 C-type lectin III 0.82 
T07C4.8 (ced-9) Bcl-2 homologue III 10.34 
C23H5.1 S-adenosylmethionine-dependent methyltransferase 
activity 
IV 2.13 
R11E3.3 RNA-directed DNA polymerase IV 4.77 
F17E9.12 (his-31) Histone IV 8.33 
F38E11.1 (hsp-12.3) Alpha-B-crystallin IV 9.45 
R11G11.7 (pqn-60) Glutamine/asparagines-rich domain, DUF148 V 0.50 
C02A12.6 DUF40 V 3.49 
C10F3.1 Aggrecan core protein repeat V 6.00 
T10H9.4 (snb-1) Synapyobrevin- vesicle transport – neurotransmitter 
release 
V 6.66 
F40G12.2 DUF263 V 14.26 
F40G12.9 CC domain V 14.29 
F23B12.8 (bmk-1) BimC kinesin-like homologue V 14.46 
T26H8.1 Transposase V 15.30 
F36G9.11 C-type lectin V 15.98 
Y68A4B.2 C-type lectin V 17.25 
R04A9.2 PAZ domain X 0.37 
F21E9.3 Transthyretin-like X 1.34 
H02F09.3 Similar to human Mucin 5 X 1.57 
F38B6.2 Worm-specific repeat type 1 X 6.70 
T23E7.4 (nlp-6) Neuropeptide-like protein gene X 17.66 
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Novel    
Y23H5A.2  I 2.62 
F58D5.8  I 12.04 
K09F6.5  II 2.27 
Y38E10A.13  II 12.62 
Y38E10A.16  II 12.63 
Y38E10A.24  II 12.68 
F35C5.1  II 12.88 
F42G4.5  II 13.07 
Y55B1AR.2  III 0.60 
K01A11.1  III 3.43 
C44B12.1  IV 1.13 
F36A4.1  IV 4.27 
W03B1.1  IV 4.33 
F19C7.5  IV 4.60 
C17H12.10  IV 6.80 
F38A5.11  IV 6.59 
C25A8.2  IV 7.01 
C46A5.6  IV 7.76 
C49H3.12  IV 7.93 
F42G8.9  IV 8.12 
T28A11.4  V 3.27 
T20D4.18  V 3.42 
C24G6.3  V 5.52 
F32B6.11  V 10.91 
C01G10.4  V 15.09 
F21H7.2  V 16.23 
T27C5.8  V 17.42 
ZK262.4  V 18.43 
M02E1.1  X 0.33 
F52D1.2  X 0.45 
T13G4.5  X 1.20 
R09H3.1  X 1.66 
T25B6.3  X 9.03 
F17H10.4  X 13.13 
C31E10.5  X 14.00 
F31B9.3  X 15.92 
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SUPPLEMENTARY FIGURE 3.1 In silico classification of RNAi candidates 
gla genes identified in the genome-wide RNAi screen were placed into functional classes 
using data from Proteome, Pfam, and InterPro. The ‘other’ and ‘novel’ classes contain 
genes that could not be grouped, or with no recognizable domains, respectively. 
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4.1 ABSTRACT 
    In this chapter, the characterization of mutations in pmk-3, a gene that encodes a p38 
MAPK, is described. pmk-3 loss-of-function mutations causes p53-independent germ cell 
apoptosis. I show that pmk-3 is expressed in the C. elegans hermaphrodite germ line, and 
that its activity is required in this tissue. Also, I demonstrate that the MAPKKK MTK-1, 
the MAPKK MKK-4, and the p38 MAPK PMK-3 act in the same genetic pathway to 
promote germ cell survival. Finally, preliminary results are presented which suggest that 
the transcription factor MEF-2 mediates PMK-3’s anti-apoptotic activity.  
 
4.2 INTRODUCTION 
    Mitogen-activated protein kinases (MAPKs) compose a family of protein kinases 
whose function and regulation have been conserved during evolution from yeast to 
humans. Metazoans have three well-characterized subfamilies of MAPKs: the 
extracellular signal-regulated kinases (ERKs), which control cell division, and the c-Jun 
amino-terminal kinases (JNKs) and p38 MAPKs, which become activated in response to 
environmental stresses (Johnson and Lapadat, 2002; Widmann et al., 1999). Each MAPK 
is part of a canonical phosphorelay where the MAPK is phosphorylated by a MAPK 
kinase (MAPKK), which is itself phosphorylated by a MAPKK kinase (MAPKKK). The 
level of regulation of these different phosphorylation cascades is very complex: it is 
tissue-specific, stimulus-specific, and many different MAPKKs and MAPKKKs can 
activate the same MAPK. For instance, in the presence of inflammatory cytokines, the 
MAPKKs MKK3 and MKK6 activate p38, whereas MKK4 and MKK7 activate JNK 
(Brancho et al., 2003). Furthemore, because of cross-talks between the different MAPK 
pathways, and also the multitude of known targets, the study of MAPK signaling 
cascades in mammalian cells is very challenging. For this reason, researchers have turned 
towards simpler systems to unravel the regulation of MAPK pathways. The yeast S. 
cerevisiae was particularly useful to study the oncogenic Ras-ERK pathway, and the fly 
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D. melanogaster to study the developmental functions of JNK (e.g. in dorsal closure). 
The worm C. elegans has members of each subfamily of MAPKs: the ERK pathway 
plays major roles during vulva development and germ cell meiotic progression, whereas 
the JNK and p38 pathways are involved in stress responses and innate immunity. In this 
chapter, I describe a novel p38 MAPK pathway that regulates germ cell survival. 
    p38 MAPKs are serine/threonine kinases important for cellular responses to 
inflammatory cytokines and environmental stresses (e.g. osmotic shock). In mammals, 
they also regulate the differentiation and survival of various cell types (e.g. 
cardiomyocytes). p38 MAPKs can be pro- or anti-apoptotic, depending on the cell type 
and the stimulus. For instance, activation of the transcription factor MEF2 by p38 MAPK 
upon excitotoxic insults (e.g. N-methyl-D-aspartate (NMDA)) is anti-apoptotic during 
neuron development, but pro-apoptotic in mature neurons (Okamoto et al., 2002). 
Mammals have four p38 MAPKs, only one of which (p38α) has been studied through 
gene targeting in the mouse: p38α-/- mice are embryonic lethal owing to placental defects 
(Adams et al., 2000; Tamura et al., 2000). 
    C. elegans has three genes encoding p38 MAPKs: pmk-1, -2, and -3. These genes are 
arranged into a single operon on chromosome IV (Figure 4.1a) (Berman et al., 2001). 
Recently, an elegant genetic screen for mutants with impaired innate immunity showed 
that the PMK-1 isoform plays an important role in the worm’s response to pathogen 
infections (Kim et al., 2002). The authors mutagenized wild-type worms, and then looked 
for mutants hyper-sensitive to Pseudomonas infections. They found that mutations in nsy-
1 (a MAPKKK), sek-1 (a MAPKK), or RNAi knockdown of pmk-1 (a p38 MAPK) 
enhance susceptibility to pathogens. Using an antibody that recognizes active PMK-1, 
they could also show that NSY-1 and SEK-1 act upstream of PMK-1, in a linear pathway. 
Another recent article took this result further, by assigning a pro-apoptotic activity to 
PMK-1 (Aballay et al., 2003). It was already known that Salmonella infections trigger an 
innate immune response in worms, resulting in increase germ cell death (Aballay and 
Ausubel, 2001). The Ausubel laboratory demonstrated that these Salmonella-induced 
germ cell deaths are completely dependent on the NSY-1→SEK-1→PMK-1 pathway 
(Aballay et al., 2003). Unfortunately, the authors could not provide a molecular model to 
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explain how PMK-1 signaling activates the core apoptotic machinery, although their 
epistasis analysis suggested that it acts upstream of ced-9.  
    In chapter 3, I reported that we had identified, in our genome-wide RNAi screen, pmk-
3 as a candidate regulator of germ cell apoptosis. We found that RNAi of or mutations in 
pmk-3 increased germ cell apoptosis in a p53-independent manner (Lettre et al., 2004). 
This suggests that, in contrary to PMK-1, PMK-3 has an anti-apoptotic role in the C. 
elegans hermaphrodite germ line. In this chapter, I characterize the pmk-3 gene, and 
identify the upstream components of this novel p38 MAPK pathway as well as one 
possible downstream effector. Finally, I discuss the possibility that ectopic activation of 
the PMK-1 pathway might be responsible, to some extent, for p53-independent germ cell 
apoptosis. 
 
4.3 RESULTS 
4.3.1 Mutations in pmk-3 cause p53-independent germ cell apoptosis 
    pmk-3 is the most 5’ gene in the ‘pmk’ operon on linkage group IV (Figure 4.1a). The 
gene has seven exons and codes for a protein of 474 amino acids. I obtained from the C. 
elegans gene knockout consortium the deletion allele ok169: this mutation removes a 
large part of the 5’ end of the gene, including exon 1 and intron 1 completely (Figure 
4.1b). Because ok169 eliminates the translational start site, I expect this mutation to be a 
strong loss-of-function, and likely a null. From the Mitani laboratory in Japan, I obtained 
pmk-3(tm745). In this mutant, a 733 base pairs deletion removes exons 2 and 3, and most 
of intron 3, thus eliminating part of the PMK-3 kinase domain (Figure 4.1b). 
    In a first step, I showed that pmk-3(ok169) mutants have a Gla phenotype (Figure 4.2) 
(Lettre et al., 2004). The same phenotype for the second pmk-3 allele, tm745, was also 
observed (Figure 4.2b). The Gla phenotype of pmk-3(tm745) animals is weaker compared 
to ok169 animals, maybe reflecting the nature of the mutations (see above).  Since the 
phenotype of ok169 appears stronger than tm745, and is therefore more likely to reflect 
the true pmk-3 loss-of-function phenotype, the remaining experiments presented in this 
chapter were performed with ok169. 
    We had also shown that pmk-3(ok169) or pmk-3(RNAi) increase germline apoptosis in 
a p53-independent manner, because the number of apoptotic corpses is not reduced in 
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cep-1(gk138); pmk-3(ok169) double mutants (Lettre et al., 2004). The results from this 
epistasis study can be found in Table 4.1; I also included the results from the pmk-
3(ok169); egl-1(n1084 n3082) strain, which were omitted in the original publication. The 
pro-apoptotic BH3-domain gene egl-1 is the main transcriptional target of CEP-1 upon 
DNA damage. As expected, the loss-of-function mutation in egl-1 does not suppress pmk-
3(lf)-induced germ cell death, confirming that the CEP-1→EGL-1 pathway is not 
required for the Gla phenotype observed in pmk-3(lf) animals (Table 4.1). 
 
4.3.2 Characterization of pmk-3(ok169) 
    The ok169 deletion allele was obtained using a TMP/UV mutagenesis protocol. In the 
past, it has been reported that this mutagen can cause genes to move from their 
endogenous positions to other genomic locations, such that there is a deletion in the locus 
but still a wild-type copy of the gene in the genome (Derry et al., 2001). To address this 
possibility, I analyzed the pmk-3 locus by Southern blotting. The genomic region 
surrounding pmk-3 is depicted in Figure 4.3a: I used a probe that anneals downstream of 
ok169, and the restriction enzymes BamHI or ApaLI. Beside the BamHI star activity 
products, I exactly obtained the predicted restriction fragments (Figure 4.3b). Based on 
these results, and the fact that it is impossible to amplify a PCR fragment with primers 
that anneal within the ok169 deletion, I conclude that ok169 is a ‘clean’ deletion and that 
there is no wild-type copy of pmk-3 in ok169 animals.  
    There is no obvious phenotype associated with pmk-3(ok169) other than the Gla 
phenotype. The worms grow normally, the brood size is normal (269±35 vs. 265±28 for 
wild-type and pmk-3(ok169), respectively (mean ±s.d., n=10)), and there is no sign of 
embryonic lethality. However, there is a synthetic phenotype with unc-119 mutant 
animals. While I was trying to build the double mutant unc-119(ed3); pmk-3(ok169) for 
bombardment, I realized that the strain grew very slowly and that most animals arrested 
at the L1 or L2 larval stage. This might suggest that pmk-3 is involved in some aspects of 
neuronal cell fate determination. This result is interesting because it is already known that 
the NSY-1→SEK-1→PMK-1 pathway is important for the cell fate of the AWC neurons 
in C.elegans (Takeda and Ichijo, 2002). 
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4.3.3 pmk-3 is expressed in the germ line 
    Berman et al. used a GFP reporter to show that the ‘pmk’ operon is expressed in 
intestinal cells (Berman et al., 2001). They did not report any expression in the germ line 
or the somatic gonad. However, this result was expected because they used extra-
chromosomal arrays for their expression analysis; since these arrays contain several 
copies of the transgene, they tend to be silenced in the germ line.  
    To determine whether pmk-3 is expressed in germ cells, I performed RNA in situ 
hybridization with the full-length pmk-3 cDNA as probe. I dissected gonads from wild-
type and pmk-3(ok169) animals, and incubated them with sense or antisense probes 
labeled with digoxigenin. The results presented in Figure 4.4 show very clearly that pmk-
3 is expressed in the death-sensitive zone of the germ line (at and distal to the bend), 
consistent with the idea that pmk-3 is important for germ cell survival. pmk-3 also seems 
to be expressed in the proximal arm of the gonad, although this observation needs to be 
confirmed because few intact gonads were observed (i.e. with both distal and proximal 
arms). As control, hybridization of pmk-3(ok169) gonads with the antisense probe, or 
wild-type gonads with the sense probe, did not give any specific signal (Figure 4.4). This 
control experiment suggests that there is no pmk-3 mRNA in ok169 mutants, maybe 
because the mutation affects the stability of the transcript, or prevents trans-splicing from 
the poly-cistronic message. Northern blot experiments are required to definitely solve this 
issue. 
 
4.3.4 Over-expression of pmk-3 in germ cells rescues the pmk-3(ok169) Gla phenotype 
    Disruptions of pmk-3 by two different alleles, ok169 and tm745, as well as its RNAi 
knockdown, cause a Gla phenotype. However, one could argue that these ‘inactivations’ 
also affect the neighboring genes in the ‘pmk’ operon (i.e. pmk-1 and pmk-2), and that the 
Gla phenotype observed is due to general inactivation of the three p38 MAPK isoforms. 
For this reason, it was important to show that the Gla phenotype in pmk-3(lf) animals can 
be rescued by over-expressing wild-type pmk-3. 
    Rescue experiments in the C. elegans germ line are never trivial because multiple 
copies of transgenes are silenced by RNAi-based mechanisms. For this reason, I used 
biolistic transformation to obtain transgenic lines carrying but a few tandem copies of 
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transgene, integrated randomly on one of the chromosome. The transgene was built such 
that the coding part from the pmk-3 locus was fused to the C-terminus of green 
fluorescent protein (GFP), and expressed under the control of the pie-1 regulatory 
sequences (Ppie-1::gfp::pmk-3). The pie-1 gene is a transcriptional repressor normally 
expressed in germ cells and early embryos; its enhancer/promoter elements have been 
used in the past to drive transgene expression into germ cells (Seydoux et al., 1996). 
    I obtained two different lines with integrated transgenes: opIs137 and opIs138. I 
crossed these transgenes into pmk-3(ok169) worms, and performed time course analysis 
to investigate if they could rescue the Gla phenotype. Both transgenes bring the number 
of germ cell deaths back to wild-type level, suggesting that, indeed, the Gla phenotype 
observed is only due to pmk-3(lf) (Figure 4.5a). This result is a very strong proof that 
pmk-3 has a major role in germ cell survival.  
    Interestingly, I found that the fusion protein GFP::PMK-3 exclusively localized to 
germ cell nuclei (Figure 4.5b). This result agrees with the dogma that active MAPKs 
translocate to the nucleus (Lee et al., 2000), and suggests that the downstream targets of 
PMK-3 are nuclear. Two reasons can explain why cytoplamic GFP::PMK-3 could not be 
observed: (1) maybe PMK-3 is constitutively active, or (2) maybe this over-expression 
setup leads to GFP::PMK-3 auto-activation. 
 
4.3.5 MKK-4 and MTK-1 are in the same pathway than PMK-3 
    I was interested to identify which MAPKK and MAPKKK act upstream of the p38 
MAPK PMK-3 to regulate germ cell death. There was no obvious candidate from the 
dataset obtained from the RNAi screen for Gla genes (see Chapter 3). Therefore, I 
decided to systematically inactivate, by RNAi or with genetic mutations, every worm 
gene encoding a putative MAPKK or MAPKKK. At this stage of this project, I was 
fortunate to obtain several deletion mutants for MAPKK and MAPKKK genes from the 
laboratory of Professor Kunihiro Matsumoto in Nagoya, Japan. I tested for a Gla 
phenotype inactivation of the MAPKK genes mek-1, mek-2, mkk-4, jkk-1, and gck-1, as 
well as the MAPKKK genes dlk-1, mtk-1, mlk-1, zak-1, and gck-2. Only the mkk-4(km23) 
and mtk-1(km33) mutant strains had increased germ cell death compared to wild-type 
animals (Figures 4.6b and 4.7b). km23 removes exons 4-to-10 of mkk-4, and km33 
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removes exons 6-to-8 of mtk-1 (Figures 4.6a and 4.7a). Importantly, neither the double 
mutants pmk-3(ok169); mkk-4(km23) and mtk-1(km33); pmk-3(ok169), nor the triple 
mutant mtk-1(km33); pmk-3(ok169); mkk-4(km23) showed any increase in the Gla 
phenotype compared to the single mutants, suggesting that all these genes lie in the same 
genetic pathway: mtk-1→mkk-4→pmk-3 (Figures 4.6b, 4.7b, and 4.7c). 
    Why were mkk-4 and mtk-1 not identified in the RNAi screen? The RNAi clone for 
mtk-1 did not grow during the original screen such that mtk-1(RNAi) could not be 
checked for a Gla phenotype. The clone for mkk-4 grew, but no Gla phenotype was 
observed, maybe because the mkk-4(RNAi) Gla phenotype is too weak. Indeed, Figure 
4.6b shows that the Gla phenotype in mkk-4(km23) animals is not as strong as in pmk-
3(ok169) worms. This would suggest that there is possibly redundancy in the cascade and 
that another unidentified MAPKK can phosphorylate PMK-3. This scenario is quite 
possible because, in mammals, at least two MAPKKs (MKK-3 and -6) can activate p38 
MAPK. 
 
4.3.6 What signals activate the MTK-1→MKK-4→PMK-3 cascade? 
    mtk-1 is a well-conserved gene, with homologues from yeast to humans. In S. 
cerevisiae, the MTK-1-like Ssk2p activates the high-osmolarity response pathway, which 
leads to the phosphorylation of the p38 MAPK Hog1p (Yuzyuk et al., 2002). To check 
whether osmotic stress is a pro-apoptotic stimulus in the C. elegans germ line, which is 
normally counter-balanced by the survival activity of PMK-3, I treated worms with high 
salt concentrations or sorbitol. Unfortunately, these experiments were not conclusive: 
weak osmotic stresses did not produce any germline phenotypes, whereas stronger 
stresses resulted in lethality or growth defects. Therefore, it remains unclear whether 
osmotic stresses can induce germline apoptosis. To properly realize this experiment, one 
would need to specifically stress germ cells, without affecting the somatic tissue. Thus, 
injection of highly osmotic solutions directly into the gonads could be attempted. 
    In mammals, MTK-1 is activated by the stress-inducible molecule GADD45 in 
response to TGF-β signaling (Takekawa et al., 2002). However, C. elegans does not have 
a GADD45 homologue. Nevertheless, because TGF-β is a well-described survival signal, 
I studied the importance of TGF-β signaling on germ cell survival. The worm has four 
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TGF-β-like proteins: DAF-7, DBL-1, UNC-129, and TIG-2. Genetic mutations or RNAi 
knockdowns of each of these genes, as well as all possible double inactivations, did not 
produce a Gla phenotype. This suggests that TGF-β signaling does not play a survival 
role in the C. elegans germ line. 
    In conclusion, I have been unable to determine what signals lead to the activation of 
the MTK-1→MKK-4→PMK-3 cascade. Genetic screens or biochemical approaches, 
such as the purification of the MTK-1 complex, could give us more insights into the 
regulation of this pathway. 
 
4.3.7 MEF-2 might be a downstream effector of PMK-3 
    Several proteins, including many different transcription factors, are known substrates 
of p38 MAPKs in mammals. Myocyte enhancer factor-2 (MEF2) is a MADS (MCM1, 
Agamous, Deficiens, and Serum response factor) box-type transcription factor implicated 
in myogenesis and neurogenesis (McKinsey et al., 2002). p38α MAPK can directly 
phosphorylate MEF2 in cell culture experiments and this phosphorylation event is 
important for the role of MEF2 in neuronal differentiation and survival/apoptosis (Mao et 
al., 1999; Yang et al., 1999; Zhao et al., 1999). Transfection of neuronal precursor cells 
with dominant-negative (DN) forms of MEF2 or p38 MAPK induces apoptosis, and co-
transfection of a constitutively active form of MEF2 with the p38 MAPK(DN) blocks the 
apoptotic response (Okamoto et al., 2000; Okamoto et al., 2002). These biochemical 
experiments put p38 MAPK upstream of MEF2, and clearly demonstrate that p38 MAPK 
can promote cell survival in mammals. Importantly, it is unknown how the p38 MAPK 
→ MEF2 pathway ensures cell survival. 
    C. elegans has one MEF2 homologue, mef-2, which is not essential for myogenesis and 
development (Dichoso et al., 2000). Because of the anti-apoptotic activity of MEF2 in 
mammalian cells and its interaction with p38 MAPK, I was interested to check whether 
worm mef-2 is an effector of pmk-3 in the C. elegans germ line. Two deletion alleles of 
mef-2 are available: gv1 is a predicted null because it removes the DNA-binding domain 
of MEF-2, whereas gv2 leaves the DNA-binding domain intact but affects the 
transactivation domain (Figure 4.8a) (Dichoso et al., 2000). The two mutant strains mef-
2(gv1) and mef-2(gv2) were scored for germline apoptosis; assuming that C. elegans 
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MEF-2 plays a similar role in the germ line than its mammalian homologue in developing 
neurons, loss of mef-2 function should cause increased germ cell death. Indeed, time-
course analysis showed that both deletion mutants have a modest, but significant, 
increase in the levels of germline apoptosis (Figures 4.8b and 4.8c). Surprinsingly, the 
Gla phenotype of mef-2(gv2) is stronger than the Gla phenotype of the putative null mef-
2(gv1). There are two possible explanations for this result: (1) mef-2(gv1) animals have 
an egg-laying defect (Egl) phenotype such that the accumulation of embryos within the 
animal renders apoptotic corpse count difficult, and (2) mef-2(gv2) is an antimorph 
(dominant-negative) allele because the encoded protein still have a DNA-binding domain 
but only a truncated transactivation domain. It should be possible to test the latter 
possibility by scoring germline apoptosis in mef-2(gv2)/+ heterozygotes. The double 
mutants mef-2(gv1); pmk-3(ok169) and mef-2(gv2); pmk-3(ok169) have a Gla phenotype 
equivalent to the Gla phenotype of pmk-3(ok169) single mutant (Figures 4.8b and 4.8c). 
The results of this epistasis analysis suggest that MEF-2 might be one of the proteins that 
mediate the survival activity of PMK-3 in C. elegans germ cells. 
    At this point, caution must be raised concerning the interpretation of the results 
presented above. I have shown that for one assay (apoptotic germ cell count), there are 
genetic interactions between mtk-1, mkk-4, pmk-3, and mef-2. However, one would like to 
test this model by so-called gain-of-function experiments, to show the specificity of the 
phenotypes. To address this important point, I built a transgene where the DNA-binding 
domain of MEF-2 is fused to the strong transactivation domain of the viral protein VP16 
(MEF-2 activated form). If the model is correct, MEF-2::VP16 should rescue the Gla 
phenotype of all the genes in this p38 MAPK pathway. I have also created a transgene 
encoding a dominant negative form of MEF-2. If MEF-2 is downstream of PMK-3, this 
MEF-2(DN) should cause a Gla phenotype even when PMK-3 is over-expressed (Figure 
4.5). Unfortunately, although these two constructs are ready, I have been unable to obtain 
transgenic animals with germline expression so far. 
 
4.3.8 Does PMK-1 activation induce physiological germ cell death? 
    In the introduction of this chapter, I mentioned that Salmonella infections can induce 
germ cell death in C. elegans, and that this induction depends on the p38 MAPK isoform 
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PMK-1 (Aballay and Ausubel, 2001; Aballay et al., 2003). Therefore, two genes, 
expressed from the same operon (Figure 4.1a), have antagonistic functions: PMK-1 is 
pro-apoptotic in the germ line upon bacterial infection, whereas PMK-3 is anti-apoptotic 
in the same tissue. It is possible that these p38 MAPKs interfere with each other: in this 
model, the Gla phenotype of pmk-3(lf) could be caused by ectopic activation of PMK-1. 
To test this model, I performed immunoblots with an antibody that recognizes the 
phosphorylated form of PMK-1 (active PMK-1), and another antibody that recognizes 
PMK-1 (Figure 4.9a). As controls, I used protein extracts from pmk-1(km25) (no PMK-1 
protein), sek-1(ag1) and nsy-1(ag3) (no phosphorylated PMK-1 because SEK-1 and 
NSY-1 are the MAPKK and MAPKKK upstream of PMK-1), and vhp-1(sa366) animals 
(more phosphorylated PMK-1, because VHP-1 is the phosphatase that inactivates PMK-
1). Interestingly, pmk-3(ok169), but also gla-1(op234), gla-3(op212), and gla-3(op216) 
mutants have elevated level of active PMK-1 when compared to wild-type worms (Figure 
4.9a). Inactivation of these three genes (pmk-3, gla-1, gla-3) causes p53-independent 
germ cell death (Chapter 3), and we have suggested that they regulate the physiological 
germ cell death pathway. Hyper-activation of PMK-1 in these mutant backgrounds is not 
a by-product of increased germline apoptosis per se, because ced-9(n1653) or irradiated 
worms, which have a Gla phenotype, do not have high level of active PMK-1. Also, 
although vhp-1(sa366) mutants have more active PMK-1 (Figure 4.9a), I could not 
observe a Gla phenotype in these worms because they have a severe growth delay 
phenotype. 
    If ectopic activation of PMK-1 is responsible for physiological germ cell death, 
disrupting pmk-1 should suppress the Gla phenotype of pmk-3(lf), gla-1(lf), and gla-3(lf). 
I built the gla-1(op234); pmk-1(km25) and gla-3(op216); pmk-1(km25) double mutants 
and scored them for germline apoptosis (obviously, the pmk-3(ok169) pmk-1(km25) strain 
could not be built as these genes are ~five kb apart on LG IV). Data presented in Figure 
4.9b shows that a mutation in pmk-1 suppresses by ~30% the Gla phenotype of gla-
1(op234) and gla-3(op216). Therefore, pmk-1 might be one of the genes that activate 
physiological germline apoptosis in C. elegans (see discussion). 
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4.4 DISCUSSION 
4.4.1 A novel p38 MAPK pathway regulates germ cell survival in C. elegans 
    p38 MAPKs are involved in stress responses and cell differentiation in metazoans. In 
C. elegans, the p38 MAPK PMK-3 promotes germ cell survival because inactivation of 
pmk-3 via mutations or RNAi results in increased germ cell apoptosis (Figure 4.2). 
Epistasis analysis has revealed that loss of pmk-3 function causes germ cell apoptosis 
independently of the worm p53 homologue cep-1 (Table 4.1), thus establishing pmk-3 as 
a possible regulator of the physiological germ cell death pathway in worms. I have also 
shown, by RNA hybridization, that pmk-3 is expressed in the death-sensitive zone of the 
germ line (Figure 4.4), and by tissue-specific rescue, that PMK-3 activity is required in 
the nuclei of germ cells (Figure 4.5). 
    MAPK are part of phosphorelays, involving upstream MAPKKK and MAPKK. 
Searching for the upstream components of the PMK-3 pathway, I found that mutations in 
the MAPKKK gene mtk-1 and in the MAPKK gene mkk-4 produce a Gla phenotype. 
Importantly, the triple mutant mtk-1; pmk-3; mkk-4 did not have a stronger Gla phenotype 
than pmk-3(ok169), suggesting that these genes all belong to the same genetic pathway 
(Figures 4.6 and 4.7). Because of the molecular nature of the proteins encoded by mtk-1, 
mkk-4, and pmk-3, it is tempting to propose a model where the MAPKKK MTK-1 
activates the MAPKK MKK-4, which itself activates the p38 MAPK PMK-3. However, 
biochemical experiments, such as immunoblotting with an anti-phospho-PMK-3 
antibody, will be required to confirm this hypothesis. 
 
4.4.2 What is upstream and downstream of the pmk-3 pathway? 
    Unfortunately, I have been unable to identify the stimulus or developmental cue that 
activates the PMK-3 pathway. This is certainly a question of great interest because we 
still ignore what triggers physiological germ cell death; it is possible that the upstream 
components of the PMK-3 pathway would give us a hint concerning the nature of the 
inducer(s). The most upstream gene in the signaling cascade described in this chapter is 
mtk-1. Therefore, identification of the proteins that interact with MTK-1 should be a 
priority to understand what regulates the anti-apoptotic activity of PMK-3 in the germ 
line. Our collaborators in Japan, Dr. Naoki Hisamoto and Prof. Kunihiro Matsumoto 
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(Nagoya University) are currently developing a functional screening system in yeast to 
identify proteins that can interact with MTK-1, and will inform us of their future results. 
In addition, one could try to co-purify the proteins that interact with a tag version of 
MTK-1 in vivo in C. elegans. 
    I have presented preliminary data suggesting that the transcription factor MEF-2 might 
act downstream of PMK-3 to promote germ cell survival. Mutations in mef-2 cause a Gla 
phenotype, and double mutants mef-2(lf); pmk-3(lf) do not have an additive Gla 
phenotype (Figure 4.8). To test the PMK-3→MEF-2 interaction, I built transgenes 
encoding an activated form (MEF-2::VP16) and a dominant negative form (MEF-2DN) 
of MEF-2, but I have not yet been able to obtain transgenic lines that express the 
constructs in the germ line. These transgenic strains would also be useful to address 
another very important issue concerning the identification of the MEF-2 targets that 
promote germ cell survival. Indeed, in silico approaches to identify MEF-2 target genes 
have so far been unsucessful. For the proposed experiment, RNA from Ppie-1::gfp::mef-
2::VP16 and Ppie-1::gfp::mef-2DN animals would be isolated, amplified and labeled, and 
hybridized on a microarray. This strategy should yield the genes that are regulated by 
MEF-2 in germ cells, including those with anti-apoptotic activity. 
    In C. elegans, MEF-2 has been shown to physically interact with the class II histone 
deacetylase (HDAC) HDA-4 by yeast-two-hybrid and in vitro pull-down assays (Choi et 
al., 2002). Histone deacetylation by HDACs is associated with heterochromatin and other 
transcriptionally silent genomic regions. As such, HDACs are thought to act as 
transcriptional repressors. Work in mammalian cells has revealed that MEF2 can interact 
with several class II HDACs, and that MEF2 phosphorylation by calcium/calmodulin-
dependent protein kinase (CaMK) is required to disrupt MEF2-HDAC interactions (Lu et 
al., 2000). If PMK-3 activates MEF-2 in the C. elegans germ line by disrupting the 
interaction between MEF-2 and HDA-4, the model predicts that removing hda-4 activity 
should suppress the Gla phenotype of pmk-3(lf) mutants. I obtained the hda-4(ok518) 
allele and built a double mutant strain with pmk-3(ok169): preliminary data show that 
pmk-3(ok169); hda-4(ok518) animals have a wild-type level of germline apoptosis 
(Apoptotic germ cells/gonad 24 hours post stage L4 (mean ±s.d.): wild-type 1.9±0.6; 
pmk-3(ok169) 4.0±0.2; pmk-3(ok169); hda-4(ok518) 2.0±0.2). If correct, this result 
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suggests that PMK-3 function is to release MEF-2 from HDA-4 repressing activity; in the 
absence of HDA-4, MEF-2 can recruit the transcriptional machinery required for the 
expression of germ cell-specific anti-apoptotic genes. Although very speculative, this 
model is nevertheless very seducing. Of course, additional experiments are required 
before it is proven correct. 
 
4.4.3 PMK-1 activation and physiological germ cell death  
    It was rather surprising to discover that a high level of active PMK-1 is present in some 
mutants (gla-1, gla-3, pmk-3) with increased levels of germline apoptosis (Figure 4.9a). 
This finding suggests that PMK-1 might be one of the key inducer of physiological germ 
cell death. Indeed, the double mutants gla-1(lf); pmk-1(lf) and gla-3(lf); pmk-1(lf) have 
significantly less apoptotic germ cells compared to the single mutant gla-1(lf) and gla-
3(lf), demonstrating that PMK-1 activation is partially responsible for the Gla phenotype 
of these animals (Figure 4.9b). However, there has to be other genes than pmk-1 that 
contribute to physiological germ cell death because pmk-1(lf) does not completely 
suppress the Gla phenotype of gla-1 and gla-3.  
    We have shown that mutations in genes of the DNA damage pathway, such as cep-1, 
weakly suppress the Gla phenotype of genes, like gla-1, that presumably act in the 
physiological germ cell death pathway (Chapter 3, Table 1). To explain this weak 
suppression, we have proposed that mutants with a strong Gla phenotype have more 
endogenous DNA damage, and that this damage leads to few cep-1-dependent apoptotic 
deaths. At this stage, it is unclear whether pmk-1 is in a p53-independent pathway (p38 
MAPK can directly phosphorylate p53 in mammalian cells) and therefore whether the 
suppression presented in Figure 4.9b is due (partially) to the absence of apoptotic deaths 
induced by endogenous DNA damage. 
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4.5 MATERIALS AND METHODS 
4.5.1 Nematode strains and culture 
    Standard procedures for nematode culture and genetic manipulation were followed 
with growth at 20oC, unless otherwise noted (Brenner, 1974; Gumienny et al., 1999; 
Sulston and Hodgkin, 1988). The wild-type N2 Bristol strain was used. C. elegans gene 
mutations relevant to this study are as followed: LGI: hus-1(op244), mtk-1(km33), gla-
1(op234), gla-3(op212), gla-3(op212), cep-1(gk138), mef-2(gv1), mef-2(gv2); LGII: nsy-
1(ag3), vhp-1(sa366); LGIII: ced-9(n1653ts), ced-9(n1950gf), unc-119(ed3); LGIV: 
pmk-1(km25), pmk-3(ok169), pmk-3(tm745), ced-3(n717); LGV: egl-1(n1084n3082); 
LGX: sek-1(ag1), mkk-4(km23). Phenotypes are described either by Riddle (Riddle et al., 
1997), or in this thesis. 
    The following PCR primers were used to genotype the deletion mutants: 
Primers to genotype deletion mutants 
Mutation Forward primer 
(5’→3’) 
Reverse primer 
(5’→3’) 
WT 
product 
size (bp) 
Mutant 
product 
size (bp) 
mtk-1(km33) CATGAACCTATGTTTAGCCTTTAAC CGAAAACAATACATGATGGTTATGG 1777 573 
mef-2(gv1) CCTTAATTAATTAATGCTGCTGCTC TAATGCAAAATTACGGTAAACGGTC 2396 1020 
mef-2(gv2) CCTTAATTAATTAATGCTGCTGCTC TAATGCAAAATTACGGTAAACGGTC 2396 1636 
pmk-1(km25) TTTGTGTCCCTAATTCCTTGATCTC TGAGTCCACGAAGAATTTGATAGAC 868 493 
pmk-3(ok169) CCCATTTTTCACTGCGTCTCAATCG TCTGCTTCTCCAGGGATTAACGGTG 3681 2397 
pmk-3(tm745) CCCATTTTTCACTGCGTCTCAATCG TCTGCTTCTCCAGGGATTAACGGTG 3681 2947 
mkk-4(km23) ATCCGAGAAAGGACCAAATATCGTG AATCGGAGGGAAGAGAGAGAGAAAG 1712 309 
 
4.5.2 Light and fluorescent microscopy 
    Microscopic analysis of cells was done using standard live-animal techniques: worms 
were mounted on 4% agarose pad and anesthetized with 30 mM NaN3 in M9 buffer. 
Observations were done using a Leica DM RXA2 microscope fitted with Nomarski 
optics. Images were captured with a ORCA-ER digital CCD camera (Hamamatsu) and 
processed with OpenLab software. Fluorescence stereomicroscopy was done with a Leica 
MZ FLIII or a Zeiss Stemi SV11 M2BIO stereomicroscope. 
 
4.5.3 Biolistic transformation 
    GFP::PMK-3 lines were constructed with pID3.01B_pmk-3 (the original vector, 
pID3.01B, is a gift from Dr. Geraldine Seydoux, John Hopkins University). The plasmid 
contains a translational fusion of gfp (N-terminus) with the full-length genomic 
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sequences of pmk-3 (ATG to stop codon). Cloning was performed using Gateway 
Cloning technology (Invitrogen) according to the protocol from the Seydoux 
laboratory. The plasmid also contains the rescuing unc-119 genomic sequence from 
pDPMM016. The construct was bombarded into unc-119(ed3) worms as previously 
described (Praitis et al., 2001). To obtain germline expression, 0.5 µg of DNA per 
bombardment was used. Integration of each construct was determined by loss of visible 
Unc-119 offspring. 
 
4.5.4 Cloning 
    Cloning was performed according to standard molecular biology techniques described 
by Sambrook and Russel (Sambrook and Russell, 2001). Some ligation reactions were 
done using the Rapid DNA Ligation Kit (Roche). TOPO TA Cloning and Gateway 
Cloning were performed according to the protocols provided by the manufacturer 
(Invitrogen). 
 
4.5.5 Polymerase chain reaction (PCR) 
    PCR was performed using Biotaq DNA polymerase (Bioline), Pfu Turbo DNA 
polymerase (Stratagene), or the Expand High Fidelity PCR system (Roche) according to 
the manufacturers’ protocols.  
 
4.5.6 Southern blotting 
    Genomic DNA from wild-type and pmk-3(ok169) worms was extracted using the 
Purogene DNA Isolation Kit (Gentra Systems). DNA transfer from agarose gel onto 
Hybond N+ membrane was done as described by Sambrook and Russel (Sambrook and 
Russell, 2001). The probe corresponds to the genomic fragment 25 137 - 26 089 of 
cosmid F42G8 (encompassing exons 2-5 of pmk-3) and was labeled using the PCR DIG 
Probe Synthesis Kit (Roche). Hybridization and detection were performed using the DIG 
DNA Labeling and Detection Kit (Roche). 
 
4.5.7 RNA in situ hybridization 
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    Gonads from 24 hours post L4 wild-type and pmk-3(ok169) worms were dissected in 
PBS/0.2 mM levamisole, and fixed for 2 hours at room temperature in 3% 
paraformaldehyde/0.25% glutaraldehyde/0.1M K2HPO4 (pH 7.2). The RNA sense and 
antisense probes were synthesized using the full-length pmk-3 cDNA (cloned into 
pBluescript SK(-) (Stratagene)) as template and the DIG RNA Labelling Kit (Roche). 
The pmk-3 cDNA is a gift from Dr. Melanie Cobb, University of Texas Southwestern. 
RNA hybridization was performed as described by Lee and Schedl (Lee and Schedl, 
2004) and online at http://www.genetics.wustl.edu/tslab/gonad_in_situ.html, with the 
following modifications: 1) probes were diluted 1:5 in hybridization buffer, 2) the 
hybridization was done for 24 hours at 48oC, and 3) gonads were incubated with the anti-
DIG antibody for 14 hours at 4oC. 
 
4.5.8 Protein extraction 
    Adult worms were washed off the plates with water, and washed once more with 
water. Worm pellets were then frozen in liquid nitrogen and kept at –80oC. To extract 
proteins, an equal volume of acid-washed glass beads (Sigma) was added to the frozen 
worm pellet, and the tubes were put in a bead beater (FastPrep FP120) for 35 seconds at 
speed 6.5. 100 µl – 300 µl of RIPA buffer [50 mM Tris (pH 8.0), 150 mM NaCl, 1% NP-
40, 1% deoxycholate, 1% SDS, Complete Mini protease inhibitor 1 tablet/10 ml (Roche)] 
or immunoprecipitation buffer [25 mM HEPES-NaOH (pH 7.4), 150 mM Nacl, 0.2 mM 
DTT, 10% glycerol, 1% Triton X-100, Complete Mini protease inhibitor 1 tablet/10 ml 
(Roche)] was added to the tubes, vortexed, and incubated on ice for ten minutes. Extracts 
were centrifuged for 15 minutes at 13,200 RPM at 4oC. Supernatants were collected and 
kept at -80oC. Protein quantification was done using the Bio-Rad protein assay as 
recommended, with bovine serum albumin (BSA) as standard. 
 
4.5.9 Protein gel electrophoresis 
    The Laemmli SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
technique for protein electrophoresis was used, as described by Westermeier 
(Westermeier, 2001), usually with a 10% acrylamide gel. Alternatively, pre-cast 
NuPAGE® 4-12% gradient gels from Invitrogen were used, as recommended. The 
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SeeBlue® Plus2 pre-stained standard (Invitrogen) was used as molecular size marker, 
and the SimplyBlue™ Safestain (Invitrogen) for protein visualization. 
 
4.5.10 Western blotting 
    Primary antibodies used in this study were: anti-ACTIVE® p38 pAb, Rabbit 
(Promega) 1:2000; anti-PMK-1 pAb, Rabbit (gift from Dr. Kunihiro Matsumoto, Nagoya 
University) 1:1000; anti-GFP mAb, Mouse (Roche) 1:1000; anti-α-tubulin mAb, Rat 
(Immunologicals Direct), 1:1000. Secondary antibodies (peroxidase-conjugated) used in 
this study were: goat anti-rabbit (Pierce) 1:30 000; goat anti-mouse (Pierce) 1:10 000; 
goat anti-rat (Jackson Immuno Research) 1:10 000. Proteins were transferred onto PVDF 
membrane (30 volts, 75 minutes) using the wet transfer apparatus from Invitrogen. Blots 
were blocked for 1 hour with TBS-T (Tween 20 0.1%) plus 5% fat-free milk at room 
temperature, or, for the anti-phospho p38 antibody, overnight with TBS-T plus 1% 
immunoglobulin-free BSA at 4oC. Primary antibodies were added (overnight at 4oC for 
all except for the anti-phospho p38 antibody, which was incubated two hours at room 
temperature). Blots were washed three times ten minutes with TBS-T, and secondary 
antibodies were added for one hour at room temperature. Blots were washed three times 
ten minutes with TBS-T. Detection was done using homemade fluorescent peroxidase 
substrate (mixing equal volume of solution A [2.5 mM luminol, 0.4 mM p-coumeric acid, 
0.1 M Tris-HCl (pH 8.5)] and solution B [0.1 M Tris-HCl (pH 8.5), 0.02% H2O2]). 
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TABLE 4.1 Epistasis analysis with pmk-3(ok169) 
Genotype Germ cell deaths per gonad1 
wild-type 1.9±0.6 
pmk-3(lf) 4.0±0.2 
ced-3(lf) 0 
pmk-3(lf) ced-3(lf) 0 
hus-1(lf) 1.0±0.1 
hus-1(lf); pmk-3(lf) 3.4±0.2 
cep-1(lf) 1.2±0.4 
cep-1(lf); pmk-3(lf) 3.7±0.6 
egl-1(lf) 1.3±0.6 
pmk-3(lf); egl-1(lf) 3.7±0.1 
ced-9(gf) 1.4±0.3 
ced-9(gf); pmk-3(lf) 3.3±0.1 
1The mean number of apoptotic corpses per gonad ± s.d. was 
obtained from 3 independent experiments. The total number 
of gonads scored for each experiment was 20. Wild-type: N2. 
pmk-3(lf): pmk-3(ok169). ced-3(lf): ced-3(n717). hus-1(lf): 
hus-1(op244). cep-1(lf): cep-1(gk138). egl-1(lf): egl-1(n1084 
n3082). ced-9(gf): ced-9(n1950). 
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FIGURE 4.1 The C. elegans pmk-3 locus 
(a) Genomic organization of the C. elegans operon on chromosome IV that contains pmk-
1, pmk-2, and pmk-3. The poly-cistronic message is transcribed from left-to-right, with 
pmk-3 at the 5’ end. The pmk-3(ok169) deletion is shown. 
(b) Genomic structure of the pmk-3 locus. The pmk-3 gene has seven exons and encodes 
a protein of 474 amino acids. The two pmk-3 deletions, ok169 and tm745, are shown. 
ok169 removes most of the 5’UTR and exon 1. tm745 removes exon 2 and 3. 
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FIGURE 4.2 Loss-of-function mutations in pmk-3 cause a Gla phenotype 
(a) Pictures of gonads from wild-type and pmk-3(ok169) worms. DIC pictures of worms 
grown at 20oC were taken 24 hours post larval stage L4. Apoptotic germ cells can be seen 
as highly refractile disks (arrows). For all the pictures, anterior is to the left and dorsal to 
the top. Scale bar, 10 µm. 
(b) Time-course analysis of germ cell death in wild-type, pmk-3(ok169), and pmk-
3(tm745) mutants. Worms were synchronized and scored for germ cell apoptosis by DIC 
every 12 hours post L4 stage. Data shown represent mean ±s.d. of three experiments 
(n=20 gonads for each experiment). 
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FIGURE 4.3 Analysis of the pmk-3 locus by Southern blotting (next page) 
(a) Schematic of the pmk-3 locus. The pmk-3 gene (black arrow), the ok169 deletion, and 
the probe used for Southern blotting are shown. Also indicated are the BamHI and ApaLI 
restriction sites in this 8 kb fragment of genomic DNA. Note that ok169 removes one of 
the ApaLI site. 
(b) Southern blotting was performed with a pmk-3 specific probe (see Material and 
methods) on genomic DNA from wild-type and pmk-3(ok169) animals. White asterisks 
indicate expected restriction products after digestion with BamHI or ApaLI. Additional 
bands can be seen in the BamHI digestion lanes; they likely represent star activity 
products. 
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FIGURE 4.3 
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FIGURE 4.4 pmk-3 is expressed in the germ line (next page) 
pmk-3 mRNA is detectable by RNA in situ hybridization at and distal to the bend of the 
gonad, in the death-sensitive zone. The antisense (AS) and sense (S) probes were 
synthesized using promoters downstream and upstream of the pmk-3 cDNA, respectively. 
Dark purple staining represents specific signal, whereas weaker pink staining corresponds 
to background. For all gonads, the distal ends are on the left of the figure and the bends 
are on the right; proximal arms are not shown. Scale bar, 25 µm. 
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FIGURE 4.4 
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FIGURE 4.5 pmk-3 over-expression rescues the pmk-3(ok169) Gla phenotype (next 
page) 
(a) Time-course analysis of germ cell death in wild-type, pmk-3(ok169), pmk-3(ok169); 
opIs137, and pmk-3(ok169); opIs138 animals. opIs137 and opIs138 are two independent 
lines carrying the same transgene: Ppie-1::gfp::pmk-3. Worms were synchronized and 
scored for germ cell apoptosis by DIC every 12 hours post L4 stage. Data shown 
represent mean ±s.d. of two experiments (n=20 gonads for each experiment).  
(b) GFP::PMK-3 is nuclear. Gonad of a pmk-3(ok169); opIs138 transgenic worm seen by 
Normarski optics (top panel) and with a GFP filter (bottom panel). Scale bar, 10 µm. 
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FIGURE 4.5 
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 FIGURE 4.6 mkk-4(km23) mutants have a Gla phenotype 
(a) Genomic structure of the mkk-4 locus. The mkk-4 gene has ten exons and encodes a 
protein of 363 amino acids. The km23 deletion removes part of exon 4, exons 5-to-10, 
and part of the 3’UTR of mkk-4. 
(b) Loss of mkk-4 function causes a Gla phenotype, and mkk-4 is in the same genetic 
pathway than pmk-3. Time-course analysis of germ cell death in wild-type, pmk-
3(ok169), mkk-4(km23), and pmk-3(ok169); mkk-4(km23) animals. Note that the strength 
of the Gla phenotype in the double mutant is not additive compared to the single mutants. 
Worms were synchronized and scored for germ cell apoptosis by DIC every 12 hours 
post L4 stage. Data shown represent mean ±s.d. of two experiments (n=20 gonads for 
each experiment). 
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FIGURE 4.7 mtk-1(km33) mutants have a Gla phenotype (next page) 
(a) Genomic structure of the mtk-1 locus. The mtk-1 gene has 15 exons and encodes a 
protein of 1420 amino acids. The km33 deletion removes exons 6 and 7, and part of exon 
8 of mtk-1. 
(b) Loss of mtk-1 function causes a Gla phenotype, and mtk-1 is in the same genetic 
pathway than pmk-3. Time-course analysis of germ cell death in wild-type, pmk-
3(ok169), mtk-1(km33), and mtk-1(km33); pmk-3(ok169) animals. Note that the strength 
of the Gla phenotype in the double mutant is not additive compared to the single mutants.  
Worms were synchronized and scored for germ cell apoptosis by DIC every 12 hours 
post L4 stage. Data shown represent mean ±s.d. of two experiments (n=20 gonads for 
each experiment). 
(c) pmk-3, mkk-4, and mtk-1 are in the same genetic pathway. Time-course analysis of 
germ cell death in wild-type, pmk-3(ok169), mtk-1(km33), mkk-4(km23), and mtk-
1(km33); pmk-3(ok169); mkk-4(km23) animals. Note that the strength of the Gla 
phenotype in the triple mutant is not additive compared to the single mutants.  Worms 
were synchronized and scored for germ cell apoptosis by DIC every 12 hours post L4 
stage. Data shown represent mean ±s.d. of three experiments (n=20 gonads for each 
experiment). 
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FIGURE 4.7 
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FIGURE 4.8 Mutations in the mef-2 locus cause a Gla phenotype (next page) 
(a) Genomic structure of the mef-2 locus. The mef-2 gene has five exons and encodes a 
protein of 340 amino acids. The gv1 deletion removes exons 2-to-4. The gv2 deletion 
removes part of exon 3, exon 4, and part of exon 5. 
(b) The mef-2(gv1) mutation causes a Gla phenotype, and mef-2 is in the same genetic 
pathway than pmk-3. Time-course analysis of germ cell death in wild-type, pmk-
3(ok169), mef-2(gv1), and mef-2(gv1); pmk-3(ok169) animals. Note that the strength of 
the Gla phenotype in the double mutant is not additive compared to the single mutants.  
Worms were synchronized and scored for germ cell apoptosis by DIC every 12 hours 
post L4 stage. Data shown represent mean ±s.d. of two experiments (n=20 gonads for 
each experiment). 
(c) The mef-2(gv2) mutation causes a Gla phenotype, and mef-2 is in the same genetic 
pathway than pmk-3. Time-course analysis of germ cell death in wild-type, pmk-
3(ok169), mef-2(gv2), and mef-2(gv2); pmk-3(ok169) animals. Note that the strength of 
the Gla phenotype in the double mutant is not additive compared to the single mutants.  
Worms were synchronized and scored for germ cell apoptosis by DIC every 12 hours 
post L4 stage. Data shown represent mean ±s.d. of two experiments (n=20 gonads for 
each experiment). 
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FIGURE 4.8 
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FIGURE 4.9 Possible role for PMK-1 in the regulation of germline apoptosis (next 
page) 
(a) PMK-1 is hyper-phosphorylated in pmk-3 (weakly), gla-1, and gla-3 mutants. 
Immunoblots with anti-phospho p38 MAPK antibody (top panel) and anti-PMK-1 
antibody (bottom panel) on protein extracts from C. elegans strains with the indicated 
genotype. PMK-1 has a molecular size of ~44 kDa. The same amount of proteins was 
loaded in each lane (40 µg), as indicated by the unspecific bands that act as internal 
loading controls. 
(b) pmk-1(km25) partially suppresses the Gla phenotype of gla-1(op234) and gla-
3(op216). Time-course analysis of germ cell death in wild-type, pmk-1(km25), gla-
1(op234), gla-3(op216), gla-1(op234); pmk-1(km25), and gla-3(op216); pmk-1(km25) 
animals. Note that pmk-1(km25) reduces the Gla phenotype of  gla-1(op234) and gla-
3(op216) by about one third. Worms were synchronized and scored for germ cell 
apoptosis by DIC every 12 hours post L4 stage. Data shown represent mean ±s.d. of two 
experiments (n=20 gonads for each experiment). 
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FIGURE 4.9 
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5.1 ABSTRACT 
   gla-1(op234) mutants have increased levels of germ cell apoptotis when compared to 
wild-type worms. To identify genes that trigger germ cell apoptosis, a gla-1(op234) 
suppressor screen was performed. After screening 21 500 haploid genomes, 16 mutants 
were recovered. Many of these mutations were in previously identified genes, including 
four alleles of ced-3, three alleles of ced-6, and one allele of ced-2. Two novel genetic 
suppressors, op385 and op387, were further characterized. Epistasis analysis implicates 
op385 and op387 in the regulation of the physiological germ cell death pathway: they act 
upstream of the bcl-2 homologue ced-9, and independently of the DNA damage pathway. 
op385 and op387 map to the middle of chromosome V and the right arm of chromosome 
X, respectively. Using SNP mapping, I narrowed down op387 to a 85 kb interval, 
containing 14 predicted genes. 
 
5.2 INTRODUCTION 
    Physiological germ cell death is the only well-characterized apoptotic pathway in C. 
elegans that is not triggered through transcriptional up-regulation of the pro-apoptotic 
gene egl-1 (Gumienny et al., 1999). As such, its study represents an interesting paradigm 
to identify novel, and potentially conserved, regulators of apoptosis. In this chapter, I 
describe a forward genetic screen that I performed to find genes that specifically control 
germ cell death, i.e. genes that play an egl-1-like role in the C. elegans germ line. To 
identify such genes, I screened for mutations that could suppress the increased germline 
apoptosis (Gla) phenotype of gla-1(op234). As discussed in chapter 2, gla-1 encodes a 
CPEB protein that might be involved in translational repression and mRNA localization 
during oogenesis. The op234 allele, which consists of a point mutation in the very 
conserved zinc finger, causes a ~eight-fold increase in the level of germ cell death 
(Chapter 2, Figures 2.2b and 2.2c). Importantly, the Gla phenotype of gla-1(lf) animals is 
independent of the p53 homologue cep-1 (Lettre et al., 2004). Therefore, this suppressor 
                                                                                                   GLA-1(OP234) SUPPRESSOR SCREEN 102
screen should not identify genes required for the activation of the apoptotic cascade upon 
DNA damage. 
    While the screen aimed at discovering pro-apoptotic genes required for physiological 
germ cell death, at least five classes of suppressors could in principle be isolated in this 
genetic screen: (1) genes essential for all apoptotic deaths in the worm (e.g. ced-3 or ced-
4), (2) genes involved in engulfment, because non-engulfed corpses do not stain with 
acridine orange (AO) (see below), (3) genes involved in germ cell development (e.g. 
mutations that cause sterility), (4) genes that specifically suppress gla-1(lf)-induced germ 
cell death, and (5) genes essential for the physiological germ cell death pathway. The 
results presented here show that I isolated mutants from classes 1, 2, and 5. 
 
5.3 RESULTS 
5.3.1 Methodology and rationale 
    I carried out an F2 screen in which parental gla-1(op234) worms were mutagenized as 
young adults with ethyl-nitroso-urea (ENU) (De Stasio and Dorman, 2001), allowed to 
self-fertilize for two generations, and then screened F2 adults using AO to identify worms 
with no or less germline apoptosis (i.e. AO-negative) (Figure 5.1). AO is a vital dye that 
specifically stains engulfed apoptotic corpses in the C. elegans germ line. I chose to 
mutagenize gla-1(lf) mutants instead of wild-type worms because the level of 
‘physiological’ cell death in the germ line of wild-type animals is not readily detectable 
by AO. Indeed, it is easier to screen for non-Gla mutants among a population of gla-1(lf) 
animals, than among a population of wild-type animals, which only have two or three 
corpses per gonad.  
    With this genetic screen, I hoped to find pro-apoptotic genes that specifically regulate 
germline apoptosis. On the assumption that mutations that will inactivate these genes 
should reduce the level of apoptosis in the germ line of gla-1(op234) mutants, I expected 
my screen to yield mostly recessive loss-of-function mutations. 
 
5.3.2 Outcome of the screen 
    I screened 21 500 haploid genomes, and isolated 16 independent mutants (Table 5.1). 
Of these 16 mutants, four (op367, op368, op380, and op382) have a Ced phenotype, that 
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is extra cells in the anterior pharynx. I performed complementation tests between these 
four mutants and the strong ced-3(n717) mutation: they all failed to complement ced-
3(n717), and are therefore all new ced-3 alleles. 
    I also isolated four mutants (op360, op369, op371, and op386) defective in the 
engulfment of apoptotic cells. These mutants still have an elevated level of germline 
apoptosis, but the corpses do not stain with AO because they are not engulfed. Stephanie 
Züllig performed complementation tests on op360, op371, and op386, and showed that 
they are new alleles of ced-6. Lukas Neukomm sequenced and characterized the ced-6 
locus in these mutants and identified the molecular lesions: op360 is a A-to-T 
transversion in the 3’ splice site of intron 2, and op371 and op380 are both T-to-C 
transitions in exon 3 that change serine at position 163 into a proline (Figure 5.2a). 
Characterization of these new ced-6 alleles in 4-fold embryos revealed that they are all 
weaker than the canonical ced-6(n1813) allele (Figure 5.2b). Doris Klingele performed 
complementation tests with op369, and showed that it is a new allele of ced-2. The ced-2 
locus in op369 animals has not been sequenced yet. 
    Of the eight remaining mutants, two, op385 and op387, were chosen for further 
analysis (Figure 5.3). The other six were discarded because they could not be 
backcrossed, or their penetrance at suppressing the Gla phenotype of gla-1(op234) was 
low. 
 
5.3.3 op385 and op387 block gla-1(op234)-induced germline apoptosis 
    op385 and op387 were backcrossed three and five times, respectively, to gla-1(op234) 
mutants before further characterization. Genetic experiments showed that these two 
mutations are recessive.  
    The backcrossed strains still have reduced levels of germ cell death (Figures 5.3 and 
5.4), but also other pleiotropic phenotypes. gla-1(op234); op385 animals have a reduced 
brood size compared to wild-type or gla-1(op234) animals, and some worms also have an 
abnormal germline morphology. In these animals, the gonads appear smaller, filled with 
vesicles, and their bend does not reach the extremities of the worm. gla-1(op234); op387 
mutants have a normal looking germ line, and the suppression of the Gla phenotype is 
almost completely penetrant (Figures 5.3 and 5.4). However, this strain has a small brood 
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size, take 12 hours longer to grow to adulthood, and the worms appear thinner than wild-
type animals. The growth delay was taken into account for the time-course analysis 
presented in Figure 5.4.  
 
5.3.3 Epistasis analysis with other Gla mutants   
    To check whether op385 and op387 are specific suppressors of gla-1(op234)-induced 
germ cell death or if they can also suppress the phenotype of other Gla mutants, I built 
double mutants with gla-3(op216) and the conditional allele ced-9(n1653). gla-3 encodes 
a TIS11-like protein involved in meiotic progression (E. Kritikou, personal 
communication), while ced-9 is the C. elegans bcl-2 homologue. We have shown that 
like gla-1, gla-3(RNAi) induces apoptosis in a p53-independent manner (Lettre et al., 
2004); it is therefore tempting to speculate that this gene might regulate one of the 
pathways that contribute to physiological germ cell death. We would expect a general 
suppressor of apoptosis, or a mutation affecting germ cell development, to block both 
gla-3(op216)- and ced-9(n1653)-induced germ cell death. In contrast, a mutation in a 
specific regulator of physiological germ cell death should suppress gla-3(op216), but not 
ced-9(n1653), which acts downstream in the apoptotic cascade. 
    As shown in Figure 5.5, op385 and op387 suppress gla-3(op216)-induced germ cell 
death. However, they both fail to significantly suppress the Gla phenotype caused by a 
temperature-sensitive mutation in ced-9. Although there are differences in the level of 
germline apoptosis between ced-9(n1653) worms and the double mutants ced-9(n1653); 
op385 or ced-9(n1653); op387, these differences might be due to the pleiotropic 
phenotypes discussed above. Taken together, these results show that op385 and op387 
can suppress the Gla phenotype of two genes (gla-1 and gla-3) likely involved in the 
physiological germ cell death pathway, and they suggest that op385 and op387 act 
upstream of the core apoptotic machinery in the germ line of C. elegans. 
 
5.3.4 op385 and op387 do not block irradiation-induced germline apoptosis  
    As mentioned earlier, it should not have been possible in this screen to isolate positive 
regulators of the DNA damage response in C. elegans because gla-1(op234) causes 
apoptosis independently of the main players in this pathway (e.g. CEP-1, HUS-1). 
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However, to confirm this hypothesis, I irradiated op385 and op387 single mutants and 
looked at the apoptotic response (Figure 5.6). I irradiated worms 24 hours post larval 
stage L4 with two different doses of X-rays (60 and 120 Gy), and monitored apoptosis six 
and 24 hours after the irradiation. As positive control, I used wild-type animals, and as 
negative control, I used the cep-1(gk138) strain, which has a putative null mutation in the 
worm p53 homologue.  
    As expected, op385 and op387 mutants respond to DNA damage, as an increase in the 
level of germ cell death can be observed after irradiation; in contrast, no response is 
observed in cep-1(gk138) animals (Figure 5.6). However, the responses in the two gla-
1(op234) suppressors are not as strong as in the wild-type strain N2, especially the 
response in op385 worms 24 hours post-irradiation. Again, it is possible that the other 
phenotypes (germline morphology, growth delay, etc.) associated with op385 and op387 
are responsible for these ‘weaker’ responses. 
 
5.3.5 Two-factor mapping of op385 and op387 
    I used classical mapping with genetic markers to locate op385 and op387 on a 
chromosome. Basically, gla-1(op234); op385 or gla-1(op234); op387 strains were 
crossed into the dpy-5(e61) gla-1(op234); rol-6(e187); unc-32(e189) or gla-1(op234); 
unc-5(e53); dpy-11(e224); lon-2(e678) mapping strains. In the F2 generation, non-Gla 
animals were picked based on the absence of AO staining, and the segregating markers 
were scored in the F3 generation. The results are summarized in Table 5.2. Clearly, op385 
maps to the center of chromosome V as no Dpy-11 animals were observed out of 34 F2 
animals analyzed (68 chromosomes). The mapping results for op387 are less evident, but 
nevertheless convincing: op387 maps on linkage group X because only one third of the F2 
non-Gla animals, instead of the predicted two-third, threw Lon-2 progenies. These data 
place op387 about 17 cM from lon-2, which is at position -6.8 cM on chromosome X. 
 
5.3.6 Three-factor mapping of op385 
    The two-factor mapping data put op385 in the middle of chromsome V, very close to 
the gene dpy-11. To determine on which side of dpy-11 op385 is located, I crossed gla-
1(op234); op385 males into gla-1(op234); unc-62(e644) dpy-11(e224) or gla-1(op234); 
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dpy-11(e224) unc-76(e911) hermaphrodites. In both cases, I singled out, in the F2 
generation, Dpy non-Unc and Unc non-Dpy recombinants, and analyzed by AO staining 
the segregation of op385 in the F3 generation (Table 5.3a). The results of these genetic 
crosses put op385 between dpy-11 and unc-76. Note that one of the Unc-62 non-Dpy-11 
recombinants segregates a Gla phenotype (Table 5.3a), suggesting that op385 is on the 
left of dpy-11. However, because the results with the dpy-11 unc-76 mapping strain are 
very convincing (Table 5.3a), I suspect this animal to be a double recombinant and 
maintain my conclusion that op385 is between dpy-11 and unc-76, at position ~+1.4 cM 
on chromosome V. 
    At this point, I stopped mapping op385. This decision was motivated by two reasons: 
(1) I was worried that the abnormal germline morphology of op385 mutants was 
indirectly causing the suppression of germ cell death, and (2) I wanted to invest more 
time in the mapping of the more promising suppressor op387 (see below). Although the 
strains are now available to begin single nucleotide polymorphism (SNP) mapping with 
op385, I would not recommend it until a detailed phenotypic characterization 
(morphology, embryonic lethality, penetrance, temperature-sensitivity) of this mutant is 
carried out. 
 
5.3.7 Three-factor mapping of op387 
    Because the two-factor mapping (Table 5.2) did not precisely indicate where op387 is 
located on chromosome X, I chose markers that span most of this chromosome. The 
crosses between gla-1(op234); op387 males and gla-1(op234); lon-2(e678) egl-15(n484) 
or gla-1(op234); dpy-6(e14) unc-3(e151) hermaphrodites put op387 on the right of egl-15 
(Table 5.3b). However, this work did not allow me to determine a right boundary for an 
interval encompassing op387. To this end, I crossed the suppressor into gla-1(op234); 
unc-3(e151) lin-15(n765ts) animals. All the Lin-15 non-Unc-3 recombinants segregated 
the non-Gla phenotype, placing op387 on the left of lin-15 (Table 5.3b). In conclusion, 
these genetic crosses located op387 between egl-15 and lin-15, an interval that 
corresponds to 20.1 cM.  
 
5.3.8 SNP mapping of op387 
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    The lack of good physical markers on the right arm of chromosome X, and the 
difficulty to build double mutants on chromosome X (because most hemizygous mutant 
males do not mate) forced me to choose a very large interval to begin SNP mapping. I 
built the following strain for SNP mapping: gla-1(op234); lon-2(e678) op387 lin-
15(n309). The genetic distance between lon-2 and lin-15 is very large (29.8 cM). 
However, this approach should still be efficient as long as enough recombinants are 
picked to reach a resolution sufficient to clone op387.  
    To use the polymorphic strain CB4856 from Hawaii in my mapping strategy, I had to 
first introduce gla-1(op234) in this background. Indeed, because I wanted to score the 
recombinants on the basis of suppression of the Gla phenotype caused by gla-1(op234), I 
needed all my parental strains to be homozygote for gla-1(op234). I outcrossed gla-
1(op234) from the original wild-type Bristol background nine times into CB4856. The 
resulting strain has Hawaii-specific molecular markers on all chromosomes, except on the 
left arm and middle of chromosome I, where it is still Bristol (gla-1 is in the middle of 
chromosome I). However, this should not affect mapping because op387 is on 
chromosome X. 
    I crossed gla-1(op234)HA males (that is, gla-1(op234) in the CB4856 background) into 
gla-1(op234); lon-2(e678) op387 lin-15(n309) hermaphrodites and singled out, in the F2 
generation, 264 Lon-2 non-Lin-15 recombinants (I did not pick Lin-15 non-Lon-2 
animals because lin-15(n309) affects gonad morphology). Out of the 264 recombinants, 
only 23 seggregated op387 (241 Gla and 23 non-Gla) (Table 5.4). Genotyping all these 
strains for various molecular markers on chromosome X allowed me to place op387 
between the markers uCE6-1494 on the left and C27C12[2] on the right (Table 5.4). This 
interval corresponds to 0.14 cM on the genetic map or 85 kb on the physical map, and is 
predicted to contain 14 genes. There are mutations available for three of the genes in this 
interval: unc-3, atf-5 and mbk-1, but none of them can suppress gla-1(RNAi)-induced 
germ cell apoptosis. 
 
5.3.9 Attempt to phenocopy op387 by RNAi feeding 
    Having narrowed down op387 to a reasonably small interval, I decided to try to 
phenocopy op387 by RNAi feeding, using clones from the Ahringer library (Kamath et 
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al., 2003). I performed RNAi at 20oC in a gla-1(op234) or a gla-1(op234); rrf-3(pk1426) 
background (rrf-3 is hypersensitive to RNAi) on 10 of the 14 predicted genes in the 
interval (Table 5.5). I screened the P0 generation by DIC microscopy for a reduction in 
the number of apoptotic corpses caused by gla-1(op234). Unfortunately, I did not identify 
a RNAi clone that reduced significantly the level of germline apoptosis in gla-1(op234). 
Negative results with RNAi must always be taken with a grain of salt as it is possible that 
RNAi knockdown, i.e. not a complete loss-of-function, is not sufficient to reproduce the 
phenotype. Also, because RNAi is gene-specific, it is possible that inactivation of the 
locus defined by op387 does not work. Finally, it remains possible that op387 inactivates 
one of the four genes not tested. To conclude, I have been unable to clone op387 during 
my doctoral studies. To clone it, I propose to refine the map position using different 
molecular markers and more recombinants, and to try to rescue the op387 phenotype with 
the most promising genes by biolistic transformation. 
 
5.4 DISCUSSION 
5.4.1 Overall success of the screen 
    To identify novel pro-apoptotic genes that specifically act in the C. elegans 
hermaphrodite germ line, I performed a gla-1(op234) genetic suppressor screen. gla-1 
encodes a RNA binding protein of the CPEB family, and its inactivation by genetic 
mutations or RNAi results in p53-independent germ cell apoptosis (Chapter 2). I 
mutagenized gla-1(op234) mutants, and screened the F2 generation for a loss of AO 
staining (Figure 5.1). AO is a vital dye that stains engulfed apoptotic germ cells in the 
germ line of C. elegans. After screening 21 500 haploid genomes, I recovered 16 
mutants, including four new alleles of ced-3, three alleles of ced-6, and one allele of ced-
2 (Table 5.1). The fact that ced-3 alleles and engulfment genes were identified in the 
screen validates the approach as it was previously known that ced-3(lf) mutations 
suppress gla-1(op234)-induced germline apoptosis, and that apoptotic germ cells do not 
stain with AO in engulfment mutants.  
 
5.4.2 op385 and op387 suppress p53-independent germline apoptosis 
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    Of the eight remaining mutants, I focused my work on op385 and op387, two 
suppressors that strongly block the Gla phenotype of gla-1(op234) worms (Figures 5.3 
and 5.4). The next important question was to determine whether op385 and op387 are 
specific to gla-1(op234), or if the can suppress the Gla phenotype of other mutants. I built 
double mutants with the TIS11-like protein coding gene gla-3 and the bcl-2 homologue 
ced-9. Both op385 and op387 suppress gla-3(op216)-induced germ cell apoptosis (Figure 
5.5), which is a candidate regulator of the physiological germ cell death pathway. In 
contrast, they fail to block the Gla phenotype caused by a conditional loss-of-function 
mutation in ced-9 (Figure 5.5). This epistasis analysis places op385 and op387 upstream 
of the worm core apoptotic machinery, likely in the physiological germ cell death 
pathway. Importantly, op385 and op387 cannot suppress DNA damage-induced germ cell 
apoptosis (Figure 5.6), confirming that they specifically act in the p53-independent 
pathway. 
    Of course, the next step was to identify the genes affected by op385 and op387. By 
two- and three-factor mapping, I could place op385 in the middle of chromosome V, and 
op387 on the far end of the right arm of chromosome X. Then, I used SNP mapping to 
locate op387 to a 85 kb (0.14 cM) interval, which is predicted to contain 14 genes. op385 
was not mapped further because of the pleiotropic phenotypes associated with this 
mutation. 
    Unfortunately, I could not clone op387. The fact that I had to choose physical markers 
really far apart (~30 cM) to carry out SNP mapping turned out to be the limiting factor. 
Indeed, too much work was required to obtain informative recombinants: at the end, I 
estimate that only 0.5% of the recombination events between lon-2 and lin-15 could have 
been informative to clone op387 (op387 is in a 0.14 cM interval, and the lon-2 lin-5 
interval is 30 cM long).  
 
5.4.3 What kind of genes could op385 and op387 be? 
    op385 and op387 can suppress the Gla phenotype of both gla-1(op234) and gla-
3(op216) strains. Because gla-1 and gla-3 are thought to act in the same genetic pathway 
to regulate meiotic progression (G. Lettre, E. Kritikou, and M.O. Hengartner, 
unpublished), it is possible that op385 and op387 affect genes involved in meiosis. For 
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instance, op385 and op387 could reduce the period of time germ cells spend in the 
pachytene stage of meiosis I, where germ cells normally undergo apoptosis. If this 
hypothesis is correct, these suppressors should not be able to block germ cell apoptosis 
caused by mutations in genes not involved in meiosis, such as pmk-3 (Chapter 4). 
Assuming that op385 and/or op387 can suppress the Gla phenotype of pmk-3(lf) mutants, 
these loci would become prime candidate regulators of the physiological germ cell death 
pathway. Building the double mutants pmk-3(lf); op385 and pmk-3(lf); op387 should be 
easy, and the results from this epistasis study very interesting. 
    Another possibility is that op385 and op387 define genes whose transcripts are bound 
by the RNA binding protein GLA-1. Indeed, maybe the CPEB protein GLA-1 represses 
translation of the pro-apoptotic genes affected by op385 and op387. In this case, the 
interaction between GLA-1 and the op385 or op387 RNAs could be influenced by GLA-
3, hence explaining the epistasis observed. Biochemical experiments to co-purify the 
RNAs bound to GLA-1, as described in Chapter 2, should address this issue.  
    Finally, op385 and op387 could disrupt genes involved in pro-apoptotic MAPK 
cascades. Indeed, at the end of Chapter 4, I presented evidences that a mutation in the p38 
MAPK gene pmk-1 partially suppress gla-1(op234)-induced germ cell death (Figure 4.9). 
Maybe there are other kinases (C. elegans has two JNK-like homologues: JNK-1 and 
KGB-1) that also positively regulate physiological germ cell death. 
    To better understand how this locus might regulate physiological germ cell death, it is 
imperative to clone op387. Also, identifying the molecular nature of op387 should shed 
light onto the developmental signals or stimuli that activate the physiological germ cell 
death pathway. More genetic mapping, RNAi knockdowns, and rescue experiments need 
to be carried out to clone op387, but I think that the specificity of the op387 phenotype 
justifies the investment of more energy into this project. 
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5.5 MATERIALS AND METHODS 
5.5.1 Nematode strains and culture 
    Standard procedures for nematode culture and genetic manipulation were followed 
with growth at 20oC, unless otherwise noted (Brenner, 1974; Gumienny et al., 1999; 
Sulston and Hodgkin, 1988). The wild-type N2 Bristol strain was used. C. elegans gene 
mutations relevant to this study are as followed: LGI: dpy-5(e61), gla-1(op234), gla-
3(op216), cep-1(gk138); LGII: rrf-3(pk1426), rol-6(e187); LGIII: ced-6(n1813), ced-
6(op360), ced-6(op371), ced-6(op386), unc-32(e189), ced-9(n1653ts); LGIV: ced-
2(e1752), ced-2(op369), unc-5(e53), ced-3(n717), ced-3(op367), ced-3(op368), ced-
3(op380), ced-3(op382); LGV: unc-62(e644), dpy-11(e224), op385, unc-76(e911), LGX: 
lon-2(e678), dpy-6(e14), egl-15(n484), unc-3(e151), atf-5(ok576), mbk-1(pk1389), 
op387, lin-15(n309), lin-15(n765ts). Phenotypes are described either by Riddle (Riddle et 
al., 1997), or in this thesis. The polymorphic strain CB4856 was used for single 
nucleotide polymorphism (SNP) mapping as described by Plasterk and co-workers 
(Wicks et al., 2001).  
 
5.5.2 Light and fluorescent microscopy 
    Microscopic analysis of cells was done using standard live-animal techniques: worms 
were mounted on 4% agarose pad and anesthetized with 30 mM NaN3 in M9 buffer. 
Observations were done using a Leica DM RXA2 microscope fitted with Nomarski 
optics. Images were captured with a ORCA-ER digital CCD camera (Hamamatsu) and 
processed with OpenLab software. Fluorescence stereomicroscopy was done with a Leica 
MZ FLIII or a Zeiss Stemi SV11 M2BIO stereomicroscope. 
 
5.5.3 Mutagenesis and gla-1(op234) suppressor screen 
    Mutagenesis was performed as described by De Stasio and Dorman (De Stasio and 
Dorman, 2001). Briefly, young adult gla-1(op234) worms were mutagenized with 0.6 
mM N-ethyl-N-nitrosourea (ENU) in M9 buffer for 4 hours. Worms were washed four 
times with M9 buffer, and allowed to recover overnight at 15oC. Four P0s were 
transferred to 10 cm NGM classic plates, and allowed to lay eggs for 8 hours at 20oC, 
then removed. Three days later, F1s were removed. Three days later, F2s were stained 
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with an acridine orange (AO) solution (Molecular Probes; 0.02 mg/ml in M9 buffer), and 
screened by fluorescent microscopy for absence of AO staining as described by Lettre et 
al. (Lettre et al., 2004). AO-negative F2s were singled out, and their progeny was scored 
for germline apoptosis (Gla phenotype) and extra cells in the anterior pharynx (Ced 
phenotype) (Hengartner et al., 1992) by differential interference contrast (DIC) 
microscopy. For the Ced phenotype, only the cells in the dorsal sector of the pro- and 
metacorpus of the pharynx, as well as the cells in the metacorpus of both subventral 
sectors of the pharynx, were scored. 
 
5.5.4 Polymerase chain reaction (PCR) 
    PCR was performed using Biotaq DNA polymerase (Bioline), Pfu Turbo DNA 
polymerase (Stratagene), or the Expand High Fidelity PCR system (Roche) according to 
the manufacturers’ protocols.  
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TABLE 5.1 Outcome of the gla-1(op234) suppressor screen 
Genotype Germ cell death1 Ced2 Phenotypes 
wild-type 2.1±0.5 0  
ced-3(n717) 0 8.0±1.1 Ced 
gla-1(op234) 14.9±1.3 0 Gla 
gla-1(op234); ced-3(n717) 0 7.5±1.4 Gla, Ced 
gla-1(op234); op358 0.5±1.0 0.9±0.7  
gla-1(op234); op359 0.2±0.4 0.3±0.7  
gla-1(op234); op360 >20 0 Engulfment, ced-6 
gla-1(op234); op367 0 3.4±2.5 Ced, ced-3 
gla-1(op234); op368 0 2.9±2.3 Ced, Unc, ced-3 
gla-1(op234); op369 >20 0.1±0.2 Engulfment, ced-2 
gla-1(op234); op370 0.6±0.4 0.3±0.5  
gla-1(op234); op371 >20 0 Engulfment, ced-6 
gla-1(op234); op376 2.5±1.3 0.2±0.4  
gla-1(op234); op380 0.7±1.6 4.5±1.9 Ced, ced-3 
gla-1(op234); op382 0.1±0.3 4.5±1.5 Ced, ced-3 
gla-1(op234); op384 0.3±0.5 0.3±0.5  
gla-1(op234); op385 3.4±0.7 0.1±0.4  
gla-1(op234); op386 >20 0 Engulfment, ced-6 
gla-1(op234); op387 1.3±0.9 0.3±0.8  
gla-1(op234); op388 1.7±1.0 0.3±0.5  
1Mean number of apoptotic germ cells ±s.d. per gonad. Corpses were counted by DIC microscopy 
three days post-L1 stage (n=15). 2Mean number of extra cells ±s.d. in the anterior pharynx. Only 
cells in the dorsal sector of the pro- and metacarpus of the pharynx, and cells in both subventral 
sectors of the metacorpus of the pharynx were counted by DIC (n=10). 
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TABLE 5.2 Two-factor mapping of gla-1(op234) suppressors 
Genotype Mapping to linkage groups1 
 dpy-5 I rol-6 II unc-32 III unc-5 IV dpy-11 V lon-2 X 
gla-1(op234); op385 n.d. n.d. n.d. 21/34 0/34 18/34 
gla-1(op234); op387 19/32 20/32 20/32 19/29 17/29 10/29 
1Fractions represent number of non-Gla worms that segregate the chromosomal marker, over the total 
number of non-Gla worms tested. For all these crosses, the strains were homozygote for gla-1(op234). 
Chromosomal linkage for op385 to linkage groups I, II, and III was not determined because of the very 
strong linkage to chromosome V. n.d., not determined. 
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TABLE 5.3a Three-factor mapping for op385 
Physical markers1 F2 recombinants Segregation of op385 
(non-Gla phenotype) 
unc-62 V (-5.2 cM) & dpy-11 V (0 cM) 9 Dpy-11 non-Unc-62   → 
10 Unc-62 non-Dpy-11 → 
0/9 non-Gla 
1/10 Gla, 9/10 non-Gla 
   
dpy-11 V (0 cM) & unc-76 V (+7.3 cM) 10 Dpy-11 non-Unc-76 → 
10 Unc-76 non-Dpy-11 → 
8/10 Gla, 2/10 non-Gla 
2/10 Gla, 8/10 non-Gla 
   
   
   
   
TABLE 5.3b Three-factor mapping for op387 
Physical markers1 F2 recombinants Segregation of op387 
(non-Gla phenotype) 
lon-2 X (-6.8 cM) & egl-15 X (+2.9 cM) 15 Lon-2 non-Egl-15 → 
15 Egl-15 non-Lon-2 → 
15/15 non-Gla 
0/15 non-Gla 
   
dpy-6 X (0 cM) & unc-3 X (+21.3 cM) 19 Dpy-6 non-Unc-3 → 
25 Unc-3 non-Dpy-6 → 
19/19 non-Gla 
0/25 non-Gla 
   
unc-3 X (+21.3 cM) & lin-15 X  
(+23.0 cM) 
10 Lin-15 non-Unc-3 → 
3 Unc-3 non-Lin-15   → 
10/10 non-Gla 
0/3 non-Gla 
1For all these crosses, the strains were homozygote for gla-1(op234). The F2 recombinants were first 
homozygosed, and then scored for the Gla phenotype using acridine orange staining. lin-15(lf) mutant 
animals are multivulva.  
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 TABLE 5.4 SNP mapping for op387 
Markers lon-2 pkP6166 uCE6-
1494 
pkP6117 C27C12[2] uCE6-
1502 
uCE6-
1503 
F20D1[3] pkP6167 lin-
15 
Genetic 
map 
-6.8 +16.8 +21.3 +21.5 +21.5 +21.5 +21.5 +21.6 +22.0 +23.0 
Physical 
map 
4.7 14.4 14.8 14.9 14.9 14.9 14.9 15.0 15.1 15.7 
           
Gla 241/241 15/241 2/241 0/241 0/241 0/241 0/241 0/241 0/241 0/241 
           
non-Gla 0/23 0/23 0/23 0/23 1/23 2/23 4/23 5/23 16/23 23/23 
           
Locations on the genetic and physical map are given in cM and Mb, respectively. The mapping cross was: gla-
1(op234)HA X gla-1(op234); lon-2(e678) op387 lin-15(n309). Only the Lon-2 non-Lin-15 recombinants were 
genotyped and scored for the Gla phenotype. Numbers represent the fraction of worms that has conserved the wild-
type (N2) allele for the Gla recombinants, and the CB4856 (Hawaii) allele for the non-Gla recombinants. See text for 
details. 
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TABLE 5.5 Candidate genes for op387 
Gene RNAi Description1 
Y16B4A.2 N Serine carboxypeptidase 
Y16B4A.1 Y unc-3, transcription factor 
F42D1.2 N Tyrosine aminotransferase 
F42D1.3 Y Rhodopsin-like GPCR superfamily 
F42D1.t1 N tRNA cysteine 
T04C10.4 Y atf-5, bZIP transcription factor 
T04C10.3 N  
T04C10.2 Y epn-1, epsin N-terminal homology, ubiquitin interacting motif 
T04C10.1 Y mbk-1, serine/threonine protein kinase 
C27C12.7 Y dpf-2, lipase, peptidase 
C27C12.2 Y Zn-finger, C2H2 type 
C27C12.5 Y Na+ channel, amiloride-sensitive 
C27C12.1 Y  
C27C12.4 Y  
1As annotated in wormbase. For the RNAi column, ‘Y’ indicates that RNAi knockdown of the gene was 
performed at 20oC in a gla-1(op234) background (Po generation). ‘N’ indicates that the corresponding clone 
was not present in the Ahringer feeding library. RNAi clones have not been sequenced yet. 
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 FIGURE 5.1 Outline of the gla-1(op234) suppressor screen 
Young adult gla-1(op234) hermaphrodites were mutagenized with 0.6 mM ENU and 
allow to self-fertilize for two generations. The F2 generation was screened by 
fluorescence microscopy for absence of acridine orange staining. 21 500 haploid 
genomes were screened and 16 mutants isolated. 
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 FIGURE 5.2 ced-6 alelles were found in the gla-1(op234) suppressor screen 
(a) Genomic structure of the ced-6 locus. The canonical allele n1813 is a one base pair 
deletion that introduces an early stop codon. op360 is a A-to-T mutation in the 3’ splice 
site of intron 2, and op371 and op380 are T-to-C mutations in exon 3 that cause S163P. 
(b) Engulfment defect in the new ced-6 mutants. 4-fold embryos were scored. Data 
shown are mean ±s.d. (n=20). 
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FIGURE 5.3 Phenotypic characterization of two gla-1(op234) suppressors: op385 and 
op387 (next page) 
Pictures of gonads from wild-type and gla-1(op234) worms, as well as from two of the 
gla-1(op234) suppressors identified in the forward genetic screen: gla-1(op234); op385 
and gla-1(op234); op387. DIC pictures of worms grown at 20oC were taken 24 hours 
post larval stage L4. Apoptotic germ cells can be seen as highly refractile disks (arrows). 
Note the almost complete absence of apoptotic corpses in the gonad of gla-1(op234); 
op385 and gla-1(op234); op387 compared to gla-1(op234). For all the pictures, anterior 
is to the left and dorsal to the top. Scale bar, 25 µm. 
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FIGURE 5.3 
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 FIGURE 5.4 op385 and op387 suppress gla-1(op234)-induced germline apoptosis 
Time-course analysis of germ cell death in wild-type, gla-1(op234), gla-1(op234); 
op385, and gla-1(op234); op387 mutants. Worms were synchronized and scored for germ 
cell apoptosis by DIC every 12 hours post L4 stage. Data shown represent mean ±s.d. of 
two experiments (n=20 gonads for each experiment). 
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 FIGURE 5.5 Epistasis analysis with op385 and op387 
op385 and op387 mutants can suppress the Gla phenotype caused by loss-of-function 
mutations in gla-1 or gla-3, but not ced-9. Worms were synchronized and scored for 
germ cell apoptosis by DIC 24 hours post L4 stage. Data shown represent mean ±s.d. of 
two experiments (n=20 gonads for each experiment). 
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 FIGURE 5.6 DNA damage response in op385 and op387 single mutants 
Wild-type (positive control), cep-1(gk138) (negative control), op385, and op387 mutant 
L4 larvae were irradiated with 60 and 120 Gy of X-rays. The apoptotic response was 
analysed six and 24 hours after irradiation. Apoptotic corpses were scored via direct 
observation using DIC microscopy. Data shown represent mean ±s.d. of one experiment 
(n=20 gonads). 
                                                                                                   GLA-1(OP234) SUPPRESSOR SCREEN 126
• CHAPTER 6 • 
PERSPECTIVES 
 
 
 
 
• CHAPTER 6 • 
PERSPECTIVES 
 
    Professor Yuri Lazebnik, one of my instructors in Cold Spring Harbor laboratory, once 
wrote about apoptosis research ‘that the more facts we learn the less we understand the 
process we study’ (Lazebnik, 2002). Sadly, it seems to me that this philosophical thought 
also applies to my doctoral project. However, it remains possible that future work, based 
on the discoveries presented in this PhD dissertation, will yield a more comprehensive 
view of apoptosis regulation during metazoan development. 
 
6.1 THREE YEARS LATER: AN OUTLOOK 
    The main objective of my thesis project was to discover the pathways that regulate 
physiological germ cell apoptosis in C. elegans hermaphrodite. To achieve this goal, I 
identified and characterized mutants with more germline apoptosis (Chapters 2 and 4), 
performed a genome-wide RNAi screen (Chapter 3), as well as a gla-1(op234) modifier 
genetic screen (Chapter 5).  Although these approaches did not help me to pinpoint the 
stimuli or developmental cues that activate (or block) physiological germ cell death, they 
provided us with a list of more than twenty genes (or mutants) to investigate further, all 
of them being possible regulators of germline apoptosis in C. elegans. 
    gla genes cause increased germline apoptosis when inactivated by genetic mutations or 
RNAi; these deaths can be p53-dependent or p53-independent. The RNAi screen 
described in Chapter 3 led to the identification of several gene knockdowns that require 
the p53 homologue CEP-1 to induce apoptosis. Although interesting because they might 
be involved in the maintenance of genome stability or p53 activation, it is unlikely that 
studying the p53-dependent class of genes will shed light on the regulation of 
physiological germ cell death.  
    To my knowledge, there are less than ten genes that can produce a p53-independent 
Gla phenotype upon inactivation. Most of them (gla-1/cpb-3, gla-3, cgh-1, daz-1, teg-1) 
can be linked to proper RNA processing during oogenesis. Because the regulation of 
RNA localization, stability, and translation is essential for oocyte maturation in most 
(all?) sexual species, I strongly believe that further study of these C. elegans genes will 
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provide extremely interesting findings concerning germ cell development. However, I 
doubt that it will lead to the identification of the signaling cascades that contribute to 
physiological germ cell death. Indeed, the Gla phenotype in these mutants is likely due to 
the activation of quality-control programs because oogenesis cannot occur nomally; 
convincing data from the study of the TIS11-like protein GLA-3 support this hypothesis 
(E. Kritikou, personnal communication).  
    The p38 MAPK gene pmk-3 is an exception among all the known gla genes that fall in 
the p53-independent group (Chapter 4). Even though a null mutation in pmk-3 does not 
result in a spectacular Gla phenotype − a bare three-fold increase in germ cell deaths 
compared to wild-type worms – the phenotype is specific to apoptosis. Indeed, extensive 
studies of pmk-3(lf) mutants have not been able to detect any germline phenotype other 
than the Gla phenotype. This suggests that the main function of PMK-3 in the germ line 
is to promote germ cell survival. Using a hypothesis-driven approach, I have identified 
MTK-1 and MKK-4 as the upstream kinases of the pathway, and the transcription factor 
MEF-2 as a possible mediator of PMK-3’s anti-apoptotic activity.  Of course, many more 
experiments are required to definitely understand how this p38 MAPK pathway regulates 
physiological germ cell death. We need to focus on the genes upstream of MTK-1 to find 
what triggers the kinase cascade, and on the MEF-2 targets to clarify how PMK-3 blocks 
apoptosis and/or promote cell survival: a genetic suppressor screen could address the first 
question, and microarray experiments the second. To my view, pmk-3 is the only gla 
gene studied now which is susceptible to give us answers concerning the regulation and 
mechanistic of physiological germline apoptosis; as such, I consider its study a very 
promising project which deserves more interest.  
 
6.2 PHYSIOLOGICAL GERM CELL DEATH: PAST, PRESENT, AND FUTURE 
    Since the first description of physiological germline apoptosis (Gumienny et al., 1999), 
the Hengartner laboratory has spent time and resources trying to understand what 
regulates this cell death pathway. The truth is that we are still a long way to answer this 
question. In the last few years, it has become apparent that some of the germ cell deaths 
that occur ‘physiologically’ in wild-type worms are due to genetic defects sensed by the 
DNA damage pathway. This is reflected by the fact that various mutants (cep-1(lf), hus-
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1(lf), ced-9(gf), etc.) defective in apoptotic responses to genotoxic treatments have less 
germline apoptosis that wild-type worms in a normal ‘un-stimulated’ situation (Lettre et 
al., 2004). This is not a surprising result since the elimination of impaired oocytes by 
apoptosis is a process conserved throughout evolution (Tilly, 2001). Therefore, it seems 
reasonable to believe that ~30% of physiological germ cell deaths are actually due to 
endogenous damage (i.e. meiotic pairing or recombination anomalies). So, how do we 
explain the remaining 70%? 
    Two other hypotheses have been proposed to explain oocyte apoptosis: competition for 
growth/survival factors, or the nurse cell behavior (Tilly, 2001). Unfortunately, there are 
no data to support or disprove neither of these two models in C. elegans. We know three 
pathways that are essential for germline apoptosis: GLP-1/Notch, Ras/MAPK, and the 
core apoptotic machinery. The latter requirement is obvious: in the absence of the adaptor 
CED-4 and the caspase CED-3, germline apoptosis cannot occur. The GLP-1/Notch 
signaling pathway regulates the proliferative versus meiotic entry decision of germ cells 
in the C. elegans hermaphrodite gonad. Mutations that activate the pathway prevent germ 
cells to enter meiosis; these mutants have tumorous germ lines, and these tumors do not 
contain apoptotic germ cells. Therefore, germ cells must enter meiosis to undergo 
apoptosis. During meiotic progression, germ cells arrest at the pachytene stage of 
prophase I; only when the Ras/MAPK pathway is activated can germ cells progress 
through pachytene and carry on development. Inactivation of Ras/MAPK by mutations 
block meiotic progression, and germline apoptosis. In conclusion, germ cells must not 
only enter meiosis, but also escape the pachytene arrest checkpoint, to die by apoptosis. 
We know that over-activation of Ras/MAPK can lead to increased p53-independent germ 
cell death (E. Kritikou, personal communication). However, it remains to be determined 
whether physiological germ cell death is due to the activation of MAPK above a critical 
threshold in some cells. And if this is the case, we need to investigate what regulates 
MAPK activation in the germ line. All these observations draw a clear link between 
proper germ cell development and apoptotic death, but do not explicitly address the 
biological significance of physiological germline apoptosis in C. elegans. 
    Could transcriptional up-regulation of ced-4 and ced-3 causes physiological germ cell 
death? This model would have the advantage to easily explain why egl-1(lf) and ced-9(gf) 
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mutations do not block physiological germline apoptosis, since CED-4 and CED-3 act 
downstream of EGL-1 and CED-9 in the apoptotic cascade. A priori, there is no argument 
against such a model, although transcriptional regulation of caspase expression seems an 
unusual way to control apoptotsis. In fact, in an attempt to test this hypothesis, I tried to 
create transgenic lines with reporter constructs for ced-4 and ced-3. Unfortunately, I have 
been unable to identify the regulatory sequences required for ced-4 or ced-3 transcription, 
and therefore those experiments were never perfomed. However, my failed attempt 
should not ruled out this quite exciting possibility. I can easily imagine a model where a 
signaling cascade (Ras/MAPK?) activates a transcription factor essential for the 
expression of ced-4 and/or ced-3 in the germ line. 
    My experience in studying germ cell death in C. elegans leads me to propose one 
genetic screen, long and painful, to identify genes responsible for physiological germ cell 
death: a Nomarski-based screen for suppressors of germline apoptosis in a cep-1(lf); ced-
6(lf) mutant background. I would use a parental strain with a loss-of-function mutation in 
cep-1 such that all germ cell deaths arise independently of the p53 pathway, and a 
mutation in an engulfment gene to increase the number of observable apoptotic germ 
cells. Because un-engulfed corpses do not stain with acridine orange, Normarski 
microscopy would be required for screening. To me, it now seems a better strategy to use 
an engulfment mutant background rather than mutations in other gla genes, such as gla-1 
or gla-3, in the parental strain because in the engulfment mutant, the increased number of 
apoptotic germ cells is not caused by developmental defects during oogenesis. This 
screen should specifically target genes involved in the physiological germ cell death 
pathway. A similar approach, without the cep-1 mutation, was used in Barbara Conradt’s 
laboratory (Dartmouth College) to identify novel regulators of germ cell apoptosis, but no 
results have so far been published. 
 
6.3 DEVELOPMENTAL APOPTOSIS IN C. ELEGANS 
    Already in 1951, Glücksmann recognized the importance of programmed cell death 
during metazoan development (Glücksmann, 1951). He divided developmental apoptosis 
in three categories: (1) phylogenetic apoptosis, i.e. the elimination of embryonic cells or 
structures of an evolutionary ancestor that are no longer needed in the adult, such as the 
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tadpole’s tail, (2) morphogenetic apoptosis, which acts as a type of organ sculpting, for 
instance to eliminate the webbing between digits, and (3) histogenic apoptosis, which 
removes cells following tissue maturation or remodelling, such as neuronal death when 
neurons fail to establish synaptic connections with their targets.  
    In C. elegans, none of these three forms of apoptosis can explain why, out of the 1090 
somatic cells that are born in a hermaphrodite, 131 undergo apoptosis. Of course, 
apoptosis in the worm can be used to eliminate useless cells, such as the hermaphrodite-
specific neurons (HSNs) in males (HSNs are required for egg-laying, a useless task for 
males). However, apoptosis does not seem to play an important role during C. elegans 
development: the fitness of ced-3 null mutants is comparable to wild-type worms in 
physiological conditions, and these mutants do not have aberrant organs or behaviors. On 
an evolution point of view, this observation does not make sense: why would a species 
spend some much energy to maintain genes involved in a dispensable process?  
    One possibility is that apoptosis is actually important for C. elegans development, but 
we have just been unable to obtain mutants with no cell death at all. Indeed, strains with 
the strongest mutations in ced-3 or ced-4 still have some apoptotic deaths (Shaham et al., 
1999). The C. elegans genome has three genes, other than ced-3, that encode putative 
caspases; it is possible that these proteins play minor roles during programmed cell death 
in the worm (Shaham, 1998). My favorite explanation is that development is not the main 
purpose of apoptosis in the worm. Indeed, it is known that ced-3 and ced-4 mutants are 
hyper-susceptible to Salmonella typhimurium infections (Aballay and Ausubel, 2001). C. 
elegans is a soil nematode, likely to encounter pathogens in its native environment. It is 
unknown how the apoptotic machinery protects C. elegans against infections, but it could 
well be that the main function of apoptosis in worms is in innate immunity. Maybe 
programmed cell death during C. elegans development is a by-product of the role of 
apoptosis in innate immunity, and that the worm is just too simple to re-wire genetic 
networks that are useless, but at least not detrimental.  
    However, having said that one has to recognize that the main reason why C. elegans 
has become such a powerful system to study apoptosis is because apoptosis is not 
essential for its development. Just for this reason, it is hard to argue that apoptosis is an 
unimportant process in C. elegans… 
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 6.4 FORWARD VS. REVERSE GENETIC SCREENS IN C. ELEGANS 
    During my doctoral studies, I performed one forward (Chapter 5) and one reverse 
genetic screen (Chapter 3). Looking back at the outcome of those screens, it is hard to 
argue which one is better. Of course, the RNAi screen yielded several genes, but genetic 
characterization of these RNAi candidates was proven difficult. The bottom line is that 
genetic mutants are required to convincingly show that genes uncovered by RNAi are 
involved in a specific biological process. And this brings us to the classical genetic 
screen, where mutants can be ‘easily’ isolated and extensively characterized. But then, 
intense effort is required, and not always successful, to clone the genes. Clearly, both 
approaches are compatible and complementary, with strengths and weaknesses. I can 
hardly imagine a C. elegans laboratory that would, in this post-genomic era, refuse to use 
both of these two methods to study any aspect of biology.  
 
6.5 CONCLUDING REMARKS 
    The past of apoptosis research in C. elegans has been glorious. It was recognized in 
2002 when the Karolinska Institut awarded Sydney Brenner, H. Robert Horvitz, and John 
E. Sulston the Nobel Prize in Physiology or Medicine for their work on organ 
development and programmed cell death. Certainly, genetic screens in C. elegans will 
identify other genes involved in apoptosis. However, I am skeptical regarding the 
importance of the new discoveries and doubt that genes as important as ced-3 or ced-9 
will be cloned. This is emphasized by the fact that most of the worm apoptotic genes 
identified recently have either a minor role during apoptosis (e.g. nex-1, cps-6, crn-1), or 
are supported by controversial evidences (e.g. icd-1, psr-1, wah-1). It is possible that the 
scientific community has identified most of the very important apoptotic genes (not only 
in C. elegans, but in all species), and that the genes that remain to be cloned will have 
species-, tissue-, or even cell-specific effects. 
    There has always been intense competition among apoptologists to discover the next 
‘big thing’. Now that the mouse and human genomes are sequenced, and that loss-of-
function phenotypes can easily be obtained in mammalian cells by RNAi, competition 
will even get worse. I sometimes wonder how long will apoptosis research in C. elegans 
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thrive in such an environment? For sure, we have to stop repeating what has already been 
discovered in other systems. C. elegans is a powerful ‘forward’ genetic model organism: 
work must be focus on the identification of novel genes, and not the characterization of 
homologues of genes from other species. The recent history of C. elegans research tells 
us that the worm has been formidable to discover new pathways (e.g. apoptosis) or 
phenomenon (e.g. RNAi), but not to explore already characterized genes from other 
species. Moreover, there are certainly enough genes in the C. elegans genome without 
assigned functions to occupy many graduate students for several years. Let’s wait to see 
how the future of apoptosis research will treat the worm… 
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Supplementary Table I : Primer list
Guillaume Lettre's primers - BOX 1
PRIMER NAME SEQUENCE PURPOSE LOCATION
BOX 1
T21C12(12057)_Fwd ACAAATCCAAGCGTCTGCC SNP 1
T21C12(12057)_Rev GAAAACCGTCAAATTGCTGG SNP 2
K11D9(29813)_Fwd CACGGAAATAGACGACACTCAC SNP 3
K11D9(29813)_Rev TTCAGTGGAAAAGTTCGACGTC SNP 4
T28D6(5428)_Fwd TTTCGTGTACGAACGTCTCC SNP 5
T28D6(5428)_Rev CATTTCTCCCACTCTTGCTG SNP 6
Y47D3B(87052)_Fwd TGTGCCTACGTGGATTAATTG SNP 7
Y47D3B(87052)_Rev AAATTGGACGGAGCTTGG SNP 8
Y41C4A(128611)_Fwd ATTTTTGTGAATTCCAGGGC SNP 9
Y41C4A(128611)_Rev TTTCAGCCAAAAAGCTCTGA SNP 10
Y56A3A(149135)_Fwd TCAACTACGACGACGCTGAC SNP 11
Y56A3A(149135)_Rev CGGTGTTTTCAGACAATTTCG SNP 12
ced9LB/Asc/Not_S
GCGTGGGCGCGCCATGGGCGGCCGCACACGC
TGCACGGCGGAC To lazyboy ced-9 (add NotI site N-ter) 13
ced9LB/Fse_AS CGCAGGCCGGCCTTACTTCAAGCTGAACATC " 14
ced9_cDNA_S_468 TGGAAATGCACAGACAGATC
To sequence ced-9 from position 468 
(cDNA) 19
eft-3 prom. Seq LB S TTGGCCAAAGGACCCAAAGG
To sequence pBMB.LBeft-3 lazyboy 
cassette from eft-3 promoter 15
poly-A seq LB AS GAGGCACGGGCGCGAGATGG
To sequence pBMB.LBeft-3 lazyboy 
cassette from poly-A sequence 16
Y47D3B(67807)MaeIII_
Fwd CTCATGCTGTGCACAAACAACAATC SNP 17
Y47D3B(67807)MaeIII_
Rev GCAGCGTATCAAGCTTACATGTACT SNP 18
W09D10(7357)BstBI_F
wd TCTGGTGGAAGTGTTAATTGGAATG SNP 20
W09D10(7357)BstBI_R
ev TTTATGGTTGTTCGCAATGGAAAGG SNP 21
Y48A6C(3473)BspMI_F
wd ATTCGGTATTCCGATCAATTTTACC SNP 22
Y48A6C(3473)BspMI_
Rev TTGACCGAAACCTGTTAGAAATGAC SNP 23
5'GFPYFPNotI ATGGGCGGCCGCAGTAAAGGAGAAGAA
To create GFP & YFP NotI cassette - YFP 
did not work! 24
3'GFP-NotI TGTGCGGCCGCCCTTGTATGGCCGGCTAG " 25
C09D4_37465' TGACTCTGCATGATAGAACATCGTC SNP 27
C09D4_37463' TCTGTCTCGGAAACTGGTATGTTTT SNP 28
F18C122332235 TTTTCCTTTGTTGCAGTTTTCCATG SNP (did not work - use other primers) 35
F18C122332233 AAAATTGAGCCATTTAAAGCGATCC SNP (did not work - use other primers) 36
K02B12152185 AAAACAGAAATTTGAAGGGATGGAG SNP 37
K02B12152183 TCAAATTTGGCACGTCATCAGTTTT SNP 38
K04F10196185 CTTTACCAGTGATCGGGATTCCATT SNP 29
K04F10196183 CCCGACATCACTATAACTACCTCCG SNP 30
F21C3183375' ACCTGCAATATGTGTATATGGAATC SNP (did not work - use other primers) 31
F21C3183373' TCGTACAATTCCTCTAGAGTTGTGT SNP (did not work - use other primers) 32
T23G1190645' ATGACACAAATAACAACAAACTGGC SNP (did not work - use other primers) 33
T23G1190643' TTGAGTCACTGGATGTTTCTTCGAA SNP (did not work - use other primers) 34
F21C3(18337)MwoI_Fw
d AGCAGATTGAGGCTGAAATATGGTG SNP 39
F21C3(18337)MwoI_Re
v TCAAGTCGAGCAGCACCAGTTATTG SNP 40
T23G11(9064)DdeI_Fw
d CGTATACATCTCTGCGTGGCTCTTC SNP 41
T23G11(9064)DdeI_Re
v CTTCGAATCCATATCGATGCGACGG SNP 42
F18C12(23323)AclI_Fw
d TTGAATCACCGCCAACATGAGAAC SNP 43
F18C12(23323)AclI_Re
v GCCAGTGTCCCGATAGAAAACACC SNP 44
F46F11(29076)NlaIII_F
wd AGTAGTTGGTATTCACCGAAATCAG SNP 45
F46F11(29076)NlaIII_R
ev GTGAGTATGCCTTTAAAGAGTACTG SNP 46
C04F1(3815)MaeIII_Fw
d GTTCTTCTCATTGTTTTCTTCTGGG SNP 47
C04F1(3815)MaeIII_Re
v CTATAGATGCTAGACAACAAGACGC SNP 48
C34G6(15466)BstBI_F
wd CTCTGAATTTTTCTGTAAAGGCACC SNP 49
C34G6(15466)BstBI_R
ev ATTTCACTTAAAATCAGAAGGCGCC SNP 50
B0207(42124)SspI_Fw
d AATTGTGAATTCTACAGGAAGGGTG SNP 51
B0207(42124)SspI_Rev GTAACGACCCACAAAATCATCCGAG SNP 52
C06A5(19725)DraI_Fw
d GATTTTTTAAAGGAAACCTCGGAGG SNP 53
C06A5(19725)DraI_Rev TCCGTAAAGCAGCTTCAAAATAGGT SNP 54
T27A3(18348)AlwNI_F
wd ATAAAGTTATTGCATGTCTACCGGG SNP 55
T27A3(18348)AlwNI_R
ev TTGAGATCTCAAACTTTTCGTGTGG SNP 56
B0414_2F GAATTGAAGAAGACTGTTGGCGG
To sequence exon 4 of gla-1 (where op234 
is) 57
B0414_2R GATACGGCAGGTAGGTCAACCAC " 58
Y47D3A48624F TCAGATGTGTAGAACGATCAAGAAG SNP 59
Y47D3A48624R ACATCTCTATGCCGAGCACTTATAC SNP 60
Y47D3A89471F TGAGTTCTTCGTTCTGGAAAATTAC SNP 61
Y47D3A89471R CTGGATCCTTATAAAGGAACATTTC SNP 62
rab35_ex1_s TCTTGGGAAATTTGGGTCAAAACTG To sequence exon 1 of rab-35 63
rab35_ex1_r CTAAGTTTCTGCTGAATTTTCTGGG " 64
rab35_ex2-3_f TCAGCTGAAAAGCTGCTTCTGCTCC To sequence exons 2 & 3 of rab-35 65
rab35_ex2-3_r TGTGTTCCTATAATACTGAAAATAG " 66
rab35_ex4_f CCCCACCTTTAAGTTAATTGTTGAG To sequence exon 4 of rab-35 67
rab35_ex4_r ACACTAAAAAGTTCCGAAAATGATG " 68
rab35_ex5_f TAATTTAGGAAGGAGGGGAAAACAG To sequence exon 5 of rab-35 69
rab35_ex5_r AAAAGCGTAAGGATTGGAATAATTC " 70
rab35(ex1)Fwd2 CCCTTAGAAAATTTGATGCCTAACC To sequence exon 1 of rab-35 71
rab35(ex1)Rev2 AAAACCCCCAATTTCCAGGCTTCTG " 72
rab35(ex2)Fwd2 CCAAATTTGTCTCTGAAATTCATAG To sequence exon 2 of rab-35 73
rab35(ex3)Rev2 GTACAATTACATCGACGTATGGCG To sequence exon 3 of rab-35 74
rab35(ex5)Fwd2 GCAGTCGATCGATTTGGAAATTGGG To sequence exon 5 of rab-35 75
rab35(ex5)Rev2 TAGGCCACTTTTTGAGCCGTCGTC " 76
Guillaume Lettre's primers - BOX 2
PRIMER NAME SEQUENCE PURPOSE LOCATION
BOX 2
F08A8(3890)TaqI_Fwd ATGACAGGGTTCGATTAATCTCAAG SNP A1
F08A8(3890)TaqI_Rev CTTCTCGTCTCACATGCTGGAATTC SNP A2
Y26D4A(7397)AatII_Fw
d GCGACGCAATTCTTCCTATGCAAGG SNP A3
Y26D4A(7397)AatII_Re
v CTTGGCGCCAAAATTGGTCAGTTGG SNP A4
ZK1053(4253)MwoI_Fw
d CAGAAATATCCTAACAGTTTTGGGG SNP A5
ZK1053(4253)MwoI_Re
v TGCGTGTTTGAAATGCATCATCTTG SNP A6
pkP1135-MaeI_Fwd CTCTTCTTCTCCCTTTGACTCATCC SNP A7
pkP1135-MaeI_Rev GACGGTGAAGAGAAATCAAATTTGG SNP A8
Y87G2A(21607)MnlI_F
wd ACTACACACATTTTGAGCCTCAACC SNP A9
Y87G2A(21607)MnlI_R
ev GTGCAAAAAGTTTTTGGGTCGATTC SNP A10
Y47D3A(126441)Seq_F
wd GTGAAAGTTAATGGGCCGTAAATAG SNP B1
Y47D3A(126441)Seq_
Rev CACGTTCTTAACCATGCGAAATTAG SNP B2
Y47D3A.26_Fwd CTTGAAATTGACTCGTTGAATGAGG SNP B3
Y47D3A.26_Rev TGAATAACTCCTACCGATTTCTGTC SNP B4
M13_Reverse CAGGAAACAGCTATGAC Colony PCR - TOPO cloning B5
M13(-20)_Forward GTAAAACGACGGCCAG Colony PCR - TOPO cloning B6
pREP1_MCS TTTCAATCTCATTCTCACTT
To sequence the insert of the pREP 
vectors B7
ced3_5'NdeI TTGTTAAATCATATGATGCGTCAAGATAG
To clone ced-3 in frame in the pREP 
vectors B8
ced3_3'XhoI TTATGATGAGGCACATTCCACG " B9
Y47D3A.28_Fwd GACGGCCAACGATGCAGTAATTTTG SNP B10
Y47D3A.28_Rev CATGTCACCGCGTTGAACACACCTG SNP C1
ced3_5'SalI AATCATATGTCGACTATGATGCGTCAACATAG
To clone ced-3 in frame in the pREP 
vectors C2
ced3_3'SalI CGTCTCGATTGTCCCATCCACG
To clone ced-3 in frame in the pREP 
vectors C3
T28D6.6_Fwd GCCAAAATTCAACTGCTCGATTTAC SNP C4
T28D6.6_Rev CCTGATTATCATAACGAGACCGCTG SNP C5
Y47D3A.gg_Fwd CTGTATTTTTCCAATTTTGGCTG SNP C6
Y47D3A.gg_Rev CTCACTAATCCTGATGGTTCTGG SNP C7
opP113(Y18D10A)BstU
I_Fwd GCTGCGCTTGTGTCGATTTACG SNP C8
opP113(Y18D10A)BstU
I_Rev GGGGGCGATCGAATTTGTGAAC SNP C9
F22G12(21724)BbsI_F
wd TTTTGAGTGATTTTCTGCTTGGCAG SNP C10
F22G12(21724)BbsI_R
ev TGGCTGGGAATTTCAATTAACAACC SNP D1
Y18D10A.17(ex1-2)Fwd ATTCTCCTATTCCCGACAATATTGC
To sequence exons 1-2 from gene 
Y18D10A.17 D2
Y18D10A.17(ex1-2)Rev GTTGTTGTATCCACGGTTAGCTTGG
To sequence exons 1-2 from gene 
Y18D10A.17 D3
Y18D10A.17(ex3-4)Fwd CGTCCAGGACGTGGAGGTTATCAGC
To sequence exons 3-4 from gene 
Y18D10A.17 D4
Y18D10A.17(ex3-4)Rev GGGTATGGGGATGTGGGGAGAAAAC
To sequence exons 3-4 from gene 
Y18D10A.17 D5
oJL102 CAACCTTGACTGTCGAACCACCATAG Mos mutagenesis D6
oJL103 TCTGCTAGTTGTTTTTGCGTTTGAG Mos mutagenesis D7
oJL104 ACAAAGAGCGAACGCAGACGAGT Mos mutagenesis D8
oJL114 AAAGATTCAGAAGGTCGGTAGATGGG Mos mutagenesis D9
oJL115 GCTCAATTCGCGCCAAACTATG Mos mutagenesis D10
oJL116 GAACGAGAGGCAGATGGAGAGG Mos mutagenesis E1
IPCR1a GACCTTGTGAAGTGTCAACCTTGACTG Mos mutagenesis E2
IPCR1b GACAATCGATAAATATTTACGTTTGCGAGAC Mos mutagenesis E3
IPCR2b CATCTATATGTTCGAACCGACATTCCC Mos mutagenesis E4
teg-1(ex1-2)Fwd CCAGGCTGAGATCGATTTTCCTCCG To sequence exons 1-2 of teg-1 E5
teg-1(ex1-2)Rev CTCATTTTCCGCGCATAATCCCAAC To sequence exons 1-2 of teg-1 E6
teg-1(ex3)Fwd ATTGAGCGTAGCATGAATTTTCTGG To sequence exon 3 of teg-1 E7
teg-1(ex3)Rev AAATTTCCGGTAAACCGACAATTGC To sequence exon 3 of teg-1 E8
teg-1(ex4)Fwd TCCTCTGAAATCAGTAAAAATTGGG To sequence exon 4 of teg-1 E9
teg-1(ex4)Rev TTGGTGAAAAACATCAAAAATAGCG To sequence exon 4 of teg-1 E10
teg-1(ex5-6)Fwd GAGATAGAGAGTGAAAACGAGATTC To sequence exons 5-6 of teg-1 F1
teg-1(ex5-6)Rev TTCAGTCAAGACAAAGTCAAAATGC To sequence exons 5-6 of teg-1 F2
teg-1_Gateway_Fwd
GGGGACAAGTTTGTACAAAAAAGCAGGCTTGC
CGAAACGCGCCGTTTCTTTCGCC
Creation of a Gateway teg-1 genomic DNA 
cassette F3
teg-1_Gateway_Rev
GGGGACCACTTTGTACAAGAAAGCTGGGTTTA
CAAATAAAGCTCGAAATCAATTCTGGC
Creation of a Gateway teg-1 genomic DNA 
cassette F4
MFG-E8_AscI(5') TACAGGCGCGCCATGCAGGTCTCCCGTGTG To lazyboy MFG-E8. Add AscI at 5' end F5
MFG-E8_NotI_FseI(3')
CTTAGGCCGGCCTTAATTAATTAGCGGCCGCC
ACAGCCCAGCAGCTCCAG
To lazyboy MFG-E8. Add NotI & FseI at 3' 
end F6
MFG-E8(449-468) CACAGCTGGGCATGGAAGGG
To sequence MFG-E8.  Numbers 
correspond to cDNA F7
teg-1_5'_3'UTR
TATATATAGCGGCCGCTGATGTTGGGTTGCAG
AAGCCTGG
To create a NotI teg-1 cassette (promoter-
teg-1-3'UTR) F8
teg-1_3'_promoter
AATTTAATGCGGCCGCCTGAAAATTGAACAATT
TGTGGAAAATTTCAGCG
To create a NotI teg-1 cassette (promoter-
teg-1-3'UTR) F9
MFG-E8(979-) CAGATGTCAGCCTCCAGCAG
To sequence MFG-E8 from bp 979 of 
cDNA F10
pkP2116.IIR(DraI)Fwd TCAATTTCTTTCCCATTTTCCTCCC BSA, Chromosome II, right arm G1
pkP2116.IIR(DraI)Rev TTCAAAAACCCAGACACTGGATCGC BSA, Chromosome II, right arm G2
Y92C3A.IIIL(13164)AatI
I_Fwd CCTAAGCCAAACTTTCCGTCTAAAC BSA, Chromosome III, left arm G3
Y92C3A.IIIL(13164)AatI
I_Rev GCCACACGGCCTGAATTATCAATAC BSA, Chromosome III, left arm G4
gla-1(WT)Fwd CCTCGAAAGTACATGCTGTATGGTATG
To genotype gla-1(op234). WT band of 530 
bp. G5
gla-1(WT)Rev TGTTGGCGGAGTCGAAAACTCTGTG
To genotype gla-1(op234). WT band of 530 
bp. G6
gla-1(op234)Fwd GAAACAGTGTGCTGACTGCGAATTAT
To genotype gla-1(op234). Mutant band of 
374 bp. G7
gla-1(op234)Rev AGGTACAAATCATTCCATGGGTTACC
To genotype gla-1(op234). Mutant band of 
374 bp. G8
CNX-1.1(FWD) AGGTAACCATGGTGAACCGGAAATG To find deletion in cnx-1 mutants G9
CNX-1.1(REV) CTTGACCTTCCTCAAACTTGATGTC To find deletion in cnx-1 mutants G10
CNX-1.2(FWD) TGATGCGAATACTTTCGTTGTTCAG To find deletion in cnx-1 mutants H1
CNX-1.2(REV) TAGGTTTTATAGGCATTCGGTGAAG To find deletion in cnx-1 mutants H2
Y26D4.2_Fwd TCTTCTCCTGATGACTCTGTGTTTG New SNP around op199 H3
Y26D4.2_Rev TTAACCGGACACAACTGGAAGACAG New SNP around op199 H4
C17H1.5(Intron2)Fwd TGTTTCACAGCCCCACAACATCAGC New SNP around op199 H5
C17H1.5(Intron2)Rev TTTGCACGTTGCAGCTCAACTTTTC New SNP around op199 H6
F17B5.2_Fwd GAAGCCTCGAACCTGATGGATCTTC New SNP around op199 H7
F17B5.2_Rev ACTGCGCCACTTGACCATTTTCAGG New SNP around op199 H8
ZK1225.1_Fwd AGACCGTGCTCAACGAAGTTGGATC New SNP around op199 H9
ZK1225.1_Rev CCTGGAAATCATTCAAGAGCAGTTG New SNP around op199 H10
K10G9.3_Promoter_Fw
d
TACAGGCGCGCCGATTTTTATTAATACGTGGTG
TCAGGC To amplify and AscI C21ORF80 promoter I1
K10G9.3_Promoter_Re
v
TACAGGCGCGCCCTGGAAAATCGAGAGATTTT
GAGG To amplify and AscI C21ORF80 promoter I2
K10G9.3_3'UTR_Fwd
TACAGGCCGGCCATTATTTTTTGTATAATATATT
ACGGATCTC To amplify and FseI C21ORF80 3'UTR I3
K10G9.3_3'UTR_Rev
TACAGGCCGGCCACTTTTTATGTGATTCACAAG
TGATTAG To amplify and FseI C21ORF80 3'UTR I4
K10G9.3_Gene_Fwd
TACAGGCGCGCCATGGGCGGCCGCCATTTCTT
TCCAATTCAATTACTGG To amplify and lazyboy C21ORF80 gene I5
K10G9.3_Gene_Rev
TACAGGCCGGCCTTAATAAACTATTTTCCATTT
GGCCG To amplify and lazyboy C21ORF80 gene I6
K10G9.3_Exon1_Rev TAAATCGCCACATGGCAGAG To sequence C21ORF80 I7
K10G9.3_Exon2_Fwd AGAGACGGCTCGCCAAGAC To sequence C21ORF80 I8
K10G9.3_Exon3_Rev GACAACTTTATGTTGCTATAAC To sequence C21ORF80 I9
K10G9.3_Exon4_Rev ATAATCTCAAAGCAGACTCC To sequence C21ORF80 I10
F17B5.4_Fwd TAACGAAGAAAGTTCAGTTTTGTTG New SNP around op199 J1
F17B5.4_Rev CAACTGCTATAGAACCTTCGTTTGAG New SNP around op199 J2
C17H1.4-5_Fwd CAATGGTTTCAACGAATATGGATGC New SNP around op199 J3
C17H1.4-5_Rev TTTTGCACCTATGGAGGGTTTTGTC New SNP around op199 J4
Guillaume Lettre's primers - BOX 3
PRIMER NAME SEQUENCE PURPOSE LOCATION
BOX 3
F17B5.1(ex1-2)F CATTCATTTTTATTGAAGTTTGGGC To sequence F17B5.1 A1
F17B5.1(ex1-2)R AATTCGACTCATCGTCTTGATTATCAC To sequence F17B5.1 A2
F17B5.1(ex3)F CCATAGAAGTTCAACAATTTCTTGTGG To sequence F17B5.1 A3
F17B5.1(ex3)R GTAATGAGCAAATCACTGTAGGCAAG To sequence F17B5.1 A4
F17B5.1(ex4-5)F TTGGGATTATTATTGGGATGGTAGG To sequence F17B5.1 A5
F17B5.1(ex4-5)R AAATGTGAGAGTCCTGGATAGCAATC To sequence F17B5.1 A6
F17B5.1(ex6-7)F ATGAGCAGTAGGAGAAAATCGGATG To sequence F17B5.1 A7
F17B5.1(ex6-7)R TGAAAACCAACCTGTCAAGAATCTG To sequence F17B5.1 A8
F17B5.1(ex8)F AAGATGAGGTTATAGCTTTGGTTGTTG To sequence F17B5.1 A9
F17B5.1(ex8)R TTTCTGTCAAGAATGCAATTTCAGG To sequence F17B5.1 A10
F17B5.1(SeqEx8)F AAAACGCAAGAAAGAGTTGG To sequence F17B5.1 B1
F17B5.1(SeqEx8)R GCCTAGCTTTCTCTTCTGCG To sequence F17B5.1 B2
R05D3.4(ExtLeft) CATTTCCGTCTCTTGACCGT To detect ok572 B3
R05D3.4(ExtRight) CATTTGTCGATTCGCTTCCT To detect ok572 B4
R05D3.4(IntLeft) TCTCTCACTCAGGTCTCGCA To detect ok572 B5
R05D3.4(IntRight) AATCTTCGATTTCACGTGCC To detect ok572 B6
pmk-3(ok169)Fwd CCCATTTTTCACTGCGTCTCAATCG To detect ok169 B7
pmk-3(ok169)Rev TCTGCTTCTCCAGGGATTAACGGTG To detect ok169 B8
pmk-3(WT)Rev TCGGGGGAAATTAGAGGAGTGTCGG To detect pmk-3(wt) B9
C17H1.4(Fwd) TAGCAATAAATTGCTAACCCAGAGAAT To find SNP around op199 B10
C17H1.4(Rev) GTCGAAAAATCACGTGTAAAAGCT To find SNP around op199 C1
C17H1.8(Fwd) CAGTATCCCAACCCATGCATATAAC To find SNP around op199 C2
C17H1.8(Rev) CGTTGCCTAAAACAAATATGGGTAC To find SNP around op199 C3
pkP5114(AluI)Rev TTCAAAACTGGCGTTGACGAAATC SNP around op385 C4
pkP5114(AluI)Fwd AGAGAGCGAGATCTTCACAGCAAG SNP around op385 C5
pkP5063(HinfI)Fwd ACCACGGCCTTCAAAAGAGTAC SNP around op385 C6
pkP5063(HinfI)Rev TTCTGCAAGAGAGTGACAGGTC SNP around op385 C7
pkP5064(DraI)Fwd TCTCTTAGATACCCTTTCTGCGCC SNP around op385 C8
pkP5064(DraI)Rev CATTCAGCGTTTGGTCTGACGTAG SNP around op385 C9
pkP5093(BspHI)Fwd TTTCAGCTAGACCTCCCATGCG SNP around op385 C10
pkP5093(BspHI)Rev ATATCAATCACATGATGCCGT SNP around op385 D1
pkP5124(DraI)Fwd TTCGGGATCTGTTTGGATTTATAG SNP around op385 D2
pkP5124(DraI)Rev GTATTGCAATTGGCTTTCTTGG SNP around op385 D3
pmk3(1613)Fw CAAATGATAAAATTGGCACGTGTAC Probe for pmk-3(ok169) D4
pmk3(2565)Re TCCATAATCTCTTTGTTGCTTCAAG Probe for pmk-3(ok169) D5
pmk3(WT)Fwd TTCCTCTTATGGGTCTCGCCATCAG Primer inside ok169 deletion D6
pmk-1(AscI)F
TACAGGCGCGCCGGTAACGGAGCCAATGTTTC
CACAG To create lazyboy pmk-1 for RNAi feeding D7
pmk-1(FseI)R
TACAGGCCGGCCCACCCAACTGACCATACATC
AACAG To create lazyboy pmk-1 for RNAi feeding D8
pmk(promo.3Kb)Fwd
TACAGGCGCGCCTAACCATCAAAGCAATACTG
AGAAG To create lazyboy pmk promoter (AscI) D9
pmk(promo.3Kb)Rev
TACAGGCCGGCCAATTTAAATGGGTTCAAGTTA
GGGC To create lazyboy pmk promoter (FseI) D10
pmk(promook169)Rev
TACAGGCCGGCCCGTTCCTGTATTGATTGATTT
TGAG To create lazyboy pmk promoter (FseI) E1
K10G9.3(prom)Fwd
TACAGGCGCGCCTTTTTATTAATACGTGGTGTC
AGGC To lazyboy K10G9.3 promoter(AscI) E2
K10G9.3(prom)Rev
TACAGGCCGGCCTGAAATTTAGAATTCTTAGAG
GGGC To lazyboy K10G9.3 promoter(FseI) E3
pmk1(QRT)Fwd ACACGCAGACTGTTGATGTATGGTCA For Q-RT-PCR with pmk-1 E4
pmk1(QRT)Rev TGGTGTTCCAGTTACTGACATGATACT For Q-RT-PCR with pmk-1 E5
pmk2(QRT)Fwd GCCTCTAGGAGAAGGAGCGTATGG For Q-RT-PCR with pmk-2 E6
pmk2(QRT)Rev TGTACTTTGAAATGGGCGAAAGAACT For Q-RT-PCR with pmk-2 E7
pmk3(QRT)Fwd GAAGCAACGGGAAACAACGAGAT For Q-RT-PCR with pmk-3 E8
pmk3(QRT)Rev GATCATCACAAATTGGAATCGTCGTT For Q-RT-PCR with pmk-3 E9
Tubulin Fwd Ask Lili For Q-RT-PCR with tubulin E10
Tubulin Rev Ask Lili For Q-RT-PCR with tubulin F1
ActinFwd GCTGATCGTATGCAGAAGGAAATCAC For Q-RT-PCR with actin F2
ActinRev AGGTGGAGAGGGAAGCGAGGA For Q-RT-PCR with actin F3
GAPDHFwd AAGGGAGGAGCCAAGAAGGTCATC For Q-RT-PCR with GAPDH F4
GAPDHRev TGTGGTCGTTGGCATGATCGTACT For Q-RT-PCR with GAPDH F5
pmk-3(Gateway)Fwd
GGGGACAAGTTTGTACAAAAAAGCAGGCTTGA
TGGCGTCAGTCCCATCGTCATCTAG
To gateway clone pmk-3 genomic
sequence and cDNA F6
pmk-3(Gateway)Rev
GGGGACCACTTTGTACAAGAAAGCTGGGTTCA
GCGATCTGCTTCTCCAGGGATTAAC
To gateway clone pmk-3 genomic
sequence and cDNA F7
pmk-3(intron1)Fwd AAACCAAATAGGAAACTGGC To sequence pmk-3 F8
pmk-3(intron3)Fwd GGAAAATTGCCAAAACTTTAG To sequence pmk-3 F9
pmk-3(intron5)Fwd AAGAACATGACTAAAACACG To sequence pmk-3 F10
PMK(operon)Fwd
TACAGGCGCGCCGTTACTGTAGAAACATAGAG
AAACG To create lazyboy pmk promoter (AscI) G1
pmk1km25)F TTTGTGTCCCTAATTCCTTGATCTC To genotype km25 deletion G2
pmk1(km25)R TGAGTCCACGAAGAATTTGATAGAC To genotype km25 deletion G3
ced-3(Pro)F
TACAGGCGCGCCTACAACCAAGGCATCGAACT
TCACG To amplify ced-3 promoter(AscI/FseI) G4
ced-3(Pro)R
TACAGGCCGGCCATCTTCGGCTGATGGTTGAC
CTCTC To amplify ced-3 promoter(AscI/FseI) G5
ced-4(Pro)F
TACAGGCGCGCCTTAAATGTTTCAGACAATCAT
CCAC To amplify ced-4 promoter(AscI/FseI) G6
ced-3(Pro)R
TACAGGCCGGCCAGAGCATCTGAAAAATCTTC
TTG To amplify ced-4 promoter(AscI/FseI) G7
ced-3(Pro)R
TACAGGCGCGCCGTAGTGGTTTTGTACTGATTT
CC To amplify ced-9 promoter(AscI/FseI) G8
ced-3(Pro)R
TACAGGCCGGCCTGACTCTCCGATGGACATTC
TTC To amplify ced-9 promoter(AscI/FseI) G9
dlk1(km12)Fwd TTTCAGGGAAAATATACTCACTTGG To genotype km12 deletion G10
dlk1(km12)Rev AACTGTTAGGTAAGTTGGAACTTGG To genotype km12 deletion H1
mkk4(km23)Fwd ATCCGAGAAAGGACCAAATATCGTG To genotype km23 deletion H2
mkk4(km23)Rev AATCGGAGGGAAGAGAGAGAGAAAG To genotype km23 deletion H3
pkP6133(DdeI)F GGTTTCGATGACGGTGTGAGAGATG To SNP map op387 on LGX H4
pkP6133(DdeI)R AGGTGAAGCAAGTTTGATTTTCCGG To SNP map op387 on LGX H5
pkP6162(SspI)F AAAGTTTTAGGCTTTTTGGGATCAC To SNP map op387 on LGX H6
pkP6162(SspI)R CAGCCAGTAAATCTGGTGTATTTTG To SNP map op387 on LGX H7
pkP6166(SspI)F GAGTCCAAACAGTTGTGTAATTGAG To SNP map op387 on LGX H8
pkP6166(SspI)R CTATGTTCCAACAACACTTCAACAC To SNP map op387 on LGX H9
pkP6167(HinfI)F TCCTGTAACTATTCACCACTATTTC To SNP map op387 on LGX H10
pkP6167(HinfI)R AGTGATTGAGCTCGTTAAGAAATTG To SNP map op387 on LGX I1
pkP6116(BfaI)F GTCCAACAAAATATAAATTACGGCC To SNP map op387 on LGX I2
pkP6116(BfaI)R ATTTTGCTGAAGGGCTATAATCCAG To SNP map op387 on LGX I3
pkP6117(FokI)F TTCACGATATGTTATTTTGTGTGCG To SNP map op387 on LGX I4
pkP6117(FokI)R AAATAAGGCAAGTTTCAGAGCAATC To SNP map op387 on LGX I5
flr-4(ex1-2)F TGCAATTTTTGCAACACGACTCGTC To sequence flr-4 I6
flr-4(ex1-2)R TTTGCCAAAAATGAAAATATCCGGC To sequence flr-4 I7
flr-4(ex3-6)F ACAAAACTTTAAAGTATGCACATAC To sequence flr-4 I8
flr-4(ex3-6)R AATAACATTTCAATGAACGTACATC To sequence flr-4 I9
flr-4(ex7-10)F CGGCAGACATTTGGTAACTGATGAT To sequence flr-4 I10
flr-4(ex7-10)R TCTCAGTTTCTCGGTGTTACAAATC To sequence flr-4 J1
flr-4(ex11-12)F ATCTAACCCAAATTACGCATTGAAC To sequence flr-4 J2
flr-4(ex11-12)R TGGAAGTTCCTGAAGTGAAATTATG To sequence flr-4 J3
F20D1[3]Fwd GGCGATGATGTTATCCAACTCTTTG To SNP map op387 on LGX J4
F20D1[3]Rev GTATTGCAGGTAAGCTTATGGTCTG To SNP map op387 on LGX J5
Guillaume Lettre's primers - BOX 4
PRIMER NAME SEQUENCE PURPOSE LOCATION
BOX 4
mak2(km24)Fwd TGTGAGTTTTTTAGAACTACTTGGC To genotype km24 deletion A1
mak2(km24)Rev TTTGAAATAAAGAGGAACCTGTAGC To genotype km24 deletion A2
mtk1(km33)Fwd CATGAACCTATGTTTAGCCTTTAAC To genotype km33 deletion A3
mtk1(km33)Rev CGAAAACAATACATGATGGTTATGG To genotype km33 deletion A4
gck2(km29)Fwd GCTGAAAGTGATCCAAGAACAAAAG To genotype km29 deletion A5
gck2(km29)Rev ATGTTTTTGCACCGTAACTCACGAG To genotype km29 deletion A6
F20D1.9(fwd) GCAAGGAAAGAAAAACGAACTGGTG To sequence F20D1.9 A7
F20D1.9(rev) GAAGGATAGGCATCAAAGATGGGTG To sequence F20D1.9 A8
F20D1.9(int) CATAATTTACTTTTCCGCCG To sequence F20D1.9 A9
C18B12[1]Fwd AAGACAATGAAACTTTAGCGGTCAG SNP around op387 A10
C18B12[1]Rev AACGTATTCGACTTTCCTGATCTCC SNP around op387 B1
H03G16[1]Fwd TTGAAAGTTCTTCAACTCACCGTTC SNP around op387 B2
H03G16[1]Rev TTAGTACCGCATATTCCCAAACTTC SNP around op387 B3
pmk-3(cDNA)CorRe CTATCAATCTTCCAATAAATGACTT To correct stop codon in pmk-3 cDNA B4
pmk-3(cDNA)CorFwd AAGTCATTTATTGGAAGATTGATAG To correct stop codon in pmk-3 cDNA B5
pmk3(QRT)F-N CAATAAAGAAGATGCGAGAACCGTTCT To measure pmk-3 transcript level B6
pmk3(QRT)R-N AGGTGTGTAGATGTCAAGAGCACAGATG To measure pmk-3 transcript level B7
hda4(ok518)F CGAAAAAGCCTTGTGAGAGAAGATC To genotype ok518 deletion B8
hda4(ok518)R AGGTAATGATTCGAGAGCAACTGAG To genotype ok518 deletion B9
mef2(gv)Fwd CCTTAATTAATTAATGCTGCTGCTC To genotype gv1 and gv2 alleles B10
mef2(gv)Rev TAATGCAAAATTACGGTAAACGGTC To genotype gv1 and gv2 alleles C1
mef2(pro)F/A
TACAGGCGCGCCTAAGTTTTTTCAGAGAGCAA
GCAAC To amplify and lazyboy mef-2 promoter C2
mef2(pro)R/F
TACAGGCCGGCCCTCCATACCGCAATAATCATT
AATC To amplify and lazyboy mef-2 promoter C3
mef-2(Gateway)F
GGGGACAAGTTTGTACAAAAAAGCAGGCTtgatg
ggtcgcaagaaaattcaaatcac To gateway clone mef-2(cDNA) C4
mef-2(Gateway)R
GGGGACCACTTTGTACAAGAAAGCTGGGTTCA
AGTCAATTGCTGTGGTCTCCACTC To gateway clone mef-2(cDNA) C5
mef2(Gat.DN)Rev
GGGG AC CAC TTT GTA CAA GAA AGC TGG 
GTT CAT TCA TCA TCC GAA TTT CCG CCT 
CCC To create mef2 dominant negative C6
mef2-VP16-Rev
GACATCGGTCGGGGGGGCTGGTCCAGGGCTT
TCATC To create mef2 activated form C7
mef2-VP16-Fwd
GATGAAAGCCCTGGACCAGCCCCCCCGACCGA
TGTC To create mef2 activated form C8
VP16(Gateway)Rev
GGGG AC CAC TTT GTA CAA GAA AGC TGG 
GTC TAC CCA CCG TAC TCG TCA ATT CC To create mef2 activated form C9
uCE6-1494F CACCAATAAAGTTGCTCCAGAGATC SNP around op387 C10
uCE6-1494R TGAACACATGTTCAAGCTTTTAGTC SNP around op387 D1
epn1-1(F) TCTATGTTTTAGCCACACCATTCAG To sequence epn-1 (T04C10.2) D2
epn1-1(R) TTTATATCTTACCAAGAGACGCGTC To sequence epn-1 (T04C10.2) D3
epn1-2(F) ACAAATTCAAGCAAAACAATCCAGG To sequence epn-1 (T04C10.2) D4
epn1-2(R) ACCATTTGTGGAGTTGTTAGTGTTG To sequence epn-1 (T04C10.2) D5
epn1-3(F) CAACTACTCCATCAACAATGCCAAC To sequence epn-1 (T04C10.2) D6
epn1-3(R) GGGAAAAACGTGGTGAGTGTATATG To sequence epn-1 (T04C10.2) D7
uCE6-1503F GGCGGATACGAAAAATAACAATGTC SNP around op387 D8
uCE6-1503R TGTAATTACGTGCGCACAAATACTG SNP around op387 D9
uCE6-1502F TAGGAATCAATCATGTTTGGAGAAG SNP around op387 D10
uCE6-1502R AATCTTTGTATTCACCGACTTCGTG SNP around op387 E1
C27C12[2]F TGGTCACAGATTATCGGAGCAAGTG SNP around op387 E2
C27C12[2]R CTTACCATATTGCGCTGGGTTGTTC SNP around op387 E3
Supplementary Table II : Plasmid list
PLASMID NAME DESCRIPTION LOCATION
BOX 1
pPD128.110 L4440 RNAi feeding vector with gfp insert (Fire kit) 1
pGL-1 Lazyboyed ced-9 cDNA cloned (AscI/FseI) into pBMB.LB_eft-3 2
pGL-2 pBMB.LB_eft-3 cut with NotI, then fill-in, creates FseI site 3
pGL-3 Lazyboyed ced-9 cDNA cloned (AscI/FseI) into pRH10 4
pGL-4 GFP cassette flanked by NotI sites,  cloned into pCR2.1-TOPO 5
L4440.LB_ced9 RNAi feeding vector with lazyboyed full-length ced-9 cDNA (AscI/FseI) 6
pREP1 Fission yeast vector 7
pREP41 Fission yeast vector 8
pREP81 Fission yeast vector 9
pBS1761 TAP-TAG vector (from Cellzone) 10
pBS1479 TAP-TAG vector (from Cellzone) 11
pDX-2 ced-3 cDNA with FLAG epitope (from Horvitz lab) 12
pY47D3A.12 RNAi feeding vector against corresponding gene (from Vidal lab) 13
pY47D3A.13 RNAi feeding vector against corresponding gene (from Vidal lab) 14
pY47D3A.16 RNAi feeding vector against corresponding gene (from Vidal lab) 15
pY47D3A.21 RNAi feeding vector against corresponding gene (from Vidal lab) 16
pY47D3A.30 RNAi feeding vector against corresponding gene (from Vidal lab) 17
pTOPO_ced3 ced-3 cDNA flanked by SalI sites, cloned into pCR2.1_TOPO 18
pREP1_ced-3 Fission yeast vector, inducible over-expression of ced-3 (cloned SalI) 19
pREP41_ced-3 Fission yeast vector, inducible over-expression of ced-4 (cloned SalI) 20
pMFG-E8 MFG-E8 cDNA (from Nagata lab) 21
pMFG-E8_D89E MFG-E8 cDNA with point mutation (from Nagata lab) 22
pPDMM016 unc-119 rescuing construct (Fire kit) 23
pLB.lim7_MFGE8 MFG-E8 cDNA driven by lim-7 promoter (AscI/FseI) 24
pTOPO_teg1 teg-1 genomic fragment cloned into pCR2.1_TOPO (with Gateway site) 25
pDONR_teg1 teg-1 genomic fragment Gateway cloned into pDONR201 26
pID3.O1B_teg1 Ppie-1::gfp::teg-1, unc-119(+) 27
pRF4 rol-6(su1006), co-injection marker 28
pTOPO_teg1(FL) teg-1 promoter, CDS, and 3'UTR, cloned into pCR2.1_TOPO (AscI/FseI) 29
pPDMM016_teg1(FL) teg-1 promoter, CDS, and 3'UTR, cloned into pPDMM016 30
pL4440.LB RNAi feeding vector with lazyboyed sites 31
pTOPO_K10G9.3 K10G9.3 gene with lazyboy sites cloned into pCR2.1_TOPO 32
pL4440.LB_K10G9.3 RNAi feeding vector with lazyboyed full-length K10G9.3 gene (AscI/FseI) 33
pTOPO_K10G9.3(3'UTR) 3'UTR of K10G9.3 cloned into pCR2.1_TOPO (FseI) 34
pTOPO_K10G9.3(gene+3'UTR) gene and 3'UTR of K10G9.3 cloned into pCR2.1_TOPO (AscI/FseI/FseI) 35
pRH10_K10G9.3(gene) K10G9.3 gene with lazyboy sites cloned into pRH10 (AscI/NotI/FseI) 36
pRH10_K10G9.3(gene)+GFP K10G9.3 gene with lazyboy sites +GFP cloned into pRH10 (AscI/NotI/FseI) 37
pHSK10G9.3 Phsp16.41::K10G9.3 (AscI/FseI) 38
pHSGFPK10G9.3 Phsp16.41::GFP::K10G9.3 (AscI/FseI) 39
pL4440_pmk1 RNAi feeding vector agains pmk-1 40
pDK177 RNAi feeding vector agains pmk-1 (from Ausubel lab) 41
pL4440_mkk4 RNAi feeding vector agains mkk-4 (Ahringer library) 42
pL4440_pmk2 RNAi feeding vector agains pmk-2 (Ahringer library) 43
pcmu5-HA #347 pmk-3 cDNA (with mutations) from the Cobb lab 44
p348 pmk-3 cDNA (with mutations) from the Cobb lab 45
pRSET_pmk3 #349 pmk-3 cDNA (with mutations) from the Cobb lab 46
pRSET_pmk2 #350 pmk-2 cDNA from Cobb lab 47
pRSET_pmk1 #351 pmk-1 cDNA from Cobb lab 48
Guillaume Lettre's plasmids - BOX 1
pcmu5-HA #352 pmk-1 cDNA from Cobb lab 49
pRH20_K10G9.3(promoter) Promoter(K10G9.3)::2XNLS::GFP (AscI/FseI), unc-119(+) 50
pRH20_pmk(promoter) Promoter(pmk3Kb)(AscI/FseI)::2XNLS::GFP, unc-119(+) 51
pRH20_pmk(promoter-ok169) Promoter(pmk-ok169)(AscI/FseI)::2XNLS::GFP, unc-119(+) 52
pTOPO_pmk3(gene) Full-length pmk-3 gene with Gateway sites cloned into pCR2.1_TOPO 53
pDONR_pmk3(gene) Full-length pmk-3 gene cloned into pDONR201 (Gateway) 54
pID2.02_pmk3 Ppie-1::pmk-3(gene), unc-119(+) (Gateway) 55
pID3.01B_pmk3 Ppie-1::gfp::pmk-3(gene), unc-119(+) (Gateway) 56
pDONR 201 Entry Vector for Gateway cloning (Invitrogen) 57
pID2.02 Destination vector for Gateway cloning (Seydoux lab) Pie-1 promoter 58
pID3.01B Destination vector for Gateway cloning (Seydoux lab) Pie-1 promoter +GFP 59
pRH20 From Randy's collection, To clone AscI/FseI promoter in front 2XNLS::GFP 60
pBMBeft3.LB From Jason's collection, eft-3 promoter, AscI/FseI sites, unc-119(+) 61
pGL-5 GFP::ced-9(cDNA) (AscI/NotI/FseI) cloned into pRH10 62
pGL-6 GFP::ced-9(cDNA) (AscI/NotI/FseI) cloned into pBMBeft3.LB 63
pBluescript SK(-) Original vector from Stratagene 64
pTOPO_pmk3(cDNA) pmk-3 cDNA with Gateway sites cloned into pRC2.1_TOPO 65
pBS_pmk3 pmk-3 cDNA cloned into pBluescript SK(-) as a EcoRI fragment 66
pRH20_ced3(pro) 3 kb upstream of ced-3 cloned into pRH20 as a AscI/FseI fragment 67
pRH20_ced4(pro) 3 kb upstream of ced-4 cloned into pRH20 as a AscI/FseI fragment 68
pRH20_ced9(pro) 3 kb upstream of ced-9 cloned into pRH20 as a AscI/FseI fragment 69
pTOPO_pmk3(new cDNA) pmk-3 cDNA with Gateway sites cloned into pRC2.1_TOPO (NO MUTATIONS) 70
pTOPO_mef2(cDNA) pmk-3 cDNA with Gateway sites cloned into pRC2.1_TOPO 71
pTOPO_mef2(promoter) 3 kb upstream and first exon of mef-2 cloned into pCR2.1_TOPO 72
pRH20_mef2(promoter) mef-2 promoter cloned into pRH20 as a AscI/FseI fragment 73
PLASMID NAME DESCRIPTION LOCATION
BOX 2
pTOPO_mef2DN 312 first bp of mef-2 cDNA, with Gateway sites, cloned into pCR2.1_TOPO A1
pTOPO_mef2ActFo
321 first bp of mef-2 cDNA fused to 237 bp of VP16, with Gateway sites, cloned into 
pCR2.1_TOPO A2
pDONR_mef2(cDNA) mef-2 cDNA Gateway cloned into pDONR 201 A3
pDONR_mef2DN mef-2 dominant negative Gateway cloned into pDONR 201 A4
pDONR_mef2ActFo mef-2 activated form Gateway cloned into pDONR 201 A5
pID3.01B_mef2(cDNA) Ppie-1::gfp::mef2(cDNA), unc-119(+) A6
pID3.01B_mef2DN Ppie-1::gfp::mef2DN, unc-119(+) A7
pID3.01B_mef2ActFo Ppie-1::gfp::mef2ActFo, unc-119(+) A8
Guillaume Lettre's plasmids - BOX 2
